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Plasmodium falciparum var genes encode the PfEMPI family of variant 
antigens expressed on the surface of infected erythrocytes. PfEMPlmediates the 
adhesion of the parasitized erythrocyte to the venular endothelium and to uninfected 
erythrocytes. PfEMP 1 variants use a range of different host molecules as receptors in 
these adhesive interactions. The expression of different PfEMPI variants may 
directly affect the clinical course of malaria infection by defining the distribution and 
intensity of parasite adhesion in the microvasculature of various organs within the 
host. 
PfEMPI is a major focus of the host immune response, and the slow onset of 
clinical immunity in endemic areas may be explained by the gradual accumulation of 
effective responses to a wide range of PfEMPI variants present in the local parasite 
population. It has been hypothesised that the immune response to PfEMPI may act 
to stratify the parasite population into co-circulating 'strains' defined by discrete, 
non-overlapping repertoires of var genes. 
Here, the DBL1 region of 56 var gene variants from 6 genetically distinct co- 
circulating Sudanese parasites have been cloned and sequenced. Sequence 
comparisons suggest that recombination and gene duplication are important 
mechanisms in the generation of new var variants. A model of the basic structural 
framework of DBL1 sequences is described and "sequence subtypes" identified 
within variable regions of sequence. Phylogenetic analysis of the Sudanese and other 
var sequences from GenBank fail to support the 'strain' model for Sudanese P. 
falciparum and suggests that the global pool of var genes is finite. 
40 Sudanese variants have been expressed as GST-fusion proteins with yields 
of varying quantity and degree of degradation. 10 of the recombinant proteins have 
been tested against a cohort of sera in a pilot ELISA, and the role of anti-PfEMPI 




1.1 Malaria: health and economics 
Malaria is a tropical disease of profound clinical and economic importance, 
with an estimated 120 million cases and around 0.5 million fatalities annually (Snow 
et al., 1999). Around 300-500 million people are estimated to be infected with 
malaria at any point in time, with the highest mortality rates in children under five in 
sub-Saharan Africa. (WHO, 1992). The 1993 World Development Report has 
estimated that around 5% of all deaths worldwide are attributable to malaria, and 
within sub-Saharan Africa, 15% of all disability-adjusted life-years (DALY) are lost 
to malaria (World Bank, 1993). An estimated US$ 1800 million is spent each year 
on malaria either directly on prevention and treatment or indirectly due to economic 
loss through illness (Foster & Phillips, 1998). This financial burden falls mainly on 
impoverished people living in high risk areas e.g. in Thailand expenditure on malaria 
accounted for 90% of household spending on healthcare (Kaewsonthi, 1989). Thus 
despite decades of research and many advances in treatment and knowledge, malaria 
remains one of the major health problems facing humanity at the start of the 21st 
century. 
1.2 Life cycle of human malaria parasites 
Malaria is caused by protozoan parasites of the genus Plasmodium. Around 
120 species of Plasmodium have been described; all have arthropod definitive and 
vertebrate intermediate hosts. Female Anophelene mosquitoes are the definitive host 
of the four species of Plasmodium that infect humans, namely P. falciparum, P. 
vivax, P. malariae and P. ovale. Most cases of human malaria are caused by P. vivax 
and P. falciparum, with the latter being responsible for the vast majority of fatalities 
(Gilles & Warrell, 1993). 
Malaria parasites have a complex multistage life cycle (Figs. 1.1 & 1.2). 
Infection in the human host is initiated by injection of sporozoites into the peripheral 
circulation via the bite of an infected mosquito. Sporozoites enter the liver where 
they invade parenchyma cells; here parasites undergo exo-erythrocytic schizogony to 
produce thousands of merozoites by asexual division. Eventually the infected liver 
cell ruptures to release 30-40,000 merozoites into the blood stream, which rapidly 
invade erythrocytes where erythrocytic schizogony takes place. In some Plasmodium 
species, notably P. vivax, a proportion of sporozoites may lie dormant in the liver 
cells for several months before further development. Dormant forms are known as 
hypnozoites and are responsible for the relapses which occur in some patients. In the 
erythrocyte, the parasite undergoes consecutive ring, trophozoite and schizont stages 
of development. Ring and trophozoite stages obtain nutrients both by degrading the 
haemoglobin content of the red cell and by uptake of metabolites from plasma. 
P.falciparum DNA synthesis starts around 28 hours post-invasion and schizonts 
becomes visible after 36 hours, with division into 16-32 merozoites over the next 12 
hours. Around 48 hours post-invasion, the infected erythrocyte bursts to release 
another round of merozoites, which invade fresh erythrocytes initiating further 
cycles of development. 
The duration of the erythrocytic cycle varies with species, 48 hours in P. 
falciparum, P. vivax, and P. ovale and 72 hours in P. malariae. It is the asexual 
blood stage parasites that cause the symptoms of clinical malaria, and the 
characteristic fevers coincide with the rupture of the infected erythrocyte and release 
of merozoites (Kwiatkowski, 1989). In P. falciparum the late trophozoite (around 24 
hours post-invasion) and schizont stages of the parasite adhere to the vascular 
endothelium and are removed from circulation. Thus only immature asexual and 
occasional mature sexual parasites are seen in peripheral blood. 
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Fig. 1.1 P. falciparum lifecycle (after Vickerman & Cox, 1967) 
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Merozoites can develop along an alternative, sexual pathway within the red 
cell leading to the formation of gametocytes. Mature male and female gametocyte 
stages are infectious to the mosquito. Gametocytes ingested by a female Anophelene 
mosquito as part of a blood meal develop into "male" (micro-) or "female" (macro-) 
gametes. The fusion of a micro- and macrogamete in the stomach of the mosquito 
produces a zygote, and develops into a motile and invasive ookinete. The ookinete 
stage traverses the gut wall and develops into an oocyst on the outer surface of the 
midgut. The oocyst contains the haploid products of meiosis which develop over 7-9 
days into thousands of sporozoites. Eventually the oocyst bursts, releasing 
sporozoites into the abdominal cavity, from where they migrate to the salivary 
glands. Mature sporozoites in the salivary glands infect human hosts during 
mosquito feeding. 
Throughout most of their life cycle malaria parasites are haploid, the brief 
diploid stage being the post-gametic fusion zygote which occurs in the mosquito. 
The fusion of micro- and macro- gametes from different parasite haplotypes to form 
the zygote, is the only point in the life cycle where conventional meiotic 
recombination between different haploid genotypes occurs (Walliker et at., 1987; 
Babiker et at., 1994). Self fertilisation (or 'selfing') can occur when gametes of the 
same parasite fuse. 
1.3 The P. falciparum genome 
The P. falciparum genome has approximately 82% AT content and consists 
of 14 chromosomes varying in length from 600Kb-3.5Mb. Individual chromosomes 
vary in size by up to 20% between parasite isolates (Lanzer et at., 1994). Most of 
this size polymorphism is due to differences in the chromosome ends, known to 
contain large numbers of repetitive DNA sequences which have been shown to 
facilitate recombination (Corcoran et at., 1988; Pologe & Ravetch, 1988). The P. 
falciparum genome project is currently sequencing the entire genome of the 3D7A 
laboratory clone and complete sequences of both chromosomes 2 and 3 have already 
been published (Fletcher, 1998; Gardner et at., 1998; Bowman et at., 1999). A 
complete, well annotated genomic sequence and genetic map is expected in 2001. 
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1.4 Clinical malaria 
The symptoms of uncomplicated malaria infection are periodic chills and 
fevers, headache, nausea, exhaustion and muscle ache. Fever occurs every 48 hours 
in P. falciparum, P. vivax and P. ovale, and every 72 hours in P. malariae, 
coinciding with the rupture of infected erythrocytes and the release of merozoites 
and parasite derived toxins into the bloodstream (Greenwood, 1996). A variety of 
complications can occur, particularly in young children and have been defined by 
WHO guidelines, including cerebral malaria, severe anaemia, renal failure, 
respiratory distress and metabolic disorders. (Warrell et al., 2000). 
The most life threatening complication, cerebral malaria, is defined as coma 
resulting from malaria infection. In highly endemic areas, cerebral malaria is found 
mainly in children over the age of 3 (Marsh & Snow, 1997) and has a mortality rate 
of 15-33% (White el al., 1985; Warrell, 1987; Marsh et al., 1995). The outcome of 
cerebral malaria is correlated with the depth of coma (Molyneux et al., 1989). 
Recovering patients can regain consciousness rapidly and neurological sequelae are 
relatively uncommon, occurring in less than 10% of children and 1-3% of adults 
(Turner, 1997). Further, in over half such cases the sequelae are temporary (Brewster 
c/ al., 1990). The rarity of permanent sequelae may indicate that cerebral malaria is 
due to metabolic imbalances, including hypoglycaemia and short term localised 
hypoxia disrupting neuronal function, rather than large scale neuronal death (White 
& Ho, 1992). Cerebral malaria is associated with the sequestration of parasitized 
erythrocytes in the cerebral vasculature and appears to be restricted to P. Jàlciparuni 
infection, although there have been reports of cerebral malaria caused by P. vivax 
(Islam & Qamruddink, 1995). Whether cerebral malaria is actually caused by large 
scale sequestration to brain endothelium remains unclear. 
Severe anaemia mainly affects children less than 3 years old in areas of 
intense malaria transmission (Marsh & Snow, 1997). It is defined by WHO as a 
haemoglobin concentration of <5gIL (Warrell et al., 2000) and is usually, but not 
always, associated with a high parasitaemia at presentation (Gilles & Warrell, 1993). 
Complicating metabolic disorders commonly involve hypoglycaemia and 
metabolic acidosis which may contribute to the occurrence of pulmonary oedema 
and respiratory distress, or cerebral oedema with raised intracranial pressure (Warrell 
etal., 1982; Marsh et al., 1995). These syndromes are more common in children and 
are associated with poor prognosis (Newton etal., 1997). Renal failure is another 
serious but rare complication of malaria infection (Marsh etal., 1995). 
Placental malaria is a serious complication, which occurs most commonly 
during first and second pregnancies (Brabin, 1985). Women in endemic areas who 
are otherwise clinically immune to malaria are, at these times, vulnerable to the 
development of placental malaria; parasitaemias as high as 65% have been observed 
in primigravid women in these areas (Brabin, 1983; Menendez, 1995). Placental 
malaria has been associated with low birth weight and higher neonatal mortality 
rates (Menendez, 1995). The pathogenesis of this condition is associated with 
adherence of large numbers of parasitized erythrocytes to the trophoblastic villi, 
extracellular villi and syncytial bridges of the placenta (Fried & Duffy 1996). 
Specific adhesion phenotypes have been associated with parasites isolated from 
placental malaria patients (discussed in section 1.7.2). 
1.5 Epidemiology of malaria 
Malaria occurs throughout the tropics and subtropics and extends into some 
temperate areas (Fig. 1.3), although a large majority of clinical cases and fatalities 
occur in sub-Saharan Africa. Historically P. vivax has occurred throughout most of 
these regions, including parts of Southern Europe; it is rare in East Africa and not 
found in West Africa, where the indigenous people are characteristically blood group 
"Duffy negative", the Duffy antigen being the receptor used by P. vivax for 
erythrocyte invasion. P. falciparum and P. ma!ariae are found throughout the 
tropics and subtropics, although the incidence of P. ma!ariae is patchy within this 
overall distribution. P. ova!e has the most restricted range, occurring only in tropical 
Africa, New Guinea and the Philippines (MacDonald 1957; Molineaux, 1988). 
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Malarious regions have been classified as areas of stable or unstable malaria 
transmission (MacDonald, 1957). In areas of stable malaria transmission the 
incidence of infection is relatively constant year to year, although there may be 
seasonal variations in intensity. Transmission in these areas is usually high and in 
many such areas is associated with reduced numbers of clinical episodes in adults. In 
areas of unstable malaria transmission, incidence varies from year to year. In such 
areas immunity is poorly developed in all age groups and outbreaks or epidemics of 
malaria may occur. Another epidemiological scheme has defined malarious areas as 
hypo-, meso-, hyper-, or holoendemic based on the incidence of splenomegaly 
(WHO, 1963) of parasitaemia (Gilles & Warrell, 1993) in the host population. 
Hypoendemic areas are areas of low malaria transmission, with parasitaemia (or 
splenomegaly) in <10% of children between the ages of 2 and 9. Mesoendemic areas 
have a corresponding rate of 11-50%. In hyperendemic areas malaria transmission is 
intense but usually seasonal; there is >50% parasitaernia in 2-9 year olds and >25 % 
splenomegally in adults. Malaria transmission in holoendemic areas is high 
throughout the year, with >75% splenomegaly in 2-9 year olds, yet rare amongst 
adults who generally have a high degree of clinical immunity. In all epidemiological 
settings children are most at risk of developing severe or fatal disease. Widespread 
use of antimalarial therapy has led to disappearance of splenomegaly in many 
endemic areas which has thus been rendered largely obsolete as a defining character 
of endemicity. There is some epidemiological evidence suggesting that severe 
malaria in Kenya may have a clustered distribution in space and time (Snow el al., 
1993). These authors suggest that particular parasites might carry genes for increased 
virulence. However, other studies have not found clustered distribution of severe 
malaria cases and thus the hypothesis that" virulent strains" are the cause of severe 
malaria does not fit well with the epidemiological data. Northern and eastern Sudan, 
the study area for this thesis, is an area of mesoendemic, highly seasonal and 
unstable malaria transmission. P. falciarum is responsible for almost all cases 
(Arnot, 1998; Babiker, 1998; Theander, 1998). 
1.6 Immunity to P. falciparum 
Protective immunity to P. falciparum develops following years of exposure 
in endemic areas and repeated malarial episodes. Immunity is not sterile, with 
microscopically patent parasitaemia being observed in clinically healthy and thus 
presumably immune individuals. The mechanisms effecting immunity remain 
controversial. The slow onset of protective immunity has been a major area of 
interest in malaria research; the traditional explanation has been that clinical 
immunity develops only after repeated infection. This is the "cumulative exposure" 
hypothesis, first expounded by Koch in 1900 based on his observations in Java. 
Protective immunity may develop through acquisition of effective responses to a 
range of alternative antigenic types found in the parasite population (Howard., 1987; 
Hommel & Semoff, 1988). Exposure to many forms of variant antigens such as 
PfEMP 1, which encodes a major target of the agglutination response, may be of 
particular importance (Baruch et al., 1995; Giha et al, 1999 a &b; Bull ci al., 1999 
& 2000). 
The pattern of immunity to falciparum malaria in a population is determined 
by transmission intensity. In areas of stable and high transmission, clinical malaria is 
mostly confined to young children (McGregor, 1986; Marsh et al., 1989). Neonates 
up to the age of 6-8 months appear to be protected by maternal antibodies and the 
parasite's inability to metabolise foetal haemoglobin (Pasvol ci al., 1977; Pasvol & 
Wilson, 1982). Older children (>2) and adults resident in areas of hyper- and holo-
endemic transmission often carry microscopically patent parasitaemia without 
symptoms; this immunity, described as clinical or protective immunity as opposed to 
sterile immunity, can be lost following a period of absence from endemic areas 
(Playfair, 1982). 
In areas of lower endemicity such as eastern and northern Sudan, all age 
groups remain susceptible to malaria attack and continuous clinical immunity does 
not appear to exist (MacDonald, 1957; McGregor, 1986). However, asymptomatic 
infections are common in eastern Sudan, indicating that the presence of parasites 
10 
does not automatically lead to clinical disease in these semi-immune hosts (Elhassan 
et al., 1995; Roper et al., 1996). A 1998 study tested serum from sixtyfour residents 
of one village in this area for ability to agglutinate five genetically different parasites 
isolated from the same village (Giha et al., 1998). Only half of the samples taken 
before the annual transmission season were able to recognise (i.e. agglutinate by 
immunoglobulin cross-linking between two or more red blood cells) one or more 
parasites. In contrast all samples taken after the transmission season could 
agglutinate at least one parasite, and 74% recognised more than one. This increase in 
an individual's agglutinating antibodies occurred independently of clinical malaria. 
It therefore appears that both clinical and asymptomatic infection can result in 
extension of the host's agglutinating antibody repertoire (Giha et al., 1999a &b). 
1.61 Species, isolate and variant specific immunity 
Acquired immunity to malaria is both species and isolate specific. This was 
first observed under controlled conditions of induced therapeutic malaria used to 
treat neurosyphilis in the pre-antibiotic era of the 
20th  century. A range of 
Plasmodium species was used in these treatments, with individual patients often 
receiving multiple inoculations. These patients developed a degree of immunity to 
re-infection with the same Plasmodium species, but no cross-species protection was 
observed. The same treatment regimes revealed an additional "strain-" (i.e. isolate-) 
specific component to immunity, with patients developing a higher level of 
protection against re-infection with homologous than heterologous isolates of the 
same species (Covel & Nicol, 1951; Jeffrey, 1966; Powell et al., 1972). Species- and 
isolate-specific protection have also been demonstrated in primate malaria models 
(Brown & Brown 1965; Brown et al., 1970 a & b; Voller & Rossan, 1969a-d). There 
is also evidence for a variant specific component to immunity which is discussed in 
section 1.8. 
A number of serological studies have revealed extensive antigenic diversity 
in P. falciparum populations (Marsh & Howard, 1986; Newbold et al., 1992; Iqbal et 
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al., 1993). The development of clinical immunity may be a function of acquiring a 
comprehensive range of specific responses against locally circulating versions of 
polymorphic and variant antigens (Howard et al., 1987; Hommel & Semoff, 1988). 
This is supported by the observation that new clinical episodes are caused by 
parasites which are not agglutinated by pre-infection sera (Bull et al., 1999; Giha ci 
al., 2000). The chronic low level parasitaemia of clinically immune adults in 
endemic areas may be explained by immune evasion through antigenic variation 
(Hommel & Semoff, 1988). 
A competing hypothesis is that clinical immunity is due to "strain 
transcending", cross reactive immune responses that develop over prolonged 
exposure. Such responses may be directed against conserved, but poorly 
immunogenic, epitopes on either variant or non-variant antigens (Day & Marsh, 
1991). One model has proposed that when the circulating parasite population 
contains a high number of variants, cross protective immune responses directed 
against conserved epitopes become the most important factors controlling parasites, 
even when the immune responses against such epitopes are less dominant than those 
directed against variant specific epitopes (Antia et al., 1996). Clinical immunity 
mediated by non-variant specific immune responses may explain the persistent low 
level parasitaemia observed in clinically immune individuals. Cytophilic IgG 
antibodies against merozoite antigens can cross link merozoites to monocytes, 
stimulating the release of cytokines which arrest parasite intra-erythrocytic 
development in an antigen non-specific manner. This antibody dependent cellular 
inhibition (ADCI) requires the presence of a critical concentration of merozoites to 
be effective. Thus parasitaemia can never be entirely eliminated by this mechanism 
(Druilhe & Perignon, 1997). In this model, variant specific responses may be 
important in the years or decades prior to the onset of clinical immunity, whilst non-
variant specific responses mediate the immunity observed in adults living in endemic 
areas. 
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1.6.2 Host age and the development of immunity 
There is good evidence that protective immunity requires prolonged exposure 
to malaria, and this explains the age distribution of infection in endemic areas. 
However, there is also evidence indicating an intrinsic age-related capacity for the 
development of immunity. Specifically, previously naive adults may develop 
protective immunity over a shorter period of exposure than naive children. This age-
dependent effect on the development of protective immunity has been noted in 
studies of a naive Javanese population emigrating en masse to an area of high P. 
falciparum transmission in Irian Jaya, Indonesia (Baird et al., 1991 & 1993; Baird, 
1995 & 1998). Early after arrival, all age groups were equally susceptible to clinical 
malaria attacks, however after two years adults suffered fewer and milder clinical 
episodes than children. Therefore natural clinical immunity may develop after 
relatively few infections, the number required being determined by age. This pattern 
is similar to that observed in therapeutically infected neurosyphilis patients. These 
adult, malaria naïve, patients became clinically completely immune to malaria after 
relatively few (10-15) challenges (Ciuca ci al., 1934; Jeffery, 1966), although the 
parasites used in these clinical treatments are thought to be much more homogenous 
than those occurring in natural populations such as in Irian Jaya. Based on these field 
studies, it has been proposed that natural age-related changes in the immune system 
including decreased ratio of naive to memory T cells switching from Th 1-like to 
predominantly Th2-like responses and increased proportion of cytophilic IgG 
subclasses (IgGi and IgG3) all encourage a rapid acquisition of clinical immunity in 
adults compared to children (Baird et al., 1998). However it is worth bearing in mind 
that better access to antimalarials by adults may have influenced the results of the 
Irian Jaya studies. Increasing dominance of cytophilic IgG subclasses of antibody 
against malaria antigens has been reported to be associated with host age and 
improved immune response by a number of workers (Bouharon-Tayoun and Druilhe, 
1992; Egan et al., 1995; Taylor et al., 1998). However, no such association was 
found between age and IgG subclass in response to P. falciparum malaria in 
residents of the Brazilian Amazon, an area of relatively low transmission intensity 
(Ferriera et al., 1996). 
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1.6.3 Host genetic differences and immunity 
Host genetic differences may also play an important role in determining the 
immune response to malaria infection. A 1998 study found differences in the levels 
and prevalence of antibodies to Pfl 55/RESA (ring-infected erythrocyte surface 
antigen) between three sympatric ethnic groups in an area of holoendemic malaria in 
Burkina Faso (Modiano et al., 1998). There is an increased incidence of certain 
single gene haemoglobinopathies, notably sickle cell anaemia and thalassaemia, in 
areas of high malaria transmission. Over fifty years ago it was proposed that the 
observed gene frequencies could be explained by an innate resistance to malaria in 
individuals heterozygous for these disorders (Haldane, 1948; Allison, 1954; Flint el 
al., 1986). Sickle cell anaemia is caused by a single amino acid substitution in the a-
chain of haemoglobin. Individuals homozygous for the sickle cell allele are at high 
risk of premature death. However, both they and heterozygous carriers exhibit some 
protection against clinical malaria, thus selecting for the sickle cell allele. The 
mechanism of protection is unclear, but may involve impaired erythrocyte invasion, 
inhibited intra-erythrocytic development of the parasite, or increased phagocytosis of 
the infected red cell (Pasvol & Weatherall, 1978; Friedman, 1978; Friedman, 1979). 
The protective effect observed in thalassaemic patients may be associated with the 
late retention of foetal haemoglobin (HbF). 
1.6.4 Immune effector mechanisms 
Both cellular and humoral arms of the immune system are important in 
protection against malaria in mice and humans. Protective effects of the humoral 
response have been long recognised from experiments involving passive transfer of 
antibody in hyperimmune plasma (Cohen et aL, 1961; Edozien et al., 1962; 
McGregor et al., 1963). Further, monoclonal antibodies can inhibit P. falciparum 
growth in culture (Perrin et al., 1981; Pirson & Perkins, 1985; McBride & Heidrich, 
1987). In addition to direct antiparasite action, antibodies may protect the host from 
disease symptoms by blocking the action of the malaria toxin released on erythrocyte 
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rupture (Schofield et at., 1993). Cytophilic IgG antibody subclasses (IgGi and IgG3) 
can enhance parasite killing by monocytes, macrophages and neutrophils (Khusmith 
& Druilhe, 1983; Bouharoun-Tayon et at., 1990 & 1995), and are associated with 
control of parasitaemia to low level (Aribot et at., 1996; Ferreira et at., 1996). 
Merozoite and sporozoite bloodstream stages have been specifically demonstrated to 
be susceptible to antibody mediated immune defences (Potocnjak et at., 1980; 
Hollindale ci' al., 1984; Oeuvray et at., 1994; Holder & Riley, 1996). 
Agglutination responses against erythrocytic stages were the only 
immunological measure correlated with protection in an extensive survey in the 
Gambia (Marsh et at., 1989). Many studies have found agglutinating antibodies to be 
acquired over the course of infection (Forsyth et at., 1989; Iqbal et at., 1993; Reeder 
el at., 1994; Riggione et at. , 1996; Flyg et at., 1997; Bull et at., 1998 & 1999; Giha 
etal., 1998, 1999b & 2000). These antibodies may interfere with the sequestration of 
P. fatciparum infected erythrocytes and result in their lysis by macrophages in the 
spleen (David el at., 1983; Udeinya etal., 1983). Sera from asymptomatically 
infected individuals generally agglutinate a wider range of contemporaneous parasite 
isolates than do sera from clinical malaria patients (Marsh & Howard, 1986; Marsh 
et at., 1989; Forsyth et at., 1989), suggesting that symptoms are more likely to be 
controlled in individuals having a more extensive range of agglutinating antibody 
responses. Agglutinating antibodies are thought to be primarily targeted against the 
variant antigen, Ptasmodiumfalciparum erythrocyte membrane protein 1 (PfEMPI) 
(Baruch ci' at., 1995; Staalsoe etal., 1999), and it has been found that variant 
antigens expressed during new parasite infections correspond to gaps in the pre-
infection agglutinating antibody repertoire of patients (Bull et al., 1999; Giha ci' at., 
2000). This suggests that only parasites expressing variant antigens not recognised 
by pre-existing agglutinating antibodies can cause new clinical infections in these 
partially immune hosts. 
T-cell responses against malaria parasites are also important, demonstrated 
by successful immunisation of B-cell deficient mice against P. chabaudi infection 
induced by injection of blood stage parasites (Grun & Weidanz, 1981). In humans, 
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an association between proliferative responses of peripheral blood mononuclear cells 
to merozoite antigens and protection against malaria has been found in patients from 
the Gambia (Riley et al., 1992) and Gabon (Migot-Nabias et al., 1999) though not in 
Ghana (Dodoo et al., 1999). During acute malaria infection, peripheral blood is 
depleted of T-cells to an extent correlated with severity of symptoms. This depletion 
is rapidly reversible by drug treatment (Theander etal., 1990; Hviid etal., 1997). 
Cytokines secreted by T-cells may protect the host both by direct anti-parasite action 
and influence on the overall host response to infection. Stimulation of peripheral 
blood mononuclear cells with malaria antigens in vitro induces secretion of 
interferon gamma (IFN-y) and Interleukin 2 (11-2) (Troye-Blomberg et al., 1985; 
Riley et al., 1988), both of which are potent activators of macrophages and 
monocytes implicated in parasite killing (Ockenhouse et al., 1984; Theander el al., 
1986). Tumour necrosis factor (TNF-(x) can stimulate endothelial cells to produce 
nitrous oxide (NO) (Clark etal., 1991). Both TNF-ct and NO are toxic to cultured 
malaria parasites (Karunaweera etal., 1992; Clark & Rockett, 1996), and levels of 
TNF-a have been associated with disease severity in a number of studies (Grau et 
al., 1989; Kwiatkowski, 1990). Fever has also been proposed to be an innate immune 
response to malaria infection, with a role in controlling the levels of parasitaemia 
(Kwiatkowski, 1989 & 1995). 
1.6.5 Non-protective immune responses 
Not all immune responses to P. falciparum may be beneficial to the host. 
Some naturally occurring anti-MSP 1 antibodies interfere with invasion blocking 
antibodies to other epitopes on the same protein (Patino et al., 1997). Also IgE levels 
to malaria antigens have been positively correlated with disease severity and 
hypothesised to contribute to pathology through induction of excess TNF-c 
(Penman et al., 1994 & 1997). Cytokines produced in response to malaria infection 
such as YNF-ct may be ambivalent in their effects with some beneficial outcomes 
balanced against detrimental effects (Kwiatkowski, 1995) discussed in 1 .7.1. 
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It has been hypothesised that most naive adults have T-cells which recognise 
certain malaria antigens, notably the circumsporozoite protein (CSP), which may 
secrete IFN-i in response to stimulation. These cross-reacting T-cells while helping 
to control parasitaemia in the early stages of infection, may also be responsible for 
disease symptoms (Good et at., 1993). They may also impair the development of 
Th2 responses necessary for production of effective antibodies, and clinical 
immunity may involve the development of tolerance within these T-cells. 
A number of malaria antigens contain repetitive sequence elements. These 
include merozoite surface proteins 1 and 2 (MSP1 and MSP2) (Holder, 1988; Fenton 
etal., 1991), the circumsporozoite protein (CSP) (Enea etal. 1984; Dame etal., 
1984) and the glutamate rich protein (GLURP) (Borre et al., 1991). These repetitive 
sequences provoke a strong, but apparently non-protective immune response in the 
host, and may act as an immune evasion strategy by diverting the hosts immune 
response away from other target antigens (Anders, 1986; Schofield, 1990). 
1.7 Pathogenesis of P. falciparum infections 
In addition to direct lysis of erythrocytes, there are two major factors in the 
pathology of P. falciparum infection. (1) Release of inflammatory cytokines, 
particularly TNF-c, stimulated by toxins and parasite antigens, is thought to induce 
most of the clinical symptoms of uncomplicated malaria (Kwiatkowski, 1990; Miller 
et al., 1994; Hommel, 1997). (2) Sequestration of parasites in the microvasculature 
of a variety of organs such as the lungs, heart, liver and kidneys potentially 
occluding blood flow and leading to localised hypoxia and metabolic imbalance 
(Aikawa et al., 1990; Pongponratn et al., 1991). Cytokine release and sequestration 
are not entirely separate processes and probably interact to produce the symptoms of 
severe malaria. An increase in inflammatory cytokines can activate endothelial cells 
resulting in upregulation of receptor molecules for parasite adhesins and increasing 
local levels of sequestration (Rothlein et at., 1988; Pober., 1988; Berendt et at., 
1989). Similar feedback mechanisms operate such that, high levels of localised 
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sequestration may cause activation of endothelial cells and increased local levels of 
inflammatory cytokines. 
1.7.1 Role of cytokines in P. falciparum pathology 
The clinical symptoms of malaria infection have been likened to those 
induced by the lipopolysaccharide of bacterial infections resulting in toxic shock 
(Clark, 1978). TNF-o produced in response to schizont rupture can be inhibited by 
monoclonal antibodies to glycophosphatidylinositol (GPI)in vitro indicating a role 
for parasite GPI in the induction of cytokine mediated symptoms (Schofield et al., 
1993). Inflammatory cytokines may also be a factor in severe anaemia through 
increased lysis of erythrocytes (Clark & Chaudhri, 1988) and suppression of 
erythropoesis (Young & Alter, 1994; Kurtzhals etal., 1997). Raised levels of TNF-a 
can drive metabolism towards acidosis and have been associated with 
hypoglycaemia in P. falciparum infections (Grau et al., 1989; Kettelhut et al., 1987; 
Shaffer etal., 1991). 
TNF-a also stimulates nitrous oxide (NO) production which may disrupt 
neuronal function (Clark etal., 1991 & 1992). Studies in Gabon (Kremsner etal., 
1996), Papua New Guinea (Al-Yaman etal., 1996), and Zambia (Weiss etal., 1998) 
have found that high levels of reactive nitrogen intermediates (a surrogate marker for 
NO) are associated with disease severity, and are particularly elevated in coma 
patients. Other studies however, have found conflicting results, in Cameroon (Cot 
et al., 1994) and Tanzania (Anstey et al., 1996) where high NO levels were 
associated with asymptomatic infections and lower levels in cerebral cases. Further, 
two clinical studies using anti- TNF-ct therapy had no effect on mortality rate, 
although both fever and the risk of neurological sequelae were lowered 
(Kwiatkowski etal., 1993; van Hensbroek etal., 1996). Thus the roles of TNF-(X 
other cytokines and NO in severe malaria remains unclear, but it is likely that their 
beneficial role in mediating and controlling immune responses to malaria 
(Karunaweera et al., 1992) is offset by their additions to the symptoms burden. 
1.7.2 Role of sequestration in P. falciparum pathology 
Sequestration was first described by two Italian malariologists in 1889 
(Bignarni & Bastianeli, 1889) and shown to be a result of parasitized erythrocyte 
adhesion to vascular endothelium in 1969 (Miller, 1969). This process allows mature 
parasites to be removed from the peripheral circulation and avoid lysis by 
macrophages in the spleen (David et al., 1983; Cranston et al., 1984; Looareesuwan 
et al., 1987). Post mortem analysis of fatal P. falciparum cases featuring altered 
consciousness has revealed parasite sequestration in liver, spleen, brain, heart, lungs 
and gastrointestinal tract and concluded that the neurological symptoms were a result 
of partial cerebral hypoxia (Spitz, 1946). Later studies have shown an increased level 
of cerebral sequestration in cases of cerebral malaria compared to other patients 
(MacPherson et al., 1985; Pongponratn etal., 1991). The main pathogenic effect of 
sequestration is thought to be simple retardation and blocking of blood flow 
(Berendt et al., 1994). This may inhibit oxygen and glucose supply and result in 
localised hypoxia, hypoglycaemia and acidosis. However, it has been shown that 
adhesion of parasitized erythrocytes to dendritic cells, which normally play a role in 
antigen presentation, can affect the maturation of these cells and their subsequent 
ability to stimulate I cells (Urban et al., 1999). Adhesion phenotypes may therefore 
play a role in pathology beyond direct occlusion of blood vessels, prompting hopes 
that anti-adhesive therapies may be developed for the treatment of severe malaria 
(Land etal., 1995). 
A range of host molecules act as receptors for this adhesion which is 
mediated by parasite encoded molecules and parasite altered host molecules found 
on the surface of the infected erythrocytes (Sherman et al., 1995; Ho & White, 
1999). Adhesion phenotype varies between isolates and is largely determined by the 
multicopy var gene family which encodes the PfEMP 1 family of variant antigens 
(Su etal., 1995; Smith etal., 1995; Baruch etal., 1996). var genes are differentially 
expressed (Chen etal., 1998; Scherfet al., 1998) and switches in var gene 
expression can potentially alter the pattern of parasite adhesion in different tissues 
and directly affect the clinical presentation of malaria in a given host (Newbold et 
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al., 1997). Specifically it has been hypothesised that binding to Intercellular 
Adhesion Molecule 1 (ICAM-1) may be important in the pathology of cerebral 
malaria raising hopes that anti-ICAM- 1 binding therapies may be used in treatment 
(Turner et al., 1994). 
ICAM-1 is expressed on the microvascular endothelium and is particularly 
abundant in the cerebral vessels (Hogg etal., 1991). Expression of ICAM-1 is 
upregulated by TNFa which is itself known to be upregulated in malaria infections 
(Hogg etal., 1991). Further, there is a direct correlation between TNFc levels and 
fatality in cerebral malaria (Kwiatkowski, 1990). A tentative association has been 
detected between cerebral malaria and the ICAM- 1 binding phenotype in parasites 
from Kenyan patients (Newbold et al., 1997 & 1999). Most studies however, have 
failed to show any association between cytoadherent phenotype in vitro and cerebral 
malaria (Marsh etal., 1998; Ho et al., 1991; Ringwald etal., 1993; Rogerson etal., 
1999; Cooke etal., 1993; Ockenhouse etal., 1991a; Chaiyaroj etal., 1996). Also, a 
case control study of Gambian children found no association between circulating 
levels of ICAM-1 and cerebral malaria (McGuire etal., 1996). Thus the link 
between ICAM- I binding and cerebral malaria appears tenuous. Further, soluble 
ICAM-1 has failed to block the binding of parasitized erythrocytes to immobilised 
ICAM-1, making the simple use of anti-ICAM-1 binding therapy an unrealistic 
treatment of cerebral malaria (Craig et al., 1997) 
Placental malaria has been associated with binding to chondroitin sulphate A 
(CSA) (Fried & Duffy, 1996; Rogerson & Brown, 1997) and more recently with 
hyaluronic acid (Beeson, et al., 2000). CSA and hyaluronic acid are widely 
distributed in various tissues and are abundant in the placenta. PfEMP 1 has been 
identified as mediating CSA binding (Reeder et al., 1999). Interestingly, sera from 
multigravid women in highly endemic areas can block the adhesion of parasitized 
erythrocytes from distant geographical regions to CSA (Fried et al., 1998). A further 
study has identified several field isolates from Ghana and Sudan which could be 
agglutinated by sera taken from Sudanese and Ghanaian adult females, but not by 
sera taken from males living in either area (Ricke et al., 2000). 
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Taken together, these data suggest that there are a limited number of CSA 
binding PfEMP1 variants conserved across wide geographical areas, and that these 
variants are not commonly expressed in non-pregnant individuals. A study of the 
adhesion of P. falciparum infected erythrocytes in ex vivo experiments using 
placentas taken from Cameroonian women found placental parasites were 
desequestered in large numbers by soluble CSA. Desequestered parasites were able 
to adhere to Saimiri brain endothelial cells (SBEC) although this binding was only 
partly ablated by soluble CSA and unaffected by anti-ICAM-1 or anti-CD36 
antibodies, indicating that these parasitized erythrocytes may utilise a further, as yet 
unidentified receptor in SBEC. All women in the study had anti-CSA adhesion 
antibodies of the IgG3 type whether they were primi- or multigravid (Gysin el at., 
1999). One study has also associated ICAM-1 binding with placental parasites, but 
this finding has not been reproduced elsewhere (Maubert el at., 1997). 
With the exception of placental malaria, it has proven difficult to uncover 
associations between clinical presentation and isolate adhesion phenotype. Studies in 
the Gambia (Marsh et at., 1998), Thailand (Ho et at., 1991; Ockenhouse et at., 
1991a; Undomsangpetch et at., 1996), Malawi (Goldring et at., 1992; Rogerson el 
at., 1999), Madagascar (Ringwald ci at., 1993) and Kenya (Newbold et at., 1997) 
have failed to find any correlation between adhesion phenotype and disease severity. 
In all studies, the majority of isolates bind to CD36, and binding to this ligand has 
been associated with severe, non-cerebral malaria infection in some studies (Ho ci 
at., 1991; Ockenhouse et at., 1991a; Newbold et at., 1997). This is an unexpected 
result, given the ubiquity of this binding phenotype and interpretation is difficult. 
Recently, a parasite expressing a panadhesive PfEMP 1 variant has been 
experimentally selected. This variant mediates binding to CD36, immunoglobulin, 
endothelial cells and blood group A antigen, as well as rosetting. It has been 
speculated that such panadhesive phenotypes may be important in the pathology of 
severe malaria (Fernandez et at., 1998). However, at this time there is no simple or 
direct association between adhesive phenotype of the parasite and most clinical 
presentations of severe malaria that holds true for all parasite populations. 
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1.7.3 Rosetting and severe malaria 
Rosetting is the adherence of uninfected erythrocytes to infected erythrocytes 
in vitro, (David et al., 1988) and has been shown to be mediated by PfEMP1 (Rowe 
et al., 1997; Chen ci al., 1998) although there may be other parasite encoded 
molecules involved (Helmby et al., 1993). Complement receptor 1 (Rowe et al., 
1997), glycosaminoglycans (Carlson ci al., 1992; Barragan ci al., 1999) and 1gM 
antibodies (dough et al., 1998) have all been implicated as host molecules involved 
in rosette formation, and it is probable that rosetting results from several different 
mechanisms. Rosetting has yet to be demonstrated in vivo and may be a laboratory 
artefact or marker for some other adherence-linked phenomenon in the host. 
Rosetting has however been shown in artificially perfused rat mesocecum (Kaul ci 
al., 1991) and rosettes have been shown to be viable under shear stress levels that 
mimic vascular conditions (Chu ci al., 1997). 
The association of rosetting phenotype with severe disease is an area of 
controversy. A number of studies have found such associations, particularly with 
severe anaemia (Carlson etal., 1990; Ringwald ci al., 1993; Rowe etal., 1995; 
Wahlgren etal., 1990; Treutiger etal., 1992; Newbold etal., 1997); but it has not 
been upheld in Malawi (Rogerson etal., 1999), Thailand (Ho etal., 1991), or Papua 
New Guinea (Al-Yaman ci al., 1995). Further, rosetting has been demonstrated in P. 
vivax (Udomsangpetch et al., 1995), P. ova!e (Angus el al., 1996) and P. ma!ariae 
(Lowe et al., 1998) although these lack PfEMP- 1, do not cytoadhere to endothelium 
and are not associated with the severe malaria syndromes of P. falciparum. Thus the 
clinical and pathological significance of the rosetting phenotype remains unclear. 
1.8 Antigenic variation in malaria 
Evidence for antigenic variation in malaria parasites has been accumulating 
since the 1960s. Each successive peak in the parasitaemia of monkeys 
experimentally infected with P. know!esi correlated with a new antigenic phenotype 
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of the parasite. Further, agglutinating antibodies present in the plasma of the infected 
monkeys could recognise parasites from previous peaks of parasitaemia, but not 
from the contemporaneous or later peaks (Brown & Brown, 1965). This alteration in 
antigenicity of parasites over time was demonstrated in P. falciparum infections in 
Saimiri monkeys (Hommel etal., 1983). Similarly, Aotus monkeys experimentally 
infected with P. falciparum yielded variant specific antisera which could 
immunoprecipitate a protein with the biochemical characteristics of PfEMP 1 from 
the homologous but not heterologous parasites (Howard et al., 1988). One criticism 
of these experiments has been that they did not use cloned parasites, and therefore 
could not rule out the possibility that changes in antigenicity observed were due to a 
succession of different parasites growing up within a mixed population. 
Work done using the P. chabaudi mouse malaria model first demonstrated 
changes in antigenicity over time of a cloned malaria line. Parasite clones were made 
by limiting dilution, and used to infect mice; immune serum from these mice was 
used to passively immunize other mice prior to inoculation with the same parasite 
clones. The level of protection conveyed by the passive immunization was higher 
against the parental clone than against parasites taken from a subsequent 
recrudescence, and thus proved the existence of clonal antigenic variation in P. 
chabaudi. (MacLean el al., 1982). 
It has been shown that spontaneous and selected changes in antigenicity of 
cultured P. falciparum are associated with altered adhesive properties (Biggs et al., 
1992). The ITO derived A4 parasite cloned line was grown for 30 cycles and 21 
subclones made from the resulting culture. Of these subclones, 10/21 had antigenic 
and adhesive properties different from the A4 parental clone. From this was 
estimated a switching rate of around 2.4% of parasites per generation (Roberts ci aL, 
1992). Demonstration of alterations in antigenicity within cloned parasite lines, 
answered the criticism that antigenic variation in P. falciparum was in reality only 
'variant succession" in uncloned populations (Biggs etal., 1991; and Roberts et al., 
1992). 
1.8.1 The discovery of var genes 
In 1995 two groups working independently, cloned genes that encoded 
members of the PfEMP1 family of variant antigens. One group had been "walking", 
by DNA sequencing, along chromosome 7 of the P. falciparum clone Dd2, in an 
attempt to identify the chloroquine resistance locus. Essentially by accident, they 
discovered three related genes encoding sequences with homology to the erythrocyte 
binding antigen (EBA 175) and the P. vivax duffy-binding antigen (DBA). These 
genes lay in a head to tail arrangement with two related pseudogenes. This family of 
PfEMPI encoding genes was given the name var. A Dd2 expressed var gene was 
also identified and located to chromosome 12, which did not hybridise to any other 
Dd2 chromosome, nor to any chromosomes from the HB3, 3D7 or A4 parasite lines, 
indicating the existence of diversity in the var repertoires of different parasites (Su el 
al. 1995). 
About the same time a second group identified 2 var genes of similar 
sequence from the Malayan Camp (MC) parasite line by screening an expression 
library using rabbit anti-PfEMP1 antisera. It was found that antibodies made against 
recombinant PfEMP1 encoded by these MC var genes recognised erythrocytes 
infected with MC parasites, but did not recognise erythrocytes infected with the 
ITG2-ICAM, ItG2-G1, or FCR3-05 parasite lines. These same antibodies blocked 
the adhesion of MC-infected erythrocytes to CD3 6 but not to thrombospondin 
(Baruch el al. 1995). 
A study of the well characterised A4/ITO clonal tree of parasites found a 
strong correlation between antigenic and adhesive phenotype and the expression of 
particular var genes. The cloned A4 parasite line is capable of binding to ICAM- 1. 
Three subcloned parasite lines (C7, C9 and C 17) derived from A4 which retained 
the ICAM- 1 binding phenotype, were found to cross react with each other and with 
the parental A4 line in co-agglutination assays. Further these subclones also 
expressed the same A4var gene as the parental line. In contrast, four subcloned 
parasites that do not bind to ICAM-1 (C4, Cl 8, C24 and C28) failed to co- 
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agglutinate with the parental A4 parasites or with each other, and expressed a 
subclone specific var gene. The C28 subclone was reselected for ICAM-1 binding 
and once more subcloned to generate a new clone, termed C281. These ICAM-1 
binding C281 parasites co-agglutinated with A4 parasites and expressed the parental 
A4var gene. These experiments provided strong evidence for the role played by var 
genes in determining the antigenic and adhesive phenotype of parasitized 
erythrocytes (Smith etal. 1995). 
var genes were the first gene family to be identified as antigenically variant 
in P. falciparum. In recent years however, there have been indications that other 
gene families, notably the related stevor and rf, may also encode variant antigens 
(Cheng etal., 1998; Kyes et at., 1999). These genes families lie in the subtelomeric 
complexes close to var genes and encode proteins with a predicted structure 
consistent with that of variant antigens. Another gene family (Pf60) has a high 
homology to var exon II (Mercereau-Puijalon, 1994; Bischoff et al., 2000) and may 
be the source of an abundant var like mRNA transcript described in the literature (Su 
et at., 1995). Recently, differential screening of expression libraries with immune 
sera to two isogenic parasite lines with differing adhesion properties has provided 
evidence for the existence of non-PfEMP 1 variant antigens (Le Scanf et al., 1999). 
1.8.2 Structure of var/PfEMPI and location within the P. 
falciparum genome 
PfEMP 1 was first identified in 1984 as an 125  Iodine labelled strain specific 
antigen on the surface of parasitized erythrocytes that could be removed from the 
membrane by mild trypsin treatment or SDS, but not by neutral detergents such as 
Triton X- 100 (Leech et at., 1984; Aley et at., 1984). var genes are approximately 8-
12 kb in length and consist of two exons separated by an intron of 0.9-1.1 kb. 
PfEMP1 proteins are 200-35OKda long and consist of a large and highly variable 
extracellular region, a single transmembrane domain and a conserved acidic C-
terminal region which acts as an anchor inside the erythrocyte membrane (Su et at., 
25 
1995). The extracellular region and transmembrane domains are encoded by exoni, 
whilst the C-terminal domain is encoded by exon 2 (Fig. 1.4). 
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Fig. 1.4 Model of var/PfEMP1 structure. DBL= Duffy binding-like 
domain. CIDR= cysteine-rich interdomain region. CTR= C-terminal region. 
The variable extracellular region is characterised by a number of relatively 
conserved cysteine rich domains. These include 2-5 Duffy Binding-Like (DBL) 
domains named after their homology to the binding region of the Duffy Binding 
Antigens (DBA) of?. vivax and P. knowlesi and the EBA-175 erythrocyte binding 
protein of?. falciparum (Adams et al., 1992; Chitnis & Miller, 1994; Sim et al., 
1994). It has been proposed that PfEMP1, DBA, and EBA-175 form a superfamily 
of related proteins involved in adhesive interactions (Su et aL, 1995). The CIDRs 
(cysteine rich inter-domain regions) are another set of cysteine rich semiconserved 
domains. Most var genes have a single CIDR immediately 3-prime to the first DBL 
domain, however, a var gene containing two CIDRs and five DBLs has been 
described (Smith et al., 1998). This thesis describes and performs analysis of 
sequence diversity within the relatively conserved DBL 1 region of PfEMP I. 
There are around 50 var loci in the P. falciparum genome, accounting for 
2% of total parasite DNA (Thompson et al., 1997). These are spread throughout all 
14 chromosomes (Rubio et al., 1996; Fisher et aL, 1997). The general pattern of var 
gene distribution within the parasite genome is conserved between different isolates. 
Most var loci lie in subtelomeric regions of P. falciparum chromosomes, but clusters 
of var genes are found in internal positions of chromosomes 4, 7 and 12 of 3D7 and 
Dd2 and individual var genes lie in internal locations on chromosome 2 and 8 
(Bourke et al., 1996). Chromosomes 4, 7 and 12 react most strongly with 
hybridisation probes based on the conserved C-terminal region, indicating that these 
chromosomes contain the majority of var loci (Rubio et al., 1996). The central var 
loci appear conserved between different parasites from geographically distant areas 
(Fisher etal., 1997; Hernandez-Rivas etal., 1997). 
I 8.3 Expression of var genes 
var gene expression appears to be exclusive, with only one PfEMP 1 variant 
expressed on the surface of the parasitized erythrocyte (Chen et al., 1998; Scherf el 
at., 1998). In asexual parasites, transcription of var genes is restricted to the ring 
stage of development with PIEMP 1 first detectable by immunofluorescence in late 
ring stages (Fisher etal, 1997; Crabb et al., 1997). PfEMP1 however, is not 
detected on the infected erythrocyte surface until the trophozoite and schizont stages 
of the parasite. Expressed PfEMP1 locates to electron dense "knobs" on the surface 
membrane of the infected cell (Baruch etal., 1995; Aikawa et al., 1996). 
var gene expression occurs from both subtelomeric (Hernandez-Rivas et at., 
1997; Rubio etal., 1996) and central loci (Su etal., 1995). Four out of five var 
genes expressed in Dd2 were located in the subtelomeric complexes (Fisher et al., 
1997), which were previously thought to be transcriptionally silent (Lanzer et al., 
1993; de Bruin etal., 1994). All expressed subtelomeric var genes have been single 
copy genes closely juxtaposed with the rep 20 repetitive DNA element (Fisher el al., 
1997). 
The mechanisms used to control expression of var genes are at present not 
well understood. Three possible control methods for regulating antigenic variation 
have been proposed. (1) Pre-transcriptional, e.g. gene conversion or reciprocal 
27 
recombination replaces the gene transcribed with an alternative variant. (2) 
Transcriptional, e.g. a switch in the promoter used. (3) Post-transcriptional e.g. a 
shift in reading frame (Borst et at., 1995). In P. falciparum, no evidence has been 
found to associate major DNA re-arrangements or gene duplication with switches in 
var expression, nor have changes in promoter sequence been noted. Thus expression 
appears somehow to be regulated in situ (Scherfet al., 1998; Deitsch et at., 1999). 
RT-PCR has detected 24 different var gene transcripts within an adhesively 
homogenous culture. Further, several different transcribed var variants have been 
identified by RT-PCR within individual ring stage parasites expressing a single 
PfEMP1 type on the infected red cell surface (Chen et al., 1998). This evidence has 
been used to argue for a developmentally regulated, post-transcriptional control of 
var gene expression. Nuclear run on experiments however, have detected only a 
single var transcript in individual trophozoites (Smith et at., 1998), an observation 
which supports control at the transcriptional or pre-transcriptional level. In a recent 
study, a fusion construct consisting of a reporter gene and an upstream element from 
an expressed var gene, was transformed into parasite lines which expressed either 
the homologous, or a heterologous var variant (Deitsch et at., 1999). The reporter 
gene was expressed at the same level in both transformed parasite lines, indicating 
that sequences immediately upstream of var genes do not appear to control levels of 
expression. On balance, current opinion favours the hypothesis that var gene 
expression is controlled by epigenetic mechanisms, possibly in concert with longer 
range alterations in DNA structure (Newbold, 1999). 
1.8.4 var gene loci and recombination 
Recombination has been extensively studied in the budding yeast 
Saccharomyces cerevisiae, which is assumed to be a model for eukaryotes, 
employing the same mechanisms that mediate DNA repair and association with areas 
of the genome containing repetitive DNA elements. The commonest recombination 
events in yeast (around 100 per meiotic division) occur at meiosis on pairing of 
homologous chromosomes prior to segregation. Mitotic recombination and 
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heterologous meioitic recombination do not involve chromosome pairing and are 
less well understood, although transcription of normally silent DNA sequences 
appears to stimulate mitotic recombination (Paques and Haber, 1999). 
The subtelomeric regions of P. falciparum chromosomes which encode 
many var gene loci, contain arrays of repetitive DNA elements which are conserved 
between isolates and have been proposed to facilitate recombination and gene 
conversion events (de Bruin et at., 1994; Pace et at., 1995). These chromosome ends 
are highly plastic and responsible for most of the extensive size differences observed 
between the homologous chromosomes of different isolates (Corcoran et at., 1988; 
Pologne & Ravetch, 1988; Lanzer et al., 1993). Recombination appears to occur 
frequently between both homologous and heterologous chromosome ends (de Bruin 
et at., 1994; Scherf, 1996; Hinterberg et at., 1994) . Many surface antigen genes of 
P. fatciparum lie proximal to the repetitive elements of the subtelomeric complex 
and it has been proposed that recombination here is a source of new antigenic 
variants (Kemp etal., 1990; Lanzer etal., 1994). This karyotypic plasticity and 
compartmentalisation of the chromosome into conserved central and highly 
polymorphic subtelomeric region containing many antigen genes is a common 
theme of parasitic protozoans (Lanzer, 1995). Subtelomeric var gene loci are closely 
associated with the rep20 repetitive DNA element (Rubio et al., 1996; Thompson et 
at., 1997) and a number of studies have detected a higher degree of similarity among 
the subtelomeric var genes within an isolate than among centrally located var genes. 
Highly homologous var genes have been found at either end of chromosome 
12, and in the subtelomeric domain of two other chromosomes of a single laboratory 
clone Further, highly similar var genes have been located to the ends of 
chromosomes 2 and 8. Suggesting that recombination between homologous and 
heterologous chromosomes at meiosis and mitosis is a major source of generation of 
new antigenic and adhesive types of PfEMP1 (Deitsch etal., 1999). Centrally 
located var genes may form a relatively stable pool of var genes, with subtelomeric 
var genes providing the raw material for generation of new variants. var loci are 
found in both orientations within the subtelomeric complex, each of which may 
define distinct subsets of recombining var genes (Fisher et at., 1997). 
Recombination is not limited only to subtelomeric var genes. Spontaneous 
recombination between var genes located within the same internal cluster on 
chromosome 12 has been demonstrated (Deitsch etal., 1999). Further, an internal 
var gene cluster on chromosome 7 contains three var genes followed by two var 
pseudogenes of high homology sequence to two of the complete genes (Su etal., 
1995), suggesting a possible role for gene duplication in the generation of new 
variants. 
An apparently untranslated mRNA transcript of 1.8-2.4 Kb of var exon II is 
found in large amounts in P. falciparum, which may have a role in facilitation of var 
gene switching and generation of new variants through effects on local chromatin 
architecture (Su etal. 1995, Deitsch etal., 1999). 
1.9 PfEMPI binding and ligands 
P. falciparum trophozoite- and schizont- infected erythrocytes have the 
capacity to bind to the host venular endothelium; to other infected erythrocytes 
(autoagglutination); and to uninfected erythrocytes (rosetting). PfEMP1 has been 
shown to play a major role in determining the adhesion characteristics of P. 
falciparurn infected red blood cells, with switches in var gene expression being 
associated with changes in adhesion phenotype (Smith et at., 1995). A range of host 
molecules are used as adhesion receptors including CD36 (Ockenhouse etal., 1989); 
ICAM-1; (Berendt etal., 1989); CSA (Chaiyaroj etal., 1996); vascular cell 
adhesion molecule 1 (VCAM-1) and E-selectin (Ockenhouse etal., 1992); platelet/ 
endothelial cell adhesion molecule-i (PECAM) (Treutiger et at., 1997); and 
thrombospondin (Roberts etal., 1985). 
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Some adhesive phenotypes are more common than others within parasite 
populations. Almost all clinical isolates in every geographical region studied can 
bind to CD36, and a significant but variable percentage to ICAM-1. CSA binding 
phenotype (see section 1.7.2) is very common in parasites isolated from placental 
malaria infections, but rarer in nongravid patients (Fried & Duffy, 1996; Rogerson & 
Brown, 1997). The proportion of rosetting parasites varies widely with geographical 
area (Carlson etal., 1990; Rowe etal., 1995; Rogerson etal., 1999). Other binding 
phenotypes are less common e.g. to VCAM-1, PECAM and E-selectin (Chaiyaroj et 
al., 1996; Udomsangpetch et al., 1996; Rogerson et al., 1999). 
Not all of the CD36 binding is mediated by PfEMP1. Binding to CD36 could 
be inhibited by a polyclonal anti-idiotype antibody to the anti-CD36 monoclonal 
antibody OKM8. This anti-idiotype antibody expresses determinants that mimic the 
CD36 binding domain for parasitized-erythrocyte adhesion, and can react with the 
infected erythrocyte surface, competing with CD36 adhesion. The anti-idiotype 
antibodies also could immunoprecipitate a 270K dalton protein "sequestrin'T in a 
soluble CD36- inhibited reaction (Ockenhouse etal., 1991a &b). The existence of 
non-variant CD36-binding molecules such as sequestrin may explain the ubiquity of 
CD36 binding in the parasite population. 
The dynamics of binding to various ligands has been studied under "flow" 
conditions, which mimic the physiological stresses encountered in the 
microvasculature (Wick & Louis, 1991; Nash etal., 1992). Under such conditions, 
CD36 mediates a 'static' adhesion and can capture flowing cells; whilst ICAM-1 
mediates a strong and rapid 'rolling' binding but cannot immobilise cells (Cooke et 
al., 1994; Cooke & Coppel, 1995; Cooke & Nash 1995). These ligands may be used 
co-operatively in a multistep binding process (McCormick et al., 1997). The 
endothelial adhesion phenotypes of parasitized erythrocytes appear earlier in the 
intraerythrocytic cycle than onset of the rosetting phenotype. It has been 
hypothesised that binding of parasitized erythrocytes to endothelium occurs first, 
followed by binding of uninfected erythrocytes to the sequestered cells. Both these 
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adhesion phenotypes appear before susceptibility to agglutination by antibodies 
present in immune serum (Treutiger et at., 1998). 
Some of the binding domains for specific ligands have been identified for 
particular PfEMP 1 variants. The DBL 1 domain has been implicated in rosetting of 
the P. falciparum clone R29 (Rowe et al., 1997), and CIDR has been identified as a 
CD36 binding site for the Malayan Camp clone (Baruch et at., 1997; Smith et at., 
1998). There is also some evidence that CSA binding by the cloned line FAF-EA8 
(derived from ItG2) is mediated by DBL3 (Reeder et at., 1999). The possibility 
remains however, that different PfEMP 1 variants may adhere to the same ligand via 
different regions of the molecule. 
1.10 The population structure of P. falciparum 
P. falciparum populations are genetically highly diverse, and have 
traditionally been viewed as panmictic i.e. consisting of randomly mating and freely 
recombining parasites. In the 1990s competing hypotheses have been proposed 
which suggest "clonal", or "strain" structure for P. falciparum populations. 
Since the discovery of the var gene family of variant antigens in 1995, var 
genes have been incorporated into the "strain" theory model of P. falciparum. 
Examination of var gene variation within defined populations will be a useful tool in 
analysing the structure and degree of outcrossing in particular parasite populations. 
The population structure debate is important for practical as well as intellectual 
considerations, as our understanding of the parasite population dynamics affects the 
development of intervention strategies. 
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1.10.1 The panmictic model 
Traditionally P. falciparum has been considered to have a panmictic 
population structure, comprising a vast number of freely outcrossing parasites and 
recombining genomes (Walliker, 1991; Babiker & Walliker, 1997). A high degree 
of genetic diversity has been observed in many geographical locations regardless of 
transmission intensity, and identical genotypes appear to be extremely rare among 
clinical isolates (Walliker & Babiker, 1997). Thus high level genetic variation in 
natural populations, obligate sexual cycle in the mosquito, and demonstration of 
recombination between different haplotypes to produce novel progeny haplotypes in 
the laboratory, appear to lend strong support to the traditional panmictic model 
(Ranford-Cartwright etal., 1993; Walliker etal., 1987; Walliker, 1989; Kemp etal., 
1990; Kerr ci al., 1994). 
In recent years however, competing theories of population structure have 
been proposed which view the P. falciparum population as more structured 
(Tibayrenc el al., 1990; Tibayrenc & Ayala 1991; Gupta & Day, 1994a & b) 
1.10.2 The clonal model 
In the early 1990s a controversial clonal model for P. falciparum was 
proposed as part of a general theory of clonality for parasitic protozoans (Tibayrenc 
ci al., 1990; Tibayrenc, 1991). The proponents of this theory argue that 
recombination between genotypes under laboratory conditions, and the existence of 
an obligate sexual stage of P. falciparum life cycle, does not convey any 
information about the degree of outcrossing in natural populations (Tibayrenc & 
Ayala 1991). Clonal theory notes the occasional occurrence of natural hybrids within 
the markedly clonal population structure of the protozoan parasite Trypanosoma 
cruzi and proposes that a limited degree of outcrossing and recombination can be 
accommodated within an overall clonal population structure (Tibayrenc, 1998). The 
degree of outcrossing between different P. falciparum genotypes in the mosquito 
33 
host is however, predicted be very low, with 'selfing' vastly preponderant over 
outcrossing. 
Evidence for the clonal model has generally taken the form of apparent 
linkage disequilibrium between P.falciparum genetic characters. Linkage 
disequilibrium is the non-random association of alleles at two or more loci, or the 
demonstration of a lower than expected degree of recombination between two points 
within a gene; and the demonstration of linkage disequilibrium has been used as a 
measure of clonality (Tibayrenc, 1994). However, the validity of linkage 
disequilibrium as a demonstration of clonality is questionable as it may occur 
through natural selection. Further, disequilibrium may be detected within a sample 
taken from a panmictic population if geographical, ecological or temporal barriers to 
outbreeding effectively subdivide the apparent population into two or more 
subpopulations (Smith et al., 1993). Two theoretical population structures other than 
clonal can give rise to linkage disequilibrium. (1) "Epidemic" i.e. basically 
panmictic but experiencing occasional rapid clonal expansions; and (2) "cryptic 
species" where the population studied consists of two or more different species 
which do not outbreed or recombine between each other. 
The original analysis on which clonal theory was based found linkage 
disequilibrium in the distribution of enzyme electropherotypes in a sample of 17 
clinical isolates (Tibayrenc et al., 1990). Criticisms of this study include low sample 
numbers and failure to take account of regional differences in allele frequencies 
(Dye, 1990; Walliker, 1990 & 1991). Further, many studies have failed to detect 
linkage disequilibrium between various genetic markers in P. falciparum populations 
in a variety of geographical locations including the Gambia (Carter & Voller 1975; 
Conway & McBride 1991), the Sudan (Babiker et al., 1991a & b), and a 
multiregional study with samples from Brazil, Thailand and Zimbabwe (Creasey et 
al., 1990). In general linkage between P. falciparum genetic characters does not 
deviate from random (Babiker & Walliker 1997). One recent study of 25 sequences 
from the single locus highly polymorphic circumsporozoite gene (csp) did find 
apparent linkage disequilibrium between different sites within that gene and a 
34 
complete absence of synonymous substitutions. On this basis the authors have 
argued for a clonal population structure in P. falciparum, and a recent evolutionary 
origin (within the last 50,000 years) through a population bottleneck. (Rich et al., 
1997 & 1998). This analysis has been criticised for relying on data heavily biased 
towards a single parasite population (Conway etal., 1999; Hey, 1999). Whilst this 
may negate the problem of geographical barriers within the sample population, it 
creates another potential confounding effect of linkage disequilibrium arising in a 
sample due to a recent local clonal outbreak. Further, if clonal theory is correct, then 
linkage disequilibrium should be demonstrable throughout the genome and not just 
within a single gene. A more comprehensive study of 547 isolates from 6 African 
populations has demonstrated that linkage disequilibrium within the polymorphic, 
single locus mspl gene of P. falciparum decreases with distance between 
polymorphic sites within the gene (Conway etal., 1999). This is the observation 
expected if recombination were occurring frequently between different mspl alleles. 
This relationship (decline in linkage disequilibrium with increasing nucleotide 
distance) was slowest within the Sudanese population, which had the lowest 
transmission intensity and therefore fewest chances for outcrossing and 
recombination, again consistent with the traditional view of P. falciparuin 
populations. Another recent study of 69 Thai isolates has shown certain regions of 
mspl are in strong linkage disequilibrium, however evidence was also found for 
recombination within different regions of the same gene (Sakihama et al., 1999). 
Widespread recombination between mspl alleles appears to be the simplest 
explanation of the observed sequence variation, with the linkage disequilibrium 
observed between particular sites due to selective constraints acting at the level of 
the protein structure or function. Further, in a study of the sequence diversity 
encoded by two polymorphic antigen genes of P. vivax from 8 countries, P. vivax 
apical membrane antigen 1 (PvAMA I) and P. vivax merozoite surface protein 1 
(PvMSP 1), the synonymous substitution rate of PvAMA 1 was found to be 8 times 
higher than that of PvMSP 1. This suggests that synonymous substitutions are not 
always selectively neutral and casts doubt on attempts to date population bottlenecks 
from the frequency of synonymous substitutions. Only 12.6% and 7.8% of observed 
sequence diversity in PvAMA 1 and PvMSP 1 respectively could be accounted for by 
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differences between populations, suggesting that whilst local populations of P. vivax 
contain a high level of diversity, major differences between geographical areas are 
unlikely (Figtree et at., 2000). 
P. falciparum oocysts contain the haploid products of meiosis, and the 
measurement of heterozygosity within oocysts from wild caught mosquitoes is a 
direct measure of outcrossing rates. This is a powerful tool for studying the structure 
of natural populations of malaria parasites. Studies using this approach in Tanzania 
(Babiker el at., 1994) and in Papua New Guinea (Paul et at., 1995) have confirmed 
that outcrossing does occur in natural P. falciparum populations. The estimated 
inbreeding coefficients for these two populations were highly different, perhaps 
reflecting the different transmission intensities of P. falciparum in the two regions. 
The Tanzanian population had an inbreeding co-efficient of 0.33, i.e. 2/3 of all 
zygotes were of biparental origin (Hill el at., 1995). In contrast that of the Papua 
New Guinean population was 0.915 i.e. less than 1/10 of zygotes were of biparental 
origin (Paul et at., 1995). In both these cases however, the level of outcrossing was 
high enough to maintain linkage equilibrium within the parasite population 
(Walliker, 1997). Further evidence for widespread meiotic recombination has come 
from a study of genetic and phenotypic diversity of parasite infections likely to have 
resulted from single mosquito bite inoculations. Multiple clones made from single 
isolates were found to contain high levels of diversity in karyotype, drug resistance 
phenotype, restriction fragment length polymorphism (RFLP) and PCR typing of 
polymorphic genes. This variation however, was within the context of a degree of 
genetic relatedness which suggested each clone resulted from recombination 
between the same two haploid parents (Druilhe et at., 1998). This suggests a high 
level of sexual recombination between P. falciparum occurs in the mosquito host. 
On balance therefore the clonal model of P. falciparum does not appear to 
accurately describe natural populations of the parasite. 
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1.10.3 The strain theory model 
The strain theory model of P. falciparum population structure is based on an 
interpretation of the patterns of immunity to P. falciparum observed in endemic 
areas. 'Strains' are not defined as clonal genotypes, but rather as particular 
combinations of polymorphic immunodominant antigens (Gupta & Day, 1994 a & 
b). Strain theory predicts that host immune pressure will result in these 
immunodominant polymorphic antigens being inherited as discrete, non-overlapping 
repertoires (Gupta et al., 1996; Gupta & Galvani, 1999; Sutherland, 1998). This 
theory can accommodate recombination between different genotypes, as only the 
immunodominant loci are predicted to be in linkage disequilibrium. The 
demonstration of outcrossing and recombination within natural populations 
(discussed in 1. 10.2) therefore is compatible with both the traditional panmictic 
model, and the strain structured model for P. falciparum. 
In strain theory, the high transmissibility of P. falciparum comprises the sum 
transmissibility of many independently co-circulating and only mildly transmissible 
'strains'. Further, within this model, immunity to particular strains may develop 
rapidly; the observed slow development of immunity to P. falciparum explained as 
being due to a low level of cross immunity between different strains (Gupta et al., 
1994). If this is correct, vaccination and control programs against P. falciparum 
might be more likely to succeed as the parasites would not be a single large, poorly 
immunogenic and highly transmissible population. Rather they would comprise a 
number of highly immunogenic and poorly transmissible smaller populations 
("strains") each of which could in theory be independently controlled. The 
assumptions made by strain theory models i.e. long-term strain-specific immunity 
that develops after a single or very few infections, a short duration of infectiousness, 
and a low reproduction rate (Gupta & Day, 1994 a & b) have been questioned by 
other mathematical models as being incompatible with the observed level of genetic 
diversity and stability of malaria in highly endemic areas (Saul, 1996). Further, 
serological responses to non-variant, polymorphic malaria antigens e.g. MSP1 have 
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been shown to be of short duration (Cavanagh et al., 1998), raising doubts over the 
assumptions of strain theory. 
PfEMPI has been specifically identified by strain theory as a polymorphic 
antigen that could serve to structure the population into strains through the action of 
immune pressure (Gupta et al., 1996). This model predicts that var genes of P. 
falciparum should be inherited as discrete, non-overlapping repertoires which define 
strains, for this reason it has been proposed that the term 'varotype' be used in 
preference to 'strain' (Sutherland, 1998). Further, it has been proposed that even 
intermediate levels of immune pressure can structure P. falciparum populations into 
subpopulations of co-circulating strains (Gupta et at., 1998). A corollary of these 
predictions is that the var repertoires of different parasite strains should be evolving 
in genetic isolation from each other and therefore variants isolated from different 
strains should be less similar than those from within the same strain. A recent 
serological study however, found evidence for overlapping antigenic repertoires of 
parasites using agglutination, mixed agglutination and flow cytometry assays. Four 
parasites taken from a single village in eastern Sudan were tested against sera from 
29 individuals from the same village. Results indicated a varying degree of overlap 
between the antigenicity of the four parasites, and also that a single infection may 
give rise to the ability to recognise more than one parasite type (Giha et at. 1999a). 
These results do not fit the expectations of the strain theory model particularly well. 
1.10.4 Effect of ecology on population structure 
It is theoretically possible for a parasite population to develop a strain or even 
a clonal population structure at low transmission rates in the absence of any active 
selection pressure from the immune response. Under such conditions the chance co-
infection of a mosquito with two different P. falciparum haplotypes may be so low 
that outcrossing within the population is negligible and a strain or clonal population 
may result (Hastings & Wedgwood-Oppenheim, 1997). However, studies carried out 
in areas of low transmission intensity in Thailand and Sudan, have found higher than 
expected numbers of P. falciparum genotypes in human hosts (Paul et al., 1998; 
Babiker, 1998). This suggests that even at low transmission rates the potential for 
multiple haplotype infection of mosquitoes and resultant opportunities for 
recombination between different parasite genomes is still high enough to generate 
extensive parasite diversity. Epidemics in previously malaria-free areas can 
however, have a clonal population structure as recently demonstrated for an outbreak 
in Cabo Verde an Atlantic island off the West African coast (Arez et al., 1999). 
1.11 Summary 
The current study analyses polymorphism present in the Plasmodium 
falciparum erythrocyte membrane protein-i (PfEMP 1) family of variant antigens. 
Sequences from genetically different parasites are compared to look for evidence of 
structure within the parasite population. Local PfEMP 1 diversity in one village in 
Sudan is compared with diversity present in a global selection of isolates. 
The Sudanese var genes are expressed as GST-fusion proteins, and used in a 
preliminary ELISA against a cohort of Sudanese sera. The role played by the anti-
var immune response in the development of host immunity is discussed. 
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Chapter 2 
Materials and Methods 
2.1 Materials 
2.1.1 Chemical and equipment 
Standard laboratory chemicals and solvents were obtained from British Drug 
House (BDH) plc. and Sigma Chemical Co. Ltd., UK. and were of analytical grade. 
The sources of other materials are given in the text. 
Centrifugation was either carried out in a bench top centrifuge MSE, (Fisons) 
or IMV-1 3 microfuge (IBI). Higher speed centrifugations were performed in a 
Sorvall-RC-5B-refrigerated centrifuge. 
2.1.2 Parasite source 
The parasites used in this work were clones SD1OI, SD 102, SD 105, SD 106, 
SD 126 and SDI 28. These P.falciparum clones were made from patient isolates 
from the 1989 transmission season in Asar village in north-eastern Sudan, and have 
been shown to differ from each other in phenotype, genotype and molecular 
karyotype (Babiker et al., 1991a & b; Bayoumi et al., 1993). These P.falciparuin 
clones are kept in the WHO Registry of Standard Strains of Malaria Parasites in the 
Centre for Parasite Biology, ICAPB, University of Edinburgh. 
EEO 
2.1.3 Erythrocytes and sera 
Fresh whole blood, group 0 Rh +, and serum used for parasite culturing was 
obtained from Edinburgh and South East Scotland Blood Transfusion Service. The 
blood was washed and centrifuged at 1500g three times in incomplete RPMI 
medium to remove citrate. The "buffy coat" of white cells was removed from the 
red cell pellet, which was resuspended in complete medium to give a haematocrit of 
50%. The washed red blood cells were kept at 4°C for up to one week (Hyde, 1993). 
2.1.4 Bacterial strains 
The following bacterial strains were used in the course of this study: 
DH5a, genotype:supE44 AlacUl69 (80 lacZA]vI]5) hsdRl 7 recA] end Al gyrA96 
thi-1 relAl. 
XL1-Blue, genotype:supE44 hsdRl7 recAl endAl gyrA46 thi relAl lac F' [proABH 
/acIqlacZAM 1 5Tnl O(tet')]. 
BL21, genotype: E. coli BF dcm ompThsdS (rB, mB ) gal. 
2.1.5 Oligonucleotide primers 
Oligonucleotide primers used in this study were synthesised by the Oswel 
DNA Service, Department of Chemistry, University of Edinburgh. The sequence of 
the primers is given below: 
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Standard sequencing primers.' 
-40M13, 5'- GTTTTCCCAGTCACGAC-3' 
Mfl, Reverse 5'- CAGGAAACAGCTATGAC-3' 
T7 Promoter 5'- TAATACGACTCACTATAGGG-3' 
SP6 Promoter 5'- ATFT'TAGGTGACACTATAGAAT-3' 
pGEX Forward 5'- GGGCTGGCAAGCCACGTTTGGTG-3' 
pGEX Reverse 5'- CCGGGAGCTGCATGTGTCAGAGG-3' 
DBL 1 primers" bc. 
Forward I (F 1) 5'-CGAGGATCCGGWGCWTGYGCWCCWTWYMG-3' 
Forward 2 (F2) 5'-CGAGGATCCCCATATAGACGATTACATSTATG-3' 
Forward 3 (F3) 5'-CACGMAGTTT TGCRGAYATW-3' 
Reverse I (RI) 5'-GCACTCGAGTTA WATRTCYGCAAAACTKCGTG-3' 
Reverse 2 (R2) 5'-GCACTCGAGTTANARRTAYTGWGGWACRTARTC-3' 
Reverse 3 (R3) 5'-GCACTCGAGTTATTCTTYTYTTTGGTTATCTATCCA-3 
a Forward 1-2 contain a recognition site for the restriction enzyme Barn HI 
highlighted in bold. Reverse 1-3 contain a Xho I recognition site highlighted in bold, 
and a stop codon which is underlined. bRedundances  MA/C; R=AG; WAT; 
SC/G; Y=C/T; KG/T; NAIC/G/T. C  The F2, RI and R3 primers were based on 
sequences kindly provided by Dr Sue Kyes, Oxford (Kyes et al., 1997). Fl and R2 
were modified from published primers (Su et al., 1995). 
21.6 General stock solutions and media 
All aqueous solutions were prepared in de-ionised glass distilled water. pH 
values of solutions were measured with a pH meter model PW 9410 (Philips). 
TAE 	50x stock solution 	242g Tris base, 37.2g Na2EDTA.21-120, 57.1ml glacial 
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acetic acid, dFI20 to 1 litre. This solution was diluted 
x50 to give lx working solution (40mM tris acetate, 
2mM EDTA). 
SDS 10% stock solution 	lOOg was dissolved in 900m1 dH20, heated to 68°C and 
the pH was adjusted to 7.2 by HC1, and made up to 1 
litre with dH20. 
PBS 1 Ox stock solution 	80g NaCl, 2g KC1, 11.5g Na2HPO4.7 H2O, 2g KH2PO4, 
were dissolved in a final volume of 1 litre of dH20. 
working solution, pH-7.3 consisted of 137mM NaCl, 
2.7mM KC1, 4.3mM Na2HPO4.7 H20 and 1.4mM 
KH2PO4. 
TE Buffer (lx) 	 10mM Tris-HC1 pH 8.0,1mM EDTA pH 8.0 
SOC Medium 	 2% Bacto-tryptone,0.5% Bacto-yeast extract, 10mM 
NaCl, 2.5mM KCI,lOmM M92C1, 10mM 
M92SO4,2OmM glucose 
Luria-Bertani Medium (LB) 1% Bacto-tryptone, 0.5% Bacto-yeast extract, 
1% NaCl, adjusted to pH 7.2 using NaOH 
LB agar 	 LB medium with 1.5% Bacto-agar 
LB-amp 	 LB supplemented with ampicillin to 50ig/ml 
X-Gal 	 Fresh dry LB-amp. plates spread with 25p1 X-Gal 
(40mg/ml stock solution in dimethyl-formamide). 
IPTG 	 Stock solution (0.1M) was made by dissolving 0.23 8g 
in dH20, filter sterilised, and stored in imi aliquots at - 
20°C. 
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DNA Loading Buffer 	50mM Na2EDTA. 0.25% bromophenol blue, 0.25% 
xylene cyanol, 40% (w/v) sucrose in H20. 20m1 
volumes were made up and stored as small aliquots at 
4°C. 
RPMI (incomplete) Medium 10.4g of RPMI 1640, 5.94g of HEPES, dissolved in 
960m1 of dH20, filtered through 0.22tM Nalgene 
filter and stored for up to four weeks at 4°C. 
Complete RPMI Medium 	Prepared by addition of 42m1 sodium bicarbonate, 
50mg/ml gentamycin, and 40m1 of heat inactivated 
human serum to 600ml of incomplete RPMI medium. 
Competent Cell Buffer 	60mM calcium chloride, 15% glycerol, filter sterilised. 
Store at -70. 
2x Gel Loading Buffer 	Core buffer: 125mM Tris pH 6.8, 4% SDS, 20% 
glycerol, 0.004% bromophenol blue in H20. Before 




2.2.1 Culture of asexual parasites 
Cultures of P. falciparum parasites were maintained using standard methods 
(Trager and Jensen, 1976; Hyde, 1993). Parasites were grown in complete RPMI 
1640 medium supplemented with 10% human serum, 37.5 mM HEPES, 5% sodium 
bicarbonate and 25 jig/mi of gentamycin sulphate. Washed human red blood cells 
(group 0) were added to a final concentration of 5%. Red blood cells and serum 
were obtained from the Blood Transfusion Service. Cultures were maintained at 
370C in a modified gas mixture of 96% N2, 3% CO2 and 1% 02. Medium was 
replaced daily. Parasitaemia was determined each day by examination of blood 
smears on glass slides fixed with 100% methanol. Blood smears were stained with 
Giemsa's solution (in Sorensen's buffer, pH7.2) for 45 minutes and evaluated by 
light microscopy. Cultures were initiated at a parasitaemia of around 0.5% and 
diluted upon reaching 10%. 
2.2.2 Preparation of parasite DNA 
5m1 of asexual culture at 5-10% parasitaemia were pelleted by centrifugation 
at 4,000 rpm for 10 minutes. The erythrocyte pellet was resuspended in 1 ml of 0.1% 
saponin in phosphate-buffered saline (PBS) and incubated at room temperature for 5 
minutes. The erythrocyte lysate was transferred to a microfuge tube and spun for 5 
minutes at 10,000 rpm. The parasite pellet was washed four times with imI of ice 
cold PBS. Lysis of the parasite pellet was carried out overnight at 50°C with 600 jil of 
10mM Tris-HCL pH 7.6, 50mM EDTA pH 8.0, 0.1% SDS, 1mg/mi proteinase K. 
The lysate was extracted twice with phenol/chloroform, then once with chloroform. 
DNA was precipitated for 15 minutes at room temperature by the addition of an 
equal volume of isopropanol and 10% volume of SM sodium acetate. DNA was 
pelleted by centrifugation at 15,000 rpm for 5 minutes, washed with 70% ethanol 
and resuspended in lOOp.! of PCR grade. 
2.2.3 Preparation of plasmid DNA 
Plasmid DNA was prepared either by the SDS-alkaline extraction method as 
described by Sambrook et al. (1989) or using the QlAprep Spin Miniprep kit 
(Qiagen Inc.) according to the manufacturers instructions. Briefly, a single colony of 
transformed E. coli was grown overnight at 37°C in 5 ml of LB broth. Cells were 
pelleted by spinning for 5 minutes at 2,000 rpm, and the medium discarded. The 
pellet was then lysed and plasmid DNA isolated following the manufacturers 
instructions. 
2.2.4 DNA quantification 
The concentration of DNA was estimated by measuring its absorbance at 
260nm in a spectrophotometer. It was assumed that an 0D260 of 1 .0 is equivalent to a 
concentration of 50p.g/ml for double stranded DNA and 35p.g/ml for 
oligonucleotides. 
2.2.5 Restriction enzyme digestion 
Restriction enzymes digests were performed using the appropriate buffers 
supplied by the manufacturers (Boehringer Mannheim and Promega). Reactions 
were carried out at 37°C for 3-6 hours, using 4-12 units of enzyme per p.g of DNA. 
Reactions were stopped by the addition of 10% volume of 50mM Na2EDTA, 40% 
w/v sucrose, containing 0.25% bromophenol blue and 0.25% xylene cyanol. 
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2.2.6 Polymerase chain reaction (PCR) 
PCR is used for the enzymatic synthesis of DNA sequences using a 
thermostable DNA polymerase such as Taq (Saiki etal., 1988). DNA is first 
denatured, then annealed with specific primers corresponding to each end of the 
target sequence, and finally the annealed primer sequences are extended towards 
each other until they meet. This cycle is repeated 20-40 times and potentially 
amplifies the target sequence by x107-109. 
Standard PCR reactions of 20-50tl volume contained 1/10 volume of 10 x 
buffer (Prornega), 1/10 volume of 10iM of each of forward and reverse primers, 
1/10 volume of 75OjiM dNTP, 1/100 volume of Taq polymerase (Promega) around 
1/10 volume of template (dependent upon DNA concentration), and PCR grade 
water to final volume. Standard PCR conditions used, unless otherwise indicated in 
the text were, 1 initial cycle of 940C for 1 minute, followed by 35 cycles of 94°C for 
30 seconds, 50°C for 30 seconds and 72°C for 1 minute, then a final cycle of 72°C for 
5 minutes. Negative controls containing no DNA template were included in each set 
of reactions. The products of PCR reactions were analysed using agarose gel 
electrophoresis. 
2.2.7 Automated DNA sequencing 
Automated sequencing of plasmid DNA was carried out using dye 
terminators with the PRISMTM  cycle sequencing kit (Applied Biosystems Inc.) and 
the 377 automated sequencer (ABI). Reactions were performed as per the 
manufacturers instructions modified to a final volume of 1 0.tl (ABI PRISM Dye 
Terminator protocol, P/N 402078). For each reaction, the reagents were aliquoted 
into a 0.5m1 PCR tube as follows: 4tl Terminator Ready Reaction Premix, 2 p1 
dsDNA Template (0.2ig/ml), 2p.l sequencing primer (0.8 pmol/ml), and 2p1 PCR 
grade H20. Cycle sequencing was performed on the HYBAID DNA thermal cycler 
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(Omnigene) with the following conditions: 25 cycles (96°C for 30 sec, 50°C for 20 
sec, 60°C for 4 mm, respectively), then keep on 4°C. PCR products were 
precipitated, washed and resuspended in 2.5tl deionized formamide and 0.5p1 of 
50.tg/ml Blue dextran in 25mM EDTA, pH 8.0. Each sample was then heated at 
90°C for 5min and 1.8j.tl of each sample was loaded onto a 6% denaturing gel and 
run at 50W for 7h. Chromatograms were viewed and data edited using the SeqedTM 
program (ABI). Standard sequencing primers were used for the majority of reactions, 
with a DBL specific sequencing primer (F3) being used where necessary to complete 
"gaps" in the data. Obtained sequences were confirmed as DBL 1 by BLAST 
analysis. 
2.2.8 Agarose gel electrophoresis and photography 
Agarose gels were used to check the quality of genomic DNA and plasmid 
preparations and to analyse PCR products and restriction digestions. 1-2% agarose 
(IBI) was dissolved in lx TAE buffer by boiling. After cooling to around 45C C, 
ethidium bromide was added to a concentration of 0.5.tg/m1 and the mix poured onto 
an electrophoresis gel plate and left to set at room temperature. The appropriate 
amount of DNA was mixed with 0.1 volume of gel loading buffer (40% w/v sucrose, 
50mM EDTA pH 8.0, 0.25% bromophenol blue, 0.25% xylene cyanol) and loaded 
into the submerged gel. Electrophoresis was carried out in 1 xTAE at 100 volts for an 
appropriate time dependent upon the size of the fragments under analysis. 
Fluorescence from DNA-bound ethidium bromide was visualised by short wave-
length UV light and photographed. 
To aid in estimation of DNA fragment size, 2jtg of DNA markers were 
loaded adjacent to DAN samples on agarose gels. The markers used were Boehringer 
Mannheim DNA Molecular Weight Markers VI and VII. Molecular Weight Marker 
VI contains DNA fragments of size 2176, 1766, 1230, 1033, 653, 517, 453, 394, 
298, 234, 220 and 154 bp. Molecular Weight Marker VII contains DNA fragments 
of size 8576, 7427, 6106, 4899, 3639, 2799, 1953, 1882, 1515, 1482, 1164, 992, 
710, 492 and 359 bp. 
2.2.9 Purification of DNA fragments from agarose gels 
DNA fragments from PCR reactions or restriction enzyme digestion were 
purified using one of the following methods: 
Phenol/chloroform extraction : Electrophoresis of the DNA fragments was 
carried out using a gel made from low melting temperature agarose (IBI) and lx 
TAE buffer. DNA fragments were visualised by fluorescence of DNA-bound 
ethidium bromide under long wave UV light (366nm) and excised. The gel slice was 
placed in a 1.5m1 microfuge tube and broken into small pieces. An equal volume of 
phenol/chloroform was added and the mix was vortexed for a few seconds before 
incubation at —70°C for 10 minutes. The frozen mixture was spun at 13,000 rpm for 5 
minutes and the aqueous upper phase removed to a clean microfuge tube. Extraction 
was carried out first with an equal volume of phenol/chloroform/3-methyl-1-butanol 
(50:48:2) and secondly with an equal volume of chloroform. DNA was precipitated 
by addition of 0.1 volume of 3M sodium acetate and 2 volumes of 100% ethanol, 
washed with 70% ethanol and finally redissolved in PCR grade water. 
Magic PCR PrepsTM DNA purification system: DNA contained in low 
melting temperature agarose gel slices was also purified using the Promega Magic 
PCR PrepsTM  DNA purification system according to the manufacturer's instructions. 
The gel slice was incubated in a 1.5m1 microfuge tube at 70°C until the agarose 
completely melted. lml of resin was added, mixed immediately, and the mix was 
passed through a mini column by syringe. The minicolumn was washed with 2m1 of 
80% isopropanol and centrifuged for 20 seconds at 13,000 rpm. The minicolumn 
was placed in a clean microfuge tube and 50jtl of PCR grade water was applied to 
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the column and incubated for 3 minutes. The microfuge tube was spun at 13,000 rpm 
for 1 minute to elute the DNA. 
2.2.10 Subcloning of PCR products into the "T-vectors" pCRII 
and pGEM-T 
The Invitrogen TA Cloning System and Promega pGEM-T Easy Vector 
System were routinely used in this study to provide a one-step cloning strategy for 
direct insertion of PCR product into plasmid vector (Mead etal., 1991). The system 
takes advantage of the non-template dependent addition of single adenosine 
deoxynucleotides by Taq to the 3' ends of PCR products. These A-overhangs are 
used to insert the PCR product into specially designed vectors with single T-
overhangs. The Invitrogen TA Cloning System uses the pCRII vector, and the 
Promega pGEM-T Easy Vector System uses the pGEM-T vector to subclone in this 
way. 
The ligation reactions were carried out using the manufacturer's instructions. 
Briefly, the appropriate amount of excised and cleaned PCR product was added to a 
clean 0.5 ml microfuge tube and vector was added to a final molar ration of 1:1 and 
11:3 vector: insert. Each ligation reaction contained, 2il (5 Ong) of vector, 1 p (around 
12.5ng) of PCR product, lil lOx ligation buffer, lil of T4 DNA ligase and 6p.1 of 
PCR grade water. Ligation reactions were incubated overnight at 16°C. 
2.2.11 Subcloning and ligation of DNA 
Plasmid vector and insert DNA were cut with suitable restriction enzymes. 
To prevent self-ligation of compatible ends (by removal of the 5'-phosphate 
residues) linearised DNA was treated with 1 unit of calf intestinal alkaline 
phosphatase (New England Biolabs) at 37°C for 1 hour and the enzyme inactivated at 
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75C for 10 minutes in 0.1 volume of 250 mM EDTA pH 8. Ligations were 
performed at vector: insert ratios of 3:1,5:1 and 10:1. Reactions comprised 1 il of 
1 Ox ligation buffer, 1 t1 DNA ligase (Promega) and DNA/PCR grade water to a final 
volume of 1 O.t1 incubated at 16°C overnight prior to transformation of competent E. 
coil. 
2.2.12 Preparation of competent bacterial cells 
The method used was modified after Hanahan (1983). Cells of the 
appropriate E. coil strain were plated on LB agar overnight at 37°C. A single colony 
was picked and grown overnight in 5ml LB broth at 37°C with shaking. The 
following morning, the culture was diluted 50-fold in LB broth and incubation 
continued for approximately 2-4 hours until the cell density was 4-7x 1 07  viable 
cells/ml (0D600 of 0.4-0.6). At the same time, 150m1 of 60mM calcium chloride in 
15% glycerol was prepared and sterilised by filtering through a 0.22.tm filter and 
kept on ice. The culture was then chilled on ice for 10 min and pelleted at 4,500 rpm 
for 5 min at 4°C. The pellet was resuspended in SOml of the ice-cold calcium 
chloride/glycerol solution, and incubated on ice for 5min then repelleted as above. 
The pellet was resuspended for a second time in 50m1 of ice-cold calcium 
chloride/glycerol and incubated on ice for 30mm. The cells were pelleted once more 
as before and resuspended in 5m1 of the ice-cold calcium chloride/glycerol solution 
and 1 O0-2OOil volumes aliquoted into sterile pre-chilled microfuge tubes. The 
competent cells could be stored at -70LIC for up to 2 months, or used directly. 
2.2.13 Transformation of E. coil 
Competent cells (50-1 OOp.l) were mixed with either SpA of a ligation reaction 
or 20ng of uncut plasmid DNA. The cells were then incubated on ice for 30 minutes, 
heat-shocked at 42°C for 60 seconds and incubated in ice for 2 minutes. To each 
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transformation, 400 jil of pre-warmed Soc medium was added and the mixture was 
incubated at 37°C with gentle shaking for 1 hour. The cells were pelleted by brief 
centrifugation in a microfuge and all but lOOmi of the medium removed. The cells 
were resuspended in the remaining medium and 25-100tl plated out on appropriate 
selective LB agarose plates. Plates were incubated overnight at 37°C. 
22.14 Identification of clones of interest 
Transformed cells were plated out on LB plates containing appropriate 
antibiotic to select for the presence of plasmid. Where appropriate a-
complementation was used to detect the presence of insert DNA. The method used 
was that presented in Sambrook et al., 1989. Briefly, 40ii of 20mg/mi X-Gal and 
40jil of 20mg/mi IPTG were added to LB plates before plating of the transformants 
Following overnight incubation at 37°C, the plates were incubated at 4°C for 2-4 
hours to allow colour development. Using this method colonies containing inserts 
(white) can be distinguished from colonies without insert (blue). 
Recombinant clones were further analysed for the presence of inserts of 
desired size by one of the four following methods: 
Direct size comparison of plasmid minipreps and control vector on agarose gels. 
Restriction enzyme digestion of plasmid minipreps. 
PCR amplification  using plasmid minipreps as DNA template using either specific 
var primers or vector derived primers to amplify inserts. 
Direct PCR performed on lysates of bacterial colonies. A sterile pipette tip was 
touched to a bacterial colony surface and then shaken in 50il of PCR grade water in 
a microfuge tube. The microfuge tube was heated to 100°C for 5 minutes and then 
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spun for 5 minutes at 13,000 rpm. 5j.tl of supernatant was then used as template in a 
standard PCR assay. 
2.2.15 Construction and expression of recombinant 
glutathione-S-transferase (GST) fusion proteins. 
The PGEX-4T- 1 vector (Pharmacia) was used to express polypeptides fused 
with glutathione-S-transferase (GST) in E. coli. BL21 or DH5ct host cells. The basic 
protocol used for expressing and purifying fusion proteins was that described by 
Smith, Johnson and co-workers (Smith & Johnson 1988; Smith et al., 1988). For 
this work, DBL1 fragments were subcloned into pGEX-4T-1 using the BamHI and 
XhoI sites on the vector, to produce a GST N-terminal fused fusion protein. BL2 1 or 
DH5ccells were used for transformation and the cells were grown overnight on LB-
amp agar plates at 37'C. Positive clones were identified by direct PCR and further 
confirmed by DNA sequencing. 
Small scale preparations were made as follows: Single colonies were picked 
and put into Sml of LB-amp broth and grown overnight at 37°C with shaking. The 
following day the culture was diluted 1:50 in 5m1 LB-amp broth and grown at 37°C 
with shaking to an 0D600 of 0.6-0.8. 1 m of culture was removed as a control before 
induction, and to the remaining culture 100mM IPTG was added to a final 
concentration of 0.1mM in order to induce fusion protein expression. Cells were then 
grown for a further 3-4 hours, and then 2x imi samples collected. The pre- and post-
induction samples were pelleted by microfugation and resuspended in 150 j.tl of ice-
cold 1xPBS. Cells were lysed by four cycles of freezing/thawing, and then spun for 
10 min at 13,000 rpm and the supernatant decanted to clean microfuge tubes. One of 
the post-induction preparations was set aside for purification, the remaining post-
and pre- induction samples were diluted 1:2 with 2x sample loading buffer, boiled 
for 5 min and run on SDS-PAGE gels. 
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2.2.16 Purification of GST fusion proteins 
Small scale preparations were prepared as above. For large scale purification 
of a soluble fusion protein, a colony of a pGEX transformant was inoculated into 
1 00m1 of LB-amp broth and grown overnight at 37°C with shaking. This culture was 
the diluted 1:50 into 500ml fresh LB-amp broth and grown at 37°C with shaking to 
an 0D600 of 0.6-0.8. The culture was centrifuged for lOminutes in a Beckman rotor 
at 5,000 rpm and the supernatant discarded. The pellet was resuspended in lOml ice-
cold 1xPBS and the cells were lysed by four cycles of freezing and thawing followed 
by centrifugation. The supernatant was collected and 1 ml of a 50% slurry of pre-
swelled S-linkage glutathione-agarose beads in PBS (Pharmacia) was added and 
mixed gently for 1 hour at room temperature. The beads were washed three times 
with 1xPBS. The pellet was resuspended in lml of ice-cold PBS and then 
transferred to a microfuge tube. The fusion protein was eluted by addition of I ml of 
50mM Tris-HC1 (pH 8.0)/5mM reduced glutathione. An aliquot of each induced 
preparation was run in parallel to pre-induced preparations on SDS-Page gels. 
2.2.17 Polyacrylamide gel electrophoresis 
Prepared protein extracts were fractionated by SDS-PAGE (Laemmli, 1970). 
Mini-gels (80mm x 70mm x 0.75mm) (Hoefer) were used in the course of this study. 
Protein samples were prepared by the addition of an equal volume of 2x sample 
loading buffer and then boiled for 5 minutes prior to loading. Gels were run in an 
electrode buffer (25mM Tris, 190mM glycine, 1%SDS) at 40mA. Separated 
proteins were then stained with Coomassie blue stain. 
The Kaleidoscope pre-stained protein molecular weight marker (Biorad) was 
used to aid estimation of band mass. This marker contained peptides of the following 
mass 6.9kDa (light blue), 17.8kDA (pink), 30.6kDa (orange), 41.8kDA (purple), 
71 kDa (green), 13' kDa (magenta), and 202kDa (dark blue). 
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2.2.18 Coomassie blue staining of protein gels 
Protein gels were stained with 0.1% Coomassie brilliant blue R-250 in order 
to visualise fractionated protein. The stain was prepared in water: methanol: glacial 
acetic acid (4:5:1) for 20mm - I  at room temperature with gentle agitation. Excess 
stain was removed by destaining the gel in water: methanol: glacial acetic acid 
(8:1:1) until the background was clear. Coomassie staining can detect approximately 
0.5-1.ig of protein per band. 
2.2.19 Quantification of fusion proteins 
The concentration of fusion proteins was estimated by the Bradford method 
(Bradford, 1976). A 0.2mg/ml solution of bovine serum albumin (BSA) was 
prepared for use as a standard. BSA standard aliquoted (Ojil, 20jil, 40il, 60111, 80111 
and 100tl) was into clean cuvettes and distilled water added to 100111. Each fusion 
protein (10 tl and 50pi) was likewise aliquoted to clean cuvettes and made up to 
100111 with distilled water. Bradford reagent (1 ml) was added to each cuvette and 
mixed. Reactions were incubated at room temperature for 2 minutes. The 
absorbance of each cuvette's contents was read at 595nm in a spectrophotometer, and 
a standard curve generated from the serial BSA dilutions. The concentration of the 
fusion protein samples was estimated by comparing absorbencies against the BSA 
standard curve. 
2.2.20ELISA assay 
ELISA assays were carried out in 96 well plates (Immunolon 4, Dynatech) 
coated overnight at 4°C with SOng of recombinant protein or GST control in 100111 
of ELI SA coating buffer (15mM Na2CO3, 3 5m NaHCO3 , pH 9.6). Antigen coated 
wells were washed x3 with 0.05% Tween-20 in PBS (PBST), and then blocked with 
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200tl per well of 1% (w/v) non-fat milk in PBST for 5 hours at room temperature. 
Wells were washed with PBST and then incubated with 1 OOj.il of sera overnight at 
4°C. Serum samples were tested in duplicate at a 1: 500 dilution. Plates were again 
washed with PBST and 1 OOjiJ of horseradish-peroxidase-conjugated rabbit anti-
human IgG (Dako) diluted 1:2000 for 3 hours at room temperature. Plates were 
washed once more with PBST and reactions developed with I 00jil of substrate 
buffer (24mM citric acid, 50mM Na2HPO4, 400mg/ml ortho-phenylenediamine 
dihydrochloride (Sigma), 0.4tl/ml 30% (w/v) H202) for 10 minutes. Reactions were 
stopped with 20p.1 of 2M H2SO4- 
Optical density (OD) values were read at 492nm. OD values specific for 
antibody reactivity with fusion proteins were obtained by subtracting averaged OD 
values of GST antigen controls from the average OD of the duplicate sample test 
wells. 
22.21 Sequence Alignments 
Deduced amino acid alignments of DBL 1 sequences were made using the 
GCG pileup and MacVector clustal functions. Alignments were created program 
default parameters with gap weight of 3.0 and gap length weight of 0.1 and edited by 
hand. 
2.2.22 Phylogenetic Analysis 
Phylogenetic analysis of DBL 1 sequences was performed using the computer 
programs PAUP 3.1.1, and PAUP 4. Oa (Swofford, 1993). Analyses were made using 
both the "maximum parsimony" and "neighbour joining" methods described below: 
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Maximum Parsimony(MP) methods search for "minimum-length trees" that 
minimize the number of evolutionary changes needed to explain the data under 
analysis (Eck and Dayhoff 1966). 
Neighbour Joining is a "distance matrix method" of analysing the 
relationships between sequencing data (Saitou and Nei, 1987). Such methods 
compute the evolutionary distances between all pairs of sequences in a given data 
set, and construct a phylogenetic tree based on those pairwise distances. 
The bootstrap re-sampling method was used to provide a measure of 
statistical significance to the sequence clusters obtained by phylogenetic analysis. 
Bootstrapping involves sampling the original data set with replacement to construct a 
series of "bootstrap replicates" (100 replicates throughout this study) of the same 
size as the original data set (Felsenstein, 1985). Each of these is analysed, and the 
variation among these replicate estimates is taken to be an indication of the error 
involved in making estimates from the original data. A majority rule consensus is 
then constructed for all of the bootstrap trees showing the percentage of trees in 
which each relationship occurs. 
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Chapter 3 
Cloning and sequencing of Sudanese var genes: Analysis of 
DBLI structure 
3.1 Introduction 
It is well established var genes show considerable sequence variation (Su et 
al, 1995; Kyes et al., 1997). However, there has been little systematic study of var 
gene diversity in terms of either variation at a single locus or in specific parasite 
populations defined in time and location. 
To investigate var gene variation in a partially defined parasite population, 
six cloned parasite lines originating from one village during one particular time 
period were analysed. The clones were made from Sudanese patient isolates taken 
during October and November of 1989 in the village of Asar (Bayoumi etal., 1993). 
The village lies in Northeast Sudan, an area of highly seasonal and unstable malaria 
transmission. Parasite clones studied were SD1O1, SD102, SD105, SD106, SD126 
and SDI 28, each of which has been shown to have a distinct phenotype, genotype 
and molecular karyotype (Babiker etal., 1991; Bayoumi etal., 1993; Bayoumi etal., 
1994). 
Since var genes are 6-12Kb in length and have a copy number of around 50, 
it was decided to focus on cloning and sequencing a defined domain of the gene. 
The DBL1 domain was chosen for a number of reasons. It is essentially the only 
region of the molecule which contains a number of characteristic conserved motifs 
suitable for use as priming sites for PCR based cloning. DBL 1 is also of intrinsic 
interest as a region with sequence homology to the binding domains of both the 
Duffy-binding antigens of P. vivax and P. knowlesi and the EBA-175 erythrocyte 
binding protein of P. falciparum (Adams etal., 1992; Chitnis & Miller, 1994; Sim 
etal., 1994). DBL1 has been implicated in the rosetting phenotype of the R29 
laboratory clone of Pfalciparum (Rowe et al., 1997) and unlike the other DBL 
domains which may be absent in particular variants, has been found in all var genes 
sequenced to date. Thus it appears that presence of DBL 1 is essential for proper 
PfEMP1 function, either directly via mediation of binding phenotype or indirectly 
through effects on the secondary or tertiary structure of the molecule. 
The DBL1 domain was originally defined as beginning with a conserved 
cysteine 90-100 amino acids from the 5' end of mature PfEMP1 , and ending at a 
conserved sequence element at position 400 (Su et al 1995). This definition of 
DBL I includes 15 highly conserved cysteines but excludes 3 other cysteine residues 
lying within the first 90 amino acids of NEW 1. In this study, the definition of 
DBL 1 domain was extended to incorporate these additional cysteines and therefore 
consists of nine pairs of cysteine residues in the first 400 amino acids of the mature 
protein. 
Transmembrane 
Do T m 
PIEMP1 IDBL1 I CIDR I 	Variable Region C-Terminal 
Domain 
-4- RI 
Primer Site 	 F3 	 -4 
DALi 
Motif 	GACAPYRRHL 	LARS[ADIG 
	
D 
- Size of  
cloned 	 —220 bp 	
—600bp 
fragment 
Fig 3.1 Annealing sites of DBL1 primers. The position of DBL 1 within PfEMP 1 
is shown. DBL 1 is expanded to show the relative positions of primer annealing sites 
and their consensus motifs. The approximate size of fragments cloned using each 
primer combination is indicated. 
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3.2 	Construction of DBLI clone libraries 
PCR amplification of DBL 1 fragments from parasite DNA template was 
performed using different combinations of either of two forward primers (F 1 and 
F2), and three reverse primers (RI, R2 and R3). The relative positions of the primer 
annealing sites and their target motifs are shown in Fig 3.1 
All primer sequences were degenerate in order to amplify as diverse a range 
ofDBL1 sequences or "variants" as possible. The forward primers overlap in their 
annealing sites, and the reverse primers, RI, R2 and R3, anneal approximately 220, 
600 and 800 bp respectively downstream. Thus the length of the cloned sequence 
is largely determined by the reverse primer used in the PCR amplification. Fig 3.2 
shows the products of a typical PCR amplification of DBL 1 sequences. 
1 2 3 4 5 6 7 
	







Fig 3.2 PCR amplification of DBL1 fragments. Lanes 1 and 6 contain molecular 
weight markers. Lanes 2 and 5 show amplification of an 220bp fragment from 
SD 105 and SDI 06 DNA respectively using the primers F2 and Ri. Lanes 3 and 6 
show amplification of an -800bp fragment from SD105 and SD106 DNA 
respectively using the primers F2 and R3. Lane 7 contains a water control. 
Fifteen different libraries were constructed with a variety of primer 
combinations and DNA templates (see section 3.3). A total of 433 transformants 
from the libraries were identified as containing inserts of the expected size and were 
sequenced. 
3.3 	Sequencing of cloned DBLI fragments 
A total of 56 DBL1 variants were obtained from the six parasite clones 
studied. Variants were assigned names indicating the parasite clone from which they 
originated followed by a specific identifier e.g. variant SD102G is "Sudanese clone 
126 variant U". Each variant was obtained from a subclone library at least twice. In 
cases where almost identical variants were obtained from a single library, 
confirmation was sought by isolating the sequence from at least two separate PCR 
based clonings. In 3 instances, the same variant sequence was isolated from two 
different source parasites (SD 101 A/SD 1 02C; SD 1 02E/SD 1 26F; and 
SD126B/SD128H). Table 3.1 lists the variants obtained from each library and gives 
their approximate lengths. Not all primer combinations were used on each parasite. 
Nucleotide sequences and GenBank accession numbers for each variant are given in 
Appendix D. 
Distinct subsets of DBL1 were cloned from individual parasite clones using 
different primer combinations. Frequently however, sequences cloned using either 
of the reverse primers R2 and R3 were also cloned as shorter fragments using the 
reverse primer Ri. In all cases, both long and short versions of individual variants 
were obtained using the same forward primer. Thus, it appeared that the specific 
forward primer used was critical in determining which variants were amplified, 
despite the overlapping of the target regions of Fl and F2. Successful cloning of 
almost all variants using the RI primer highlights the highly conserved nature of the 
LARSFADIG motif to which it anneals. In contrast, the two other reverse primers 
amplified narrower, distinct sets of DBL 1 variants, no single variant being 
separately cloned with R2 and R3 as the reverse primer. Each primer combination 
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Parasite Primer Approx. No. of DBL1 
Clone Pairing Amplicon Clones Variants 
DNA Used Length Sequenced Identified 
SDIOI F2/R2 -600bp 7 SDIO1A,SDIO1B 





SDI05 Fl/RI 210 bp 33 SD105G,SDI05L2, 
SDIO5N, SDIO5P 
Fl/R2 -600bp 19 SD1O5A,SDIO5B, 
SDI05D, SD105E, SD105F, 
SD 105K 
F1/R3 840 bp 11 SDI05C,SD105J, 
SDI05L, SDI05M 
F2/RI -2lObp 53 SD105T 
F2/R3 -840bp 63 SDI05Q,SDI05R, 
SD105S, SD105U 
SDI06 F2/RI -.2lObp 27 SDI O6B,SD1O6D, 
SD106E, SDI06F, SD106G 
F2/R3 840 bp 59 SDI06A, SDI06C 
SD126 Fl/RI -2lObp 34 SDI26E,SDI26F, 
SD1260, SDI26H, SDI26J, 
SD 126K, 
5D126N 
F1/R3 -840bp 3 5D126M 
F2/R1 210 bp 39 5D126D 
F2/R3 -840bp 12 SDI26A,5D126B, 
SDI26C 
5D128 Fl/RI 210 bp 4 5D128J 
F2/R1 -2lObp 27 5D128A,SD128C, 
SDI28D, SDI28E, SDI28G, 
SD 128H, 
5D128K. SD128L 
Table 3.1 Subclone libraries. Fifteen subclone libraries were made from 6 Sudanese 
parasite clones using a variety of primer combinations. Table shows the approximate 
lengths of the cloned fragments, the number of transformants sequenced, and the 
DBL1 variants identified for each library. Many of the isolated variants were cloned 
as 220bp fragments using the primer RI, and also as either -600 bp fragments or 
—840bp fragments using R2 or R3 respectively. In those cases only the longer of the 
cloned fragments is shown in the table. There were no cases where the same variant 
was isolated using the R2 and R3 primers 
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used amplified only a portion of DBL 1 variants, and 5 of 6 possible combinations 
amplified only 19 variants from an expected total of 45-50 from SD 105. Further, 
within particular clone libraries certain sequences were found to be numerically 
dominant e.g. SD1O5R was found in 27 of 63 clones analysed in the SD1O5/F1/R3 
library. Thus even within the subset of DBL 1 sequences capable of being amplified 
by a given primer combination there appeared to be bias towards certain variants. 
This quantitative bias within the DBL 1 sequences recognised by particular primer 
combinations may be due to a simple preferential annealing of the primers to 
particular variant templates. Alternatively, it may be due to the presence of 
particular variants at multiple loci within the genome, increasing their chances of 
being amplified compared to single copy variants. Awareness of primer bias 
necessitates caution in interpreting RT-PCR based studies of var gene expression, as 
only a subset of var genes defined by the primers in use may be detected. 
3.4 	Alignment and Structure of Sudanese DBLlsequences 
Deduced amino acid alignments of the Sudanese DBL1 sequences were 
made using the GCG pileup and MacVector clustal functions. Alignments were first 
created using program default parameters with a gap weight of 3.0 and gap length 
weight of 0. 1, and then edited manually. The region between the primers F2 and RI 
is common to all 56 cloned sequences and is presented in Fig 3.3. The remaining, 
downstream portion of the 22 longer sequences cloned using the R2 and R3 reverse 
primers is shown in Fig 3.4. The part of each sequence determined by the primers 
used in the cloning procedure is not included in the alignments. Continuity of the 
figures is shown by an overlap of the first four residues of Fig 3.4 and the last four 
residues of Fig 3.3. 
The diversity encoded by the DBL 1 regions of this parasite population, and 
by individual parasites within the population is considerable (Figs 3.3 and 3.4). 
However, it was noted that within the overall context of variability, there are a 
63 
number of identifiable conserved elements such as, cysteine residues, aromatic residues 
and a range of conserved sequence "boxes" which punctuate the length ofDBL1. 
Further, it was found that "blocks" of variable sequence alternate with the conserved 
boxes, within which it was possible to discern sequence "subtypes" on the basis of 
partial homology among variants. Thus despite the high level of diversity, an overall 
basic sequence pattern is found in all variants. Each of the elements contributing to this 
pattern is discussed in more detail below. 
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Fig 3.3 Alignment of 56 Sudanese DBL1 variants. The region aligned lies between the primers F2-RI 
(see Fig 3.1) and is common to all 56 cloned variants. Conserved residues are boxed and shaded red on dark 
grey; conservatively substituted residues are boxed and shaded light grey. Cysteine residues are highlighted in n 
on yellow and conserved aromatic residues are highlighted in blue at four positions. There are two highly 
conserved cysteine positions corresponding to cysteines 6 and 7 in Fig 3.5. Two blocks of variable sequence (I 
II) are found within the aligned area and are delineated by red boxes. Three of the variants shown above 
(SD126B/SD128H, SD102E/SD126F, and SD101A/SD102C) were each isolated from two different parasite 
clones. Two of the sequences isolated from a single parasite clone (SID 1O5Q and SD lOSS) are identical over tb 
region portrayed, but diverge downstream. 
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Fig 3.4 Alignment of 22 Sudanese DBL1 sequences from four parasite clones. This alignment shows the 
region from the E3 to R3 primer annealing sites (see Fig 3.1). The first four positions overlap with the last four of 
Fig 3.3. Conserved residues are boxed and shaded red on dark grey; conservatively substituted residues are boxed 
and shaded light grey. Cysteine residues are highlighted in red on yellow and conserved aromatic residues are 
highlighted in blue. There are twelve conserved cysteines contained in the alignment, corresponding to cystemes 
7-18 in Fig 3.5. There are twentytwo well conserved aromatic positions within this region, of which five tryptophan 
residues are absolutely conserved, at many of the other aromatic positions tryptophan and tyrosine residues appear 
interchangeable. Ten blocks of variable sequence can be identified within this region (VIII-XII). Variable blocks VIII-X 
are separated by only 2-4 conserved nucleotides, but are defined as different blocks due to strongly identifiable sequence 
subtypes within these individual blocks (see section 3.4.3). Variable block XII contains three consensus cysteines and a 
conserved aromatic position, but no discernable sequence subtypes and so is treated as one sequence block, The 
sequences SD105Q and SD105S are identical until the conserved CT box between variable blocks X and XI after 
which they diverge. In contrast the sequences SD105C and SD105J are highly divergent until variable block X after 
which they are almost identical These observations may indicate a possible recombination hot spot in this region. 
Pairwise alignments of these sequences are presented in Fig 3.8 (a) and (b). 
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3.4.1 Conservation of Cysteine Residues 
Highly conserved cysteine residues are characteristic of all DBL domains of 
PfEMP1 (Su et al, 1995), and Figs 3.3 and 3.4 combined contain 13 conserved 
cysteines which correspond to cysteines 6-18 in a schematic model of DBL 1 shown 
in Fig 3.5. Cysteine residues located at different positions in an imaginary linear 
polypeptide, but proximal in the three-dimensional structure are capable of forming 
disulphide bonds which play a major role in stabilising the structure of many 
extracellular and secreted proteins. The conserved cysteine residues of DBL 
domains may therefore be crucial in maintaining correct conformation for binding 
and other functions either of the individual domains or of the whole PfEMP 1 
molecule. However, in the Sudanese variants, not all the cysteine residues of the 
DBL1 sequences are absolutely conserved. In Fig 3.3, cysteine 6 (position 28 in the 
figure) is absent in 7 of 56 variants (SD 1O5A, SD1O6D, SD126C, SD 126D, 
SDI26M, SD126N and SD128C) and replaced in 5 cases with leucine, and once 
each with phenylalanine (SD126C) and serine (5D128C). Variant SD126D, which 
is missing the consensus cysteine 6, has a cysteine at an unusual position eight 
residues upstream (position 15, Fig 3.3). Cysteine 7 (Fig 3.3) is missing in only 1 of 
56 sequences (SDI 06E) where it is replaced with tyrosine. Cysteines 9 and 11 are 
each absent from 1 of the 22 sequences encoding those positions, SDI 05L and 
SD 1 05 respectively (Fig 3.4 positions 118 and 134 respectively). As these cysteine 
positions lie within a more variable region of sequence than cysteines 6 and 7 it is 
not possible to say whether they have been replaced by another residue or deleted. 
Cysteines 8 and 10 are conserved in all 22 variants. SD1O1A has an additional 
cysteine adjacent to cysteine 8 (position 102, Fig 3.4). Cysteines 12-18 lie within the 
most cysteine rich region of the molecule and with the exception of a substituted 
proline for cysteine 17 in SDI 05L, they are absolutely conserved in the 14 variants, 
which incorporate this region. Table 3.2 (a)summarises the position and degree of 
conservation of cysteine residues in DBL1. 
It is possible that the loss of a conserved cysteine, or the addition of an 
'extra' cysteine at an unusual position may give rise to conformational changes 
Me 
conferring novel binding properties or differences in antigenicity. Rapidly evolving 
gene families often generate non-functional members, including pseudogenes such 
as the var pseudogene loci found close to related functional genes in a cluster on 
chromosome 7 of Dd2 (Su et al., 1995), and it is possible that variants lacking 
consensus cysteines represent non-functional DBL is. 
F3 
F1/2 	IBM 	 4 	Al 
5' Block GACA Box Block I LLSI Block II LARSFADIG Block Ill 
107-135 12 aa 15-20 aa Box16 aa 13-19 aa Box 21 aa 8-15 za 
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Fig 3.5 Schematic model of DBL1 structure. DBL1 can be divided into alternating regions of 
conserved and variable sequence. Conserved sequence "boxes" are outlined in red, and variable 
"blocks" in black. The order of these sequence blocks, their sizes, and primer annealing sites are 
shown. The positions of conserved cysteines are indicated in yellow. With the exception of the 
Cysteine-Rich Variable Block, all the conserved cysteines lie within the conserved boxes . These 
conserved boxes are rich in aromatic residues, notable the KAITC and FEEWAED boxes which 
contain 5 and 8 aromatics respectively. 
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Table 3.2 
(a) Conserved cysteine residues within DBL1 
Proportion 
Location 	 of Variants 
Cysteine 	within DBL1 	Containing 	Alternative 
Identifier (see Fig 3.5) Cysteines Residues 
Cl-C3 	5' Block 	 Not cloned 
C4,C5 GACA Box Not cloned 
C6 	 LL. .SI Box 	49/56 	 L -105D,106D,126D, 
126M, 126N 
F - 126C 
S - 128C 
C7 LARSFADIG Box 55/56 Y - 106E 
C8 KAITC Box 22/22 
C9 YY. .CG Box 21/22 ? - 105L 
CIO CRC Box 22/22 
Cli CRC Box 21/22 ? - 105D 
C12 FEEWAED Box 14/14 
C13 CR Box 14/14 
C14 YC Box 14/14 
C15 C. .T Box 14/14 
C16 Variable 14/14 
Block XII 
C17 Variable 13/14 P - 105L 
Block XII 
C18 Variable 14/14 
Block XII 
(b) Cysteines at unusual positions 
Variant 	Location within DBL1. (see Fig 3.5) 
126D 	Variable Block I 
101A Variable Block V 
Table 3.2 
shows the location of each of the conserved cysteine residues 1-18 in the 
schematic model of DBL1 presented in Fig 3.5. The proportion of variants 
containing each of the cysteines is indicated and variant residues noted where they 
occur. 
shows the location of cysteine residues found at unusual positions in two DBL 1 
variants. 
3.42 Conservation of Aromatic Residues 
The large aromatic amino acids phenylalanine, tryptophan and tyrosine are 
also well conserved among DBL1 variants, though less so than cysteine residues (see 
Tables 3.3 ). This has been observed previously for the related Duffy-binding 
antigens (DBA) of P. knowlesi and P. vivax (Chitnis & Miller, 1994). Tryptophan 
residues are absolutely conserved at positions 87, 88, 96, 167 and 171 in Fig 3.4. 
Non-conserved tryptophans are rare, SDI 26B contains an unusually located residue 
at position 221 of Fig 3.4 and 4 of 14 sequences (SDI 05J, SDI 05C, SD 105R and 
SDI 06A) have tryptophans at position 231 of Fig 3.4. No tryptophans are found as 
alternatives to tyrosine or phenylalanine at the other aromatic sites. However, 
tyrosine and phenylalanine residues appear to be interchangeable at many positions 
and are generally less well conserved than tryptophan. In three positions (Fig 3.3 
positions 33 and 42; and Fig 3.4 position 46) histidine, another large ring containing 
amino acid, appears as a favoured non-aromatic alternative to tyrosine and 
phenlyalanine. It is possible that the presence of bulky aromatic residues at the 
conserved sites is important in the conformation of many DBL 1 domains. 
Table 3.3 Conserved Aromatic Residues 
Proportion of 
Location variants with Identity of Residue and 
Position 	 within Conserved proportion of variants 
in Figs. DBL1 (see Aromatic Non- 
3.3 & 3.4 	Fig 3.5) Residues Aromatic 	Aromatic 
33 Fig 3.3 LLSI Box 42/56 Y 30/56; F 12/56 H 12/56 
42 Fig 3.3 Block II 45/56 Y 45/56 H 7/56 
46 Fig 3.3 Block II 39/56 Y 37/56; F 2/56 H 7/56 
51 Fig 3.3 Block II 31/56 Y 31/56 N 11/56 
8 Fig 3.4 LARSFADIG 22/22 F 22/2) 
21 Fig 3.4 LARSFADIG 21/22 Y 13/22; F 8/22 S 1/22 
45 Fig 3.4 LEIF Box 21/22 F 21/22 V 1/22 
61 Fig 3.4 Block IV 17/22 Y 17/22 
80 Fig 3.4 KAITC Box 17/22 Y 14/22; F 3/22 
81 Fig 3.4 KAITC Box 16/22 Y 13/22; F 3/22 
87 Fig 3.4 KAITC Box 22/22 W 22/22 
88 Fig 3.4 KAITC Box 22/22 W 22/22 
96 Fig 3.4 KAITC Box 22/22 W 22/22 
112 Fig 3.4 YFCG Box 22/22 Y 22/22 
113 Fig 3.4 YFCG Box 20/22 F 20/22 N 1/22; 
S 1/22 
157 Fig 3.4 FEEWAED 21/22 Y 21/22 N 1/22 
158 Fig 3.4 FEEWAED 21/22 F 21/22 M 1/22 
160 Fig 3.4 FEEWAED 14/14 Y 14/14 
164 Fig 3.4 FEEWAED 13/14 Y 9/14; 	F 4/14 L 1/14 
167 Fig 3.4 FEEWAED 14/14 W 14/14 
171 Fig 3.4 FEEWAED 14/14 W 14/14 
175 Fig 3.4 FEEWAED 14/14 F 14/14 
201 Fig 3.4 YC Box 14/14 Y 14/14 
207 Fig 3.4 Block X 11/14 Y 11/14 L 3/14 
235 Fig 3.4 Block XII 14/14 F 8/14; 	Y 6/14 
Table 3.3 shows the positions of conserved aromatic residues within the sequence 
alignments (Fig 3.3 and 3.4), and model (Fig 3.5). The type of aromatic residue 
found at each position is indicated. Tryptophan residues are absolutely conserved, 
whereas tyrosine and phenylalanine residues are interchangeable alternatives to each 
other at many of these sites. Commonly substituted non-aromatic resides are also 
shown. 
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3.4.3 Schematic model of DBLI, and identification of 
sequence "subtypes" within variable sequence blocks 
It was found that a schematic model of DBL 1 could be constructed from the 
sequencing results (see Fig 3.5). The two alignments (Figs 3.3 and 3.4), together 
show an alternating pattern of conserved sequence "boxes" and variable sequence 
"blocks". The conserved boxes contain most of the cysteine and aromatic residues. 
Within the 12 variable blocks (I-XII, Fig 3.5) sequence "subtypes" could be 
identified, based on partial sequence homology of the particular variable block 
among the variants. Sequence subtypes of each variable block were identified by a 
single letter a, b, c etc., and occasionally subdivided further, a, a], a2 to reflect the 
varying levels of homology within particular subtypes. Variants which could not be 
placed in any subtype for a particular variable block were assigned the letter "x". 
Thus individual DBL 1 variants can be described in terms of a string of variable 
block subtypes e.g. the "subtype composition" of SD105C can be represented as m-
d-a-a-c-b-a-x-x-a-a-a. Variants cloned using the RI reverse primer contain only the 
first two variable blocks e.g. SDI 02A has the subtype compositionj-b. Those cloned 
using the R2 and R3 primers include seven and twelve variable blocks respectively. 
Frequently, variants which belong to the same subtype for a particular variable block 
are highly divergent in other variable blocks, examples of this are discussed more 
fully in section 3.5.3 below. This system allows rapid recognition of sequence 
patterns which might indicate relationships amongst variants. This is an attempt at a 
classification tool, which could be extended to other DBL domains and might allow 
association of these designated subtypes to variant specific functional aspects of the 
gene e.g. adhesion or antigenic phenotype. 
To date it has proved difficult to identify sequence characteristics common to 
var genes expressing a similar variant phenotype e.g. chondroitin sulphate binding. 
Computer packages which look for relationships in multiple alignments of protein 
sequences emphasise changes within conserved elements. Variant specific 
phenotypes of var genes however, may be determined by particular subtypes at one 
or more variable blocks. Comparisons of subtype compositions may therefore reveal 
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associations between particular phenotype and sequence elements that might be 
overlooked using computer analysis of primary sequence data. 
Table 3.4 lists the sequences designated as subtypes for each variable block 
and their associated variants. The subtypes are assigned with a degree of stringency 
dependent upon the overall level of variation/homology within the block. Table 3.5 
shows the subtype composition of each variant over the 12 variable blocks of 
sequence. 
Table 3.4 DBL1 variable block sequence subtypes 
Variable Sequence Amino Acid DBL1 
Block Subtype Sequence Variants 
a DQHLSHMNAGKTNTTDN 106F 
DQHLSHMKAEKINSKIJN 1065 
DQHLSHMKAEKIKNKHN 126A, 	105M 
DQHLEHMDTNKINNTHN 128C 
b DHHLSYMNAGKTNTTDN 128L, 	105K 
C VRNLENISALDKINNDT 101A/102C, 
106G 
ci VRNLINISNYGKINNDT 105N 
d NKNFPNMNSKDSLKAKND 105F 
NKNFPNNNSKDSSKAKHD 105G 
e HHNLETIGTTSTTKHD 102H 
HHNLETIETTSTTKHD 102B 
f NKNMEKNDSTKIKDKNV 105R 
VRNLEKMDSTKIKDKNV 106C 
g HHNLETIETTSKTSTDT 105J 
HHNLETIETTSTTTNK 1021 
h DQNLELIKPKNITTHN 105Q, 	loss 
i DKNLEQIKVEQITTHN 126C 
DKNLEQIEPDKITTHN 102G 
j DKNIQQIKAEQITTHN 102A 
DKNIQQIKTENITTHN 105D, 	1065 
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Table 3.4 DBL1 variable block sequence subtypes (continued) 
Variable Sequence Amino Acid DBL1 
Block Subtype Sequence Variants 
k SHNLETIDTKSTTSDT 102F, 102F2 
I HHNLENIKDVNNIDNDT 105L, 
M HHNLESIDTTSMTHK 128K 
SHNLESIDTTSMTHK 105B, 105C 
n DQNLETIKPHQITSTHN 126E 
DRNLEQIDPAKITTTHN 106N 
DRNLEKIEPDQITSTHN 126M 
II a SGYYPRYQTKYKDSGSTI 105T 
SGRYRQYQNKYDDSPSQI 128E 








d DTHYPQHQRTNEDSPSQI 105C 
GTHYPQHQRTNEDSPSQI 105B 
e KTHYTPYKHKYGDSASQL 102H, 102B 
f VEKHKEFKKTHNDSNI 106E, 106F 
g IDNYPSDHHNKEGI 106D 
INNYPDNRDKKEGI 126M 
h SRNHGKHQLTNSYSQL 126G. 126J 
i KTYRGKYQLTNHGFHTNI 105Q, 105S 
III a HGNSQEKEKRDE 105B 
YGNSKEKEKRDE 105C 
b RGNNKEKDR 105S, 105Q 
RGNDKEKDR 106A 
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Table 3.4 DBL1 variable block sequence subtypes (continued) 
Variable Sequence Amino Acid DBL1 
Block Subtype Sequence Variants 
IV a GKIHEKLKDKECAETRYGSDTT 105B, 105C 
b KQLYEELTKNNKNEAIKTHYQDDDP 105Q, 105S 
V a DEENKLGGYL 105D 
DEENKLGGNA 105F 
b NAGGGNR 105E 
N1GGGT 126B 
V bi NAGSYQ 105U 
C DVHGSD 105B, 105C 
d GAAGGT 126A, 106A 
GACGSQ 126M 
GAGGSK 105Q, lOSS 
VI a GTGTPTDDK 105Q, 105S 
al GSGKTPTDDK 126M 
a2 GTCTGTNDK 126B 
a3 GTGTWTNEK 106A 
b GDKETTATRVKDK 105B, 105C 
VII a KDENGKKPGSNADQV 105B, 105C 
b VNTDP 105A 
INGDP 105M 
C AINDV 105S, 105Q 
d IAGDV 105U 
ICASV 105K 
ISGDV 101A 
VIII a KDVKTN 105J, lOSS, 
105Q 
b KDAIQK 126B, 106C, 
105L 
C QNAKEQ 105M, 126A, 
126M 
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Table 3.4 DBL1 variable block sequence subtypes (continued) 
Variable Sequence Amino Acid DBL1 
Block Subtype Sequence Variants 
IX a GENGTDR 105Q, 	105S 
X a SGNGYD 105J, 	105C, 
105R 
al SGNGLD 105S, 	105Q 
b DLNGYD 126B, 	105M, 
126C 
bi DLNRYD 106C, 	105L, 
126A 
b2 DLNGYN 126M 
b3 DRDGYN 105U 
XI 	 a IYKKGKLVIGEH 105J, 	105C 
b IRGKKKLVSDIE 126M 
bi IRGKKKLVEGAD 126C 
XII 	 a CTNCSVWCRLYEK 1051 
CTKCSVWCRLYES 105C 
Table 3.4 lists the "sequence subtypes" defined for each variable block. Subtypes 
were assigned on the basis of sequence homology, as shown. Each sequence subtype 
within a variable block is identified by a single letter. Some subtypes could be 
further divided e.g. variable block XI above contains two subtypes, "a" and 'b', of 
which the b subtype is subdivided into "b' and 'b]". 
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Table 3.5 Sequence "subtype compositions" of Sudanese DBL1 variants 
Sequence I II III IV V VI VII VIII IX X XI XII 
101A c x x x x x d 
biB x x x x x 










105A x x x x x x b 
105B m d a a c b a 
1050 in d a a c b a x x a a a 
105D j b x x a 
1055 x x x x b x 
105F d x x x a 
105G d 
1051 g x x x x x x a x a a a 
105K b x x x x x d 
105L 1 c x x x x x b x bi 
105L2 1 
105M a x x x x x b c x b 
105N c2 
105p 
105Q h i b b d a c a a al 
105R f x x x x x x x x a 
loss h i b b d a c a a al x x 
105T x a 
105U x x x x b x d x x b3 
106A x x b x d a3 x x x x 
bO6B j b 
1060 f x x x x x x b x b x x 
106D n g 
106E a f 
bO6F a f 
bO6G c 
126A a x x x d x x c x b1 x 
126B x x x x b a2 x b x b x 
1260 1 x x x x x x x x b bi x 
126D x 
1265 n x 
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Table 3.5 Sequence "subtype compositions" of Sudanese DBL1 variants 
(continued) 
Sequence I II 	III 	IV 	V 	VI 	VII 	VIII 	IX 	X 	XI 	XII 
1268' x x 
126G c h 
126H x 
126J c h 
126K x x 
126M n g 	x 	x 	d 	al 	x 	c 	x 	b2 	b 
126N x 
128A x x 
128C a 
128D 
128E x a 
128G 
128H x x 
128J 
128K in x 
128L b 
Table 3.5 The sequence encoded by each DBLI variant can be summarised as a 
string of consecutive variable block subtypes. These "subtype compositions" are 
listed for each of the Sudanese variants. The letter x is used to indicate where no 
subtype was assigned. 
The individual variable blocks and conserved boxes of DBL 1 can be 
described as follows. 
The 5' block forms the amino terminal portion of mature PfEMP 1 proteins 
and lies upstream of the area cloned in this study. In published variants it is 110-
135 amino acids long and of highly variable composition. Three consensus cysteines 
are found in this region of PfEMP1 (Su eta!, 1995; GenBank submissions). 
The GACA box is the first of the conserved boxes. It contains the annealing 
sites for the two forward cloning primers (Fl and F2). The two primers overlap in 
annealing sites and each incorporates one of two conserved cysteine codons. The 
GACA box is 12 amino acids long and has the consensus sequence GACAP(y/f)RR 
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LHVC. This portion of the cloned variants is primer derived and therefore omitted 
from both the alignment in Fig 3.3, and the GenBank submissions. In published 
sequences, the conserved aromatic position within the GACA box can be either a 
tyrosine or a phenylalanine. A region of sequence related to the GACA box, but less 
well conserved, is found in a similar position within the other (non-DBL 1) DBL 
domains of all published var gene sequences. 
Block I is the first variable sequence block of the cloned DBL1 variants. It 
varies in length from 15-20 amino acids, with 47 of 56 variants being 17-18 residues 
long. Whilst this region contains a high degree of variability, 36/56 variant 
sequences could be assigned to 13 discernible sequence subtypes (a-n, Table 3.4) 
considered in turn as follows. Subtype a groups five variants, two of which 
(SD 1 05M and SD 1 26A) are identical in this block. There are two identical variants 
in subtype b, SD128L and SD1O5K. Subtype c contains five variants, one of which 
(SD 101 A/SD 1 02C) was isolated from two parasite clones. Three of the other 
subtype c variants (SD 1O6G, SD126G and SD126J) are identical. The remaining 
subtype c variant (SD105N), designated ci, is less closely related to the others. 
Sequence subtypes d and e each consist of two similar variants from a single parasite 
clone that differ by two and one residues respectively. Sequence subtypef also 
consists of 2 sequences, SD1O5R and SD1O6C, which have no homology for the 
first 4 residues of this block and then match perfectly at the remaining 13 positions. 
Sequence subtype g, containing two variants of 16 and 17 amino acids in length 
(SD 1 02J and SD 1 05J respectively), is the only subtype defined for block I that 
contains sequences of different length. Subtype h consists of the SDI 05Q and 
SDI 05S variants, which are notable as their sequences are identical over the first 
645 of 729 nucleotides (including variable blocks I-X) after which they diverge 
completely. Thus they are grouped into the same subtype over most of DBL I. 
Sequence subtype i contains SD 1 26C and SD 1 02G, which are identical except for 
3 consecutive residues in the middle of the block. Subtypej contains 3 variants, of 
which SD1O5D and SD 106B are identical and SD1O2A is divergent at 2 positions. 
Sequence subtypes k and 1 each contain two variants from the same parasite that are 
identical for block I, and closely related to each other throughout the rest of their 
W. 
length (SD 1O2F and F2; and SD1O5L and L2 respectively. These two pairs of 
variants are discussed in more detail in section 3.6 . Sequence subtype m has 3 
variants SD128K, SD1O5B and SD 105C, the latter 2 being identical here and highly 
homologous throughout their downstream sequence, again see section 3.6. Sequence 
subtype n, although less conserved than the other block I subtypes, contains 
discernible homology for SDI26E, SD1O6N and SD126M). 
The LLSI box which follows block I is 16 residues in length, and includes a 
number of variable positions. The consensus motif for the LLSI box is 
LL(a/v)(d/e)VC(l/m)AakyEGxS (ill). 
Variable block II encodes 13-19 amino acid residues. Thirty-six of 56 
variants are 17 residues long, and a further 15 have a length of 15 residues. Only 
one variant contains an even number of residues for this region (SDI 26K, 18 amino 
acids). Block II is more variable than block I and only 22/56 sequences could be 
assigned to 9 sequence subtypes, however some groupings noted in block I are again 
seen here. Variants SDI 05T and SD 128E, not assigned to any of the block I 
subtypes, are grouped in subtype a. The variants SD102A, SD105D and SD106B 
comprise subtype b, and is the same group of variants that made up subtype j of 
block I; SD1O5D and SD1O6B are identical over block II. Subtype c contains 5 
variants, including the 2 variant pairs that make up subtypes k and 1 of block I. 
Subtype dconsists of the SD 105B and SDI 05C sequence variants. The variants 
SD 1 02B and SD 1 02H, identical over block II make up sequence subtype e; these 
same two variants formed subtype e of block I. Subtype fconsists of SD 106E and 
SDI 06F, identical over block II, which were assigned to subtype a for block I. 
Subtype g consists of SDI 06D and SD126M both of which were classified as 
subtype n of block I. Subtype h contains the variants SD 126J and SD 126G which 
were identical in block I. Sequence subtype i contains the SD1 05Q and SDI 05S 
variants. The observation that groupings of variants within one block are maintained 
in other blocks lends weight to the validity of the subtype classification as having 
some meaning for DBL1 sequence organisation as a whole. 
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Relating the subtype composition of all variants over blocks I and II, 17 of 
56 match subtype with at least one other variant over both blocks. For example, both 
SD 1 02F and SD 102172 have the subtype composition k-c. One subtype composition, 
f-b, is found in three variants (SD 1O2A, SD1O5D and SD 10613). This is discussed 
further in section 3.6, 
The LARSFADIG box is named after a characteristic DBL1 motif found in 
all variants published to date. It is 21 amino acids long and has the consensus 
sequence CT(v/m)LARSFADIGDI(v/i)RGKDL(y/f), the central 11 amino acids of 
which are absolutely conserved in all var genes and can be considered as the 
definitive identifying mark of a PfEMP 1 protein. The highly conserved nature of this 
region may indicate some important role in structure or function of all DBL 1, but 
make it less likely to be involved in variant specific functions. The non-DBL 1, DBL 
domains of PfEMP 1 contain less well conserved sequence elements of some 
homology to LARSFADIG at similar positions. The LARSFADIG box is the region 
to which the R  reverse cloning primer and F3 sequencing primer anneal. 
Variable block III is 8-15 residues long and highly variable in composition. It 
contains only two identifiable sequence subtypes, accounting for 5 of 22 variants. 
Subtype a contains SD1OSB and SD1O5C. Whilst these two variants are clearly of 
the same block III subtype, this region contains 3 of the 4 amino acid positions at 
which these sequences diverge from each other. The other subtype, b, consists of the 
closely related SD105Q and SD105S sequences grouped together with the variant 
SD1O6A. 
The LEIF box is 9 amino acids in length, and has the consensus sequence 
LExNLKxIF. It is the only conserved box other than the 3' WINQK box which does 
not contain a conserved cysteine. 
Variable block IV is the most diverse sequence block in terms of length, with 
a range of 15-29 residues. Within this size range there is an even spread of variants. 
It is not surprising then, that only 4 of 22 variants can be grouped into sequence 
Mf 
subtypes, and that these are the highly homologous sequence pairs SID 1O5B/SD1O5C 
(subtype a) and SID 1O5S/SD1O5Q (subtype b), both of which are identical over block 
IV. 
The KAITC box has the consensus sequence (NYY)(q/k)LREDWWxaNRxx 
VW KAITC. The first 3 residues of the consensus sequence are missing in 5 of 22, 
and the initial asparagine in 7 of 22 variants, hence the size of this conserved box 
varies from 19-22 residues. The KAITC box contains five conserved aromatic 
positions. 
Block V 12 of 22 variants could be grouped into four subtypes of 6-12 amino 
acids long. Subtype a contains SD1O5D and SID 1O5F, matching at 8 of 10 residues. 
Subtype b contains 3 variants (SD 1O5E, SD26B and SID 1O5U) of 6-7 residues. The 
SDIO5B and SD1O5C variants, which make up subtype c are 5 residues long. 
Subtype d contains 5 variants of 6 residues, of which there are 2 pairs of identical 
sequence (SD105Q/SD105S and SD106A/SD126A). 
The YFCG box is 8 residues long in 20 of 22 variants and has the consensus 
sequence YFrxTCg. In the two remaining variants (SD 1 05J and SD 101 A) the YFCG 
box is 9 amino acids long, containing an additional asparagine between the threonine 
and cysteine residues. 
Variable block VI varies from 7 to 12 amino acids in length, with a bias 
towards 8 and 12 residues. Two sequence subtypes have been defined for this block. 
Sequence subtype a contains 5 variants, of which three have been further 
subclassified as al (SD 126M), a2 (SD 126B), and a3 (SD 1O6A). The other two 
variants of subtype a are SD105Q and SD105S. Subtype b consists of SD105B and 
SD1O5C. 
The CRC block of conserved sequence, which separated blocks VI and VII, 
is only three amino acids in length. 
E1 
Variable block VII varies in length from 5-15 residues, with 13 of 22 variants 
being 5 amino acids long. Four sequence subtypes have been defined, with 
subtypes a and c containing the SD105B/SD105C and SD105Q/SD105S pairs of 
variants respectively. Subtype b contains SD105A and SD105M, whilst subtype d 
consists of SD1O1A, SD1O5K and SDIO5U. 
The FEE WAED box is a highly conserved sequence element and the region 
to which the R2 primer anneals. At 30 amino acids in length it is the longest of the 
conserved sequence blocks. The consensus sequence of this region is 
PTYFDVVPQYLR WFEEWAEDFCRKRKHKL, and includes eight conserved 
aromatic residues. 
The region from variable block VIII to the cysteine rich variable block (block 
XII) forms the least conserved stretch of DBL1. The conserved motifs that separate 
variable blocks VIII - XI are only 2-4 amino acids long and based around single 
conserved cysteines. However, despite this high degree of variation, the sequence 
subtypes defined for the variable blocks within this region are clearly discernible. 
Further, although the residue composition of this region is highly variable, four of 
the five variable blocks (VIII, X, XI and XII) contained in this stretch of DBL 1 are 
of fixed length. 
Variable block VIII is 6 residues long, and 9 of 14 sequences can be grouped 
into three well defined sequence subtypes each containing three identical variants. 
Sequence subtype a contains SD105J, SD105S and SD105Q; sequence subtype b 
SD1O5L, SD1O6C and SID 126B; and sequence subtype c SID 1O5M, SID 126A and 
SD 1 26M. 
The CR box, which lies between variable blocks VIII and IX, is only two 
residues long. 
Variable block IX varies in length from 5-9 amino acids, with half of the 
variants being 7 residues long. The only subtype discernible in this block (subtype 
a) contains the identical SD105Q and SD105S variants. 
The YC box is another dual residue conserved element, which separates 
variable blocks IX and X. 
Variable block X is 6 amino acids long in all variants. There are two 
sequence subtypes defined for block X, including 12 of 14 variants. Both subtypes 
can be subdivided further into variants with identical sequence. Subtype a contains 
the identical variants SD105J, SD105C and SD105R. Subtype a] contains SD105S 
and SDI 05Q, and differs from subtype a at a single position. Subtype b contains 
three identical variants (SD126B, SD105M and SD126C); subtype bi also has three 
identical variants (SD 1O6C, SD1O5L and SD126A); subtype b2 has only one variant 
(SDI 26M). The subdivisions of subtype b differ from each other at 1 or 2 positions 
(see Table 3.4). Until variable block X the variants SD1O5J and SD1OSC have had 
very low levels of mutual homology, but from this point until the end of the cloned 
region their sequences are convergent. This observation is discussed in more detail in 
section 3.5.3. 
The CT box consists of two conserved residues sandwiching two variable 
residues. It separates variable block X, which contains well defined sequence 
subtypes from variable block XI where few variants can be assigned to sequence 
subtypes. The CT box is the point at which the previously identical SDI O5S and 
SD105Q variants abruptly diverge from one another (see section 3.6 below). 
Variable block XI is 12 amino acids long in all variants. Despite this 
conservation in length, only 4 of 14 variants can be assigned to sequence subtypes in 
this block. Subtype a contains the identical variants SDI 05J and SDI O5C, and 
subtype b contains SD126M and SDI 26C. 
The C-rich variable portion (variable block XII) contains three consensus 
cysteines and a consensus tyrosine / phenylalanine aromatic residue. It has only one 
discernible sequence subtype (subtype a) grouping the SD 1 05J and SD 1 05C 
variants. Block XII is 13 amino acids long in all variants. 
The WINQK box is the final sequence element in the model, and marks the 3' 
end of the DBL 1 domain. It contains the annealing site for the R3 cloning primer. 
The WINDK box is not included in the alignments (Figs 3.3 and 3.4) or the 
GenBank submissions as its' sequence is primer determined. The WINQK box is 
conserved in published sequences, but does not contain any cysteine residues. 
3.5 Analysis of homologies between DBLlvariants 
Comparisons between Sudanese DBL 1 variants in multiple and pairwise 
sequence alignments allow the following observations to be made: 
in three cases (SD 1O1A/SD1O2C, SD1O2E/SD126F and 
SD 1 26B/SD 1 28H) identical variants were isolated from two genetically different 
parasite clones (see Fig 3.3). 
in a number of cases, multiple variants of almost identical sequence 
were isolated from the same parasite clone (discussed in section 3.5.1, and Figs 3.6 
(a)-(e) below). Multiple clonings of each of the variants, make it unlikely that they 
were artefacts induced by PCR error. Variants of such high similarity were isolated 
more rarely from different parasite clones (section 3.5.2, Fig. 3.7) 
there are a number of cases, discussed in section 3.5.3, where different 
variants share a high degree of sequence identity over one or more variable blocks of 
DBL I, but are highly divergent in composition over other blocks (see Figs 3.8 (a)-
(i)). Examples of this occur both within individual parasite genomes and amongst 
variants from different parasites. 
3.5.1 Highly similar DBLI variants from single genomes 
Examples of highly homologous DBL 1 variants cloned from the same parasite 
are considered in Figs 3.6 (a)-(e). In all cases similar variants were cloned using the 
same forward primer, indicating that the use of particular primers may select subsets of 
related var genes. 
Variable Block I 
10 	 20 	 30 
SD10214 111 H N L E T I U T T S T T K H D L L A D V C L A A K Y E G D S I 
SD102B H H N L E T I E T T STTKHDLLADVCLAAKYEGDS I 
I-I I-I N L E T I 	T T S T T K I-I D L L A I) V C L A A K Y E U D S I 
Variable Block II 
Sequence Primers 
40 50 subtype Used 
SDJ02H IK T H Y T P Y K H K Y G D S A S Q L C T V L 
Q L C T V Li  
e-e F1/R1 
SD102B K T H Y T P Y K H K Y G D S A S e-e F1/R1 
KTHYTPYKHKYGDSA S Q L C T V L 
Fig 3.6 (a) Pairwise alignment of SD102H and SD10213, two highly homologous 
DBL 1 variants cloned from the same parasite clone. They differ at a single position 
within variable block I, where glycine (SD102H) and glutamic acid (SD102B) are the 
alternative residues. Both variants have the subtype composition e-e and were cloned 
with the Fl/Ri primer combination. 
Variable Block I 
10 	 20 	 30 
SD102F2 IS H N L E T J 0 T K S T T S 0 T L L L E VCMAAKYEGQSI 
SD1O2F S H N L E T I D T K S T T S 0 T L L L E VCMAAKYEGQSI 
S H N L E T I DT K S VT S 1) I L L I. E V C M A A K V F C Q S I 
Variable Block II 	 Sequence Primers 
40 	 50 	 subtype Used 
SD102F2 IT C Y V P 1 V Q T K V N U V G S T V C T V L 	k-c 	F1/R1 
SD102F T G Y V P 1 V Q T K V N D Y C S P1 I C T V Ll 	k-c F1/R1 
TGYYPIYQTKYNDYGS .CTVL 
Fig 3.6 (b) Pairwise alignment of SD102F and SD102F2. Highly homologous 
variants isolated from the parasite clone SD 102. The same combination of primers 
(Fl/RI) was used to clone both variants. SD102F and SD102172 differ at two 
consecutive positions within variable block II, where a proline-isoleucine in SDI 02F 
is replaced with a threonine-valine in 5D102172. Both variants have the subtype 
composition k-c. 
Variable Block I 
10 	 20 	 30 
SD105L2 JH H N L E N I K 0 V N N I U N D T L L A EVCMAAYYE C G S L 
SD1OSL HHNLENIKDV N N I D N D T L L A EVCMAAYYE G F S L 
I-IHNLENIKDVNNIDNDTLLAEVCMAAYYFG SL 
Variable Block II Sequence Primers 
40 	 50 	 subtype 	Used 
SD105L2 
I
TRYNP I YQTKYKDS GSIKJI CTELI 	I-c F1/R3 
SD105L TRYNPIYQTKYKDSGSITIMCTELI I-c 	Fl/Ri 
T R Y N P I Y Q T K Y K D S G S 	C T E L 
Fig 3.6 (c) Pairwise alignment of SD105L and SD105L2. These variants differ at 
a single position within the LLSI box, where SD105L has a glutamic acid, and 
SDi05L2 a glycine. They also differ at the same two consecutive positions within 
block II as SD102F/SD102F2 (3.8 (b)). Here the threonine-methionine of SD105L 
becomes a lysine-isoleucine in SD105L2. Both sequences are of subtype 
composition i-c and were cloned using the same forward primer (F 1). 
Variable Block I 
10 	 20 	 30 
126j V R N L E N I S A L HKINNHTLLADVCLAALHG G A A I flS
126gVRNLENISALHKINNHTLLADVCLAALHEGAAI 
VRNLLN I SALHKI NNIITLLADVCLAALH G A A I S 
Variable Block II 	 Sequence Primers 
40 	 50 	 subtype Used 
1261 RNHGKHQLTNSYSQLCTEL 	c-h 	F1/R1 
126g IRNHGKHQLTNSYSQLCTEL c-h F1/R1 
R N Ii C K II Q L T N S Y S Q L C T E L 
Fig 3.6 (d) Pairwise alignment of SD126G and SD126J. Highly homologous 
variants, isolated from the same parasite clone, differ at a single residue within the 
LLSI box, where SD126J has a glycine and SD126G a glutamic acid. Both variants 
were cloned using the same primer combination (Fl/Ri) and have the sequence 
subtype composition c-h. 
Variable Bock 
10 	 20 	 30 
105c S1-1N1,ESIDTTSMTHKLLLEVCMAAKYEGNSI 
705b S H N L E S I D T T S M T H K L L L E V C M A A K V E G N S I 
S 1 N L ES I D T T SM 1' H K L LI. EV C M A A KY EON S I 
Variable Block II 
40 	 50 	 60 
105c D T H V P Q H Q R T N E D S P S Q I C T M L A R S F A D I G D 
105b 0 T H V P Q H  Q R T N E D S I' S Q I C TMLARS FAD I G D 
T 11 Y P Q H Q R T N F H S P S Q 1 (''1 51 F A R S 1 7 A D I 0 I) 
Variable Block Ill 
70 	 80 	 90 
705c IVRGKDLIYGNSK EKE KRDELETNLKTIFGK 
105b IVRGKDLSHGNSQEKEKRDELETNLKTIFGK 
	
I V F (1 K I) F 	0 N S 	F K F K F H F I, FT N F K T I F 0 K 
100 	 110 	 120 
705c I I H E K L K D K E G A E T R Y G S D T T N V Y Q L R E I) W W Y 
105b I I-I E K L K D K E G A E T R V G S D T T N V Y Q L R E D W W Y 
Variable Block V 	 Variable Block VI 
130 	 140 	 150 
105c A N R A T V W K A I T C D V H G S D V F R Q T C G D K K T T A 
105b J A N R A T V W E A I T C D V H G S D V F R Q T C G D K E T I A 
A N F A I V W F A I T C 0 V If 0 S H Y F F Q T C 0 D K E T T A 
Variable Block VII Sequence Primers 
subtype Used 
160 	 170 	 180 
105c T R V K D K C R C K D K N G K K I' G S N A D Q V P T V F m-d-a-a-c-b-a F1/R3 
105b F1/R2 
TRVKDKCRCKDENOKKPGSNADQVPTYF 
Fig 3.6 (e) Pairwise alignment of SD105B and SD105C. Highly homologous 
variants, both identified from the same parasite clone, differ at only 4 out of 183 
positions, three of which lie within variable block III, and one in variable block II. 
They were both cloned using the same forward primer (171), and have the subtype 
composition m-d-a-a-c-b-a. 
3.5.2 Highly similar DBLlvariants from multiple genomes 
Highly similar variants were found more rarely from different parasites. Fig 
3.7 shows three similar variants, each obtained from a different parasite clone. The 
high level of similarity between these sequences suggests they may be derived from 
a shared ancestral variant. 
Variable Block I 
10 	 20 	 30 
106b DKN IQQIKTEN ITTHNLLLDVCLAAKFEGQS I 
105d D K N I Q  I K T E N I T T H N L L L D V C L A A K Y E G E S  
102a D K N I Q Q I K A EQ ITT H N L L11D  V CM A A K FE G Q S I 
I) K N I Q Q I 	K 1' U N 	ITT II 	N I. 	I. L 1) V 	C L AA K i 	E U Q S I 
Variable Block II Sequence Primers 
40 50 Subtype Used 
106bLGYHPQYEVQYPSSGSTMCTML j-b F2IR1 
1O5dGYH[j]QYEVQYPSSGSTMCT[]L j-b Fl/R2 
102a[GYHPQY 1) lA'FIYPHSGSTMCTML j-b Fl/Ri 
U Y II P Q Y Ii V Q Y P S S U S T VI C T Nil L 
Fig 3.7 Alignment of three highly homologous variants, each isolated from 
different parasite clones. All were cloned using different primer combinations and 
have the same subtype composition f-b. 
3.5.3 DBLI Variants sharing a high level of similarity in one 
region are often highly divergent elsewhere 
Alignments of particular Sudanese variants revealed a high degree of 
homology within some variable blocks, but divergence within other regions of 
DBL 1. This is strongly suggestive of widespread recombination between DBL 1 
variants, possibly anchored at the conserved boxes. Examples of such alignments 
are shown in Figs 3.8 (a)-(O. 
Variable Block I 
10 	 20 	 30 
SD1Q5S D Q N L E L I K P K N I I T H N L L V D VCLAAKFEAESLI  
SDIO5Q D  Q N L E L I K P K N I T T H N L L V D V C L A A K F E A E S L 
DQNLELIKPKNI TTIJNLLVDVCLAAKFEAESL 
Variable Block II 
	
40 	 50 	 60 
SDI05S K T Y R 0 K V Q LTNHGFHT N I C T E L A R S F A D I 0 D I 
SDIO5Q K T V R G K Y Q L T N H 0 F Fl I N I C T E L A R S F A D I G D I 
K 'F Y R C K Y Q L T N I-I C F Ii T N I C T E F A K S F A D I G D I 
Variable Block III 
70 	 80 	 90 
SDIOSS I R 0 K D L YRGNNKEKDR LEDNLKKIFKQLYEEL 
SD 05Q I I R G K D L YRGNNKEKDR L E D N L K K I F K Q LYEELI  
I R G K D L Y R G N N K E K D R L E D N L K K I F K Q L Y EEL 
100 	 110 	 120 
SD1O5S T K N N K N E A I K T H V Q D D D P N Y V K L R N A W W E A N R 
SD1O5Q I T K N N K N E A I K T H V p D D D P N Y V K L R N A W W E A N R 
TKNNKNEAIKTHYQDDDPNYYKLRNAWWEANR 
Variable Block V 	 Variable Block VI 
130 	 140 	 150 	 160 
SDIO5S Q E V W K A I T C 0 A G G S K V F R I-I T C G T G T P 1 D D K C R 
SDIO5Q Q E V W K A I T C G A G G S K Y F R H T C G T G T P T D D K C R 
Q E V W K A I T C G A G G SKY F R H T C G T G T P T D D K C R 
Variable Block VII 
170 	 180 	 190 
SD1OSS C A I N D V P 1 Y F D V V P Q Y L R W F E E W A E D F C R K R K 
SDI05Q C A I NDVP TYF D Y VP Q Y L RWF EEWAEDF C R KRK 
C A I N D V P T Y F D Y V P Q Y L R W F E E W A E D F C R K R K 
Varahh Bock Vifi 	Variable Block IX Variable Block X 
- 	 - 
200 	 210 	 220 
SDIO5S H K L K D V K T N C R GENGTDR Y CSGNGLD C E K T VI N 
SDIOSQ I H K L K D V K T N C R GENGTDR Y C S G N G L D C T K T I R 
HKLKDVKTNCRGENGTDRYCSGNGLDC KT. 
Sequence Primers 
230 240 subtype Used 
SD1O5S A R C K V K M G K G C T C N P V V D h-i-b-b-d-a-c-a-a-al-x-x F2/R3 
SD1O5Q AKY IYA 105 
DflCFMFA 
ECTKSLCGFYKK h-i-b-b-d-a-c-a-a-al-x-x F2/R3 
A. 	 .G CT C F C. V 
Fig 3.8 (a) Alignment of SD105Q and SD105S, cloned using the F2/R3 primer 
combination, are identical for the first 215 of 263 amino acids, including variable 
blocks I-X, after which they are highly divergent. The subtype of each of these 
variants is h-i-b-b-d-a-c-a-a-al-x-x. 
ME 
Variable Block I 
10 20 	 30 
105c S riHi N L E S 	I DI I S M T - - H K L L L E V C M A A K Y E G N S I 
705j H_H N L E I I F T I S K T S T D T L L A_E V C M A A Y Y E G EIS L 
H N L E 	I 	TI S 	T F. I. 	F V C M A A 	Y F G 	S 
Variable Block Il 
40 50 	 60 
105c D T H Y P Q H  Q K[77N   EMDS P S 
T R H V K H K LT 	SV 
Q I C I M L A R S F A D I G D I V
105j N I N I C T V L A R S F A D I G D I V 
.11. 	TN D .ICT.LARSFADIGDIV 
Variable Block Ill 
70 	 80 90 
105c R G K D L F Y G N S KMEK E K R D E L F T N L K T I F C K I H E K 
105j RGKDLFYGNTYS T RKVLDDNLKT IF 	- - 	- - 	EN 
RGKDLFYGN. 	E R 	L. 	N L K T I F F 
100 	 110 	 120 	 130 
105c 	1. K D K E G A B T R Y C S D T T N Y Y Q L R E D W W Y A N R A I V 
105j I K K S D T K L 1K L N DU ------Q I RET WWE A N R F TV 
K 	 T 	 Q N F WW ANR TV 
Variable Block V Variable Block VI 
140 150 160 
105c 	W F A I I C - - D V H C S D Y F R Q T C G D K BFC I T A T R V K 57K 
105j W K  I I C S DID L K N S S Y F R TIT Al -  - 	- - 	A G T R 'F N D K 
W A 	I T C 	D. 	.S Y F R 	T. T  D  
Variable Block VII 
170 	 180 	 190 
105c 	CRC K D F N G K K P G S N A D Q V P 1 V F D V V P Q V L R W F E 
105j C R C I K S S G - - - A K V D D Q V P 1 Y F D V V P Q V L R W F E 
CRC 	 C 	 DQVP'I'YIDYVPQYLRWFE 
Variable Block VIII 	Variable Block IX 	Block X 
200 	 210 220 	 - 	230 
105c 	EWAEDFCRKKKKKLEKLEQQCRDYKQNLYCSGN 
105j EWAEDFCRKKNKKIKDVKTNCRDEKE-KYCSGN 
E W A E D F C R K K 	K 	. , C R D 	K. 	YCSCN 
240 	 250 	 260 
105c G V D C T K T I Y K K G K L V I G E H C I N C S V W C R L V E S 
105j G Y D C R K I I Y K K G K L V I G E H C I N C S V W C R L V E K 
G Y D C 	K T I Y K K G K L V I G E H C T N C S V W C R L Y E 
Sequence Subtype Primers Used 
105c m-d-a-a-c-b.-a-x-x-a-a-a F1/133 
g-x-x-x-x-x-x-a-x-a-a-a F1/R3 
Fig 3.8 (b) Alignment of variants SD105C and SD105J. Variants have highly 
divergent sequences until variable block X after which they are almost identical. 
Both variants were cloned from the same parasite using the primer combination 
F1/R3. The subtype composition of SD105C is m-d-a-a-c-b-a-x-x-a-a-a, and that of 
SD1O5J is g-x-x-x-x-x-x-a-x-a-a-a 
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From Figs 3.8 (a) and (b), it is tempting to suggest that the region ofDBL1 
from block X to the CT box may constitute a hot spot for recombination. Within this 
short stretch, previously identical variants SD105Q and SD105S abruptly diverge, 
and the previously highly dissimilar sequences of SID 1O5C and SD1O5J equally 
abruptly converge. 
Comparisons over the region encoded by the '-220bp variants suggest that 
recombination may also occur frequently between var loci at the LLSI box lying 
between variable blocks I and II. There are a number of examples (Figs 3.8(c)-(i)) of 
variants sharing a high degree of homology over either block I or block II, but very 
little over the other block. 
Variable Block I 
10 	 20 	 30 
105k D H H L S Y M N A G K T N T T D N L L L E V C M A A Q V E G Q S I 
1281 
	
D H H L S Y M N A G K T N T T D N L L L E V C M A A Q F E G K S I 
D II II I. S V M N A C K I N I 1 D N L 1, 1, I- V C NI A A Q F Ci 	S 	I 
Variable Block II 
Sequence Primers 
40 50  Subtype Used 
105k 	RGQHDKHKLDNNNSSSQLCTVL 
1281 SGRYPQYVAKYGDLGS TIM CTVL 
b-x F1/R2 
b-x F2/R1 
G. S 	CT 
Fig 3.8 (c) Pairwise alignment of SD128L and SD105K . Two variants with an 
identical block I sequence subsequently diverge in the LLSI box and block II. Each 
of these variants was cloned using a different primer combination. 
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Variable Block I 
10 	 20 	 30 
126A DQHLSHMKAEKIKNKHNLLLEVCLAAKHEGQS 11 
105m DQHLSIIMKAEKINNKHNLLLEVCLAAKYEGESLI 
D Q H L S H M K A E K I NKHNLLLEVCLAAK EG. S. 
Variable Block II 
40 	 50 	 60 
726A A]QHG KY H T D (iG[- - TM CT V L AR S F A D I G  I I 
705m K[JYJD K V N A T Y[DR S Q L C T V L A R S F A D I G D I I 
G H KY.. S S 	.CTVJ,ARSIADIGDII 
Variable Block Ill 
70 80 90 
126A 	RGKDLYIRNKR- K-- 
705m R G K D L F IGYDKKDRVQKKKLQDSLKNI 
- - - EKDRLEKNLKKIFFKM 
FIG NYN 
RGKLIL. I 	 .K . 	L. L  IF I 
100 	 110 	 120 	 130 
126A - - - - - fl-RNNRMLSTLEDD -  - - - - - - -QIREYWWEflL 
7 05 E L T T S K N V DA K A R Y N OP KG D F F Q L R E D WW A 
G N K . 	D 	 Q.RE WW L 
Variable Block V 	 Variable Block VI 
140 	 150 	 160 
126A NREMVWYAITCGAAGGTYFRGVG-RNSTNEK 
705m N R E K V W S A I T C N A Q G N K_V F R 
P[TQC 
SG G E S I A H IN K 
N R E VW AITC.A G. 	Y F R T 	G 	.. 	K 
Variable Block VII 
170 	 180 	 190 
726A MCRCPSHKVPTYFDYVPQYLRWFEEWAEDFCTKR 
105m TCINGDPPTYFDYVPQYLRWFEEWAEDFCRKR 
C C 	I'TYFDYVPQYLRWFEEWAEDFC KR 
Variable Block VIII 	Variable Block IX 	Vrahle Block X Primers 
Used -- 	






l KHKLQNAKEQCRG - 
DK Y
G N - 






KI-IKLQNAKEQCRG 	K 	G 	..Y CDJ.N Y D C 	.T 
Sequence 
240 	 250 Subtype 
126A K S A KflHEMLV Q G E E 	C C K K 	S V V C I P F G P a-x-x-x-d-x-x-c-x-b1-x- 
105m I S A E 	KF P D SID C N K C S V S C I P FIR T a-x-x-x-x-x-b-c -x -b -x- 
SA . L 	.0 	K C S 	C I 	P F 
Fig 3.8 (d) Pairwise alignment of SD105M and SD126A. Variants cloned using 
different primer combinations, differ at only one position within block I, and two 
within the LLSI box, but have highly dissimilar block II sequences. Further 
downstream they again converge over the course of variable blocks VIII and X, but 
otherwise are heterologous in sequence. 
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Variable Block I 
10 	 20 
	
30 
106c V R NI. E K M D S T K I K D K N V  L AE V C Y A A K Y E G 1' S L 
105R N K NM EKMD ST K I KD KN V L LA E V C Y A AKY E G KSL 
N. EKMI) S T K I K D K N V L L A E V C Y A A K Y E 
	
S L 
Variable Block II 
Sequence 
40 ____ 50 ______ Subtype 
106c K U Y H D Q II K 0 T N P D S - 	K I C T f-x 
105R V E K Y K P Y K Q P N N D S D T DI 	C T f-x 





Fig 3.8 (e) Pairwise alignment of SD!05R and SD106C. Variants are highly 
homologous over variable block I but they diverge almost completely throughout 
blocks II-XII. (Only the first two blocks of variable sequence are shown). 
Variable Block I 
10 	 20 	 30 
1059 NKNFPNMNSKDSSKAKHDLLVDVCMAAKYEGES 
7051 NKNFPNMNS KDS LKAKNDLLVDVCYAAKYEAES 
NKNIPNMNSKDS K,\K.DLLVDVC A A K Y E ES 
Variable Block II 
Sequence Primers 
40 50 Subtype Used 
105g 
PL 
KVYHEQYEVQYP S SGSTMCTE L d-x F1/R1 
105f I PYHI)QYKLTYGD- - SQVCTv L d-x F1/F2 
L 	YH.QY . 	Y S CT L 
Fig 3.8 (1) Pairwise Alignment of SD105F and SD105G. Two variants, isolated 
from the same parasite clone, have a highly homologous block I, after which they 
diverge. Both were cloned using the F 1/Ri primer combination. 
I 
Variable Block I 
10 	 20 	 30 
SD728K HHNL ES I D T TS MT H K L L L E V C M A A K Y E G N S JIEIIY 
SD105C H N L E S I D T T S MT Fl K L L L E V C MA A K Y E G N S I DrT H V 
SD105B 
IS 
S H N L E S I D T T S MT H K L L L E V CMA AKY E GNS ICiITHY 
S 	tIN LIE S I DY T S MT H K L L L EV CMA A KY EG N S I THY 
Variable Block II 
40 	 50 	 Sequence Primers 
SD 128K 'r 	' IQ-7H N N E IG mA I Q L C T J 	
Subtype 	Used 
SDI05C p Q H  Q  R I N E D S P S Q 	
MT 
m-x F2Rl 
SD105B IP Q  HO R T N E D S P S Q I C T MI 	
m-d 	F1/R3 
m-d F1/R2 
P Q H Q R T N E D S P S Q I C T M L  
Fig 3.8 (g) Alignment of SD105B, SD105C and SD128K. Three variants, almost 
identical in block I, after which SD 128K diverges from the two SDI 05 
sequences. SD105B and SD105C also share a high degree of homology throughout 
blocks III-VII, see Fig 3.6 (e). 




V R N L E N I S A LJK I N NJT L L A D V C L A A L H E G[2JI 
VRNLEN IS ALHKINNHTLLADVCLAALHJGAAI 
VRNLEN IS ALHKI NNLJITLLADVCLAALHEGAA I 
V R N L E N I SALHK I NNHTLLADVC LAALI -  EGAA I 
Variable Block ii 
Sequence Primers 40 50 
Subtype Used 
106g QID Y P[hJ1\ Q Y A S S F 1 JS Q I C TJfl C-X F2/R1 




S R N H G K H Q L T N S Y S Q L C T E L 
Fig 3.8 (h) Alignment of SD126G, SD126J and SD106G. All three sequences share 
a high level of homology within block I, but SD1O6G diverges from the two SD 126 
variants in block II. SD126G and 5D126J are identical in both blocks I and II, and 





Variable Block I 
10 	 20 	 30 
102f 	sIH N L E T I DI- FT 
K S T I S D T L L LEVCMAAKYEGQS
102f2 
CH 
HNLET 1 J2i - IKS T T S D TL LL EVCMAAKYEG Q SI  
105/ 	 HNLENIIKDVINNIDNDTLLAEVCMAAYYEGLSL 
105/2 HNLENI[JDVNN I DNDTLLAE VCMAAYYEGjSL 
102d 	H N L E T I El-  T T SMT 1' II DIL L L E V C MA A K Y E G Q S I 
HHNL In- TI. 	TSTDTLLLEVCMAAKYEGQSI 
Variable Block H 	 Sequence Primers 
40 	 50 	 Subtype Used 
102f 	
IT 
G Y V P I V Q I K Y N D V G sJi C I V L 	k-c 	Fl/Ri 
102f2 GYYPIYQTKYNDYGSTVCTVL k-c F1/R1 
105/ 	 RY NP I Y QT KY K D S G ST M CT FL 	I-c 	Fl/R3 
105/2 RYNPIYQTKYKDSGSDICTEL I-c F1/R1 
102d 	R 1)_Y Y P 1 Y Q T K Y N D Y G S T I C T V L 	X-C 	F1/R1 
T YYPIYQTKYNDYGSTICTVL 
Fig 3.8 (i) Alignment of five variants (SD102D, SD102F, SD102F2, SD105L and 
SDD105L2). All five variants in this alignment share high levels of homology in 
block II (subtype c). In block I they diverge into two pairs of high homology 
(SD IO2F and SID IO2F2, subtype 1; and SID 1O5L and SID 1O5L2, subtype k), and one 
sequence of low homology to the others (SD102D, no assigned subtype). Pairwise 
alignments of SD102F/SD102F2, and of SD105L/SD105L2 are shown in Figs 3.6 
(b) and (c) respectively. All five were cloned using the same forward primer (F 1). 
3.6 Conclusions 
A number of conclusions can be drawn from these results: 
PCR amplification of var gene sequences is clearly influenced by primer 
bias, resulting in the amplification of particular subsets of variants. 
Highly related DBL 1 sequence are found within the genome of single 
parasites. Such closely related variants may occur more rarely between different 
parasite clones. 
Identical DBL 1 sequence variants may be found within the genome of 
genetically different parasite clones whose overall var repertoires are not identical. 
Behind the sequence diversity of DBL 1 there is a framework structure of 
highly conserved cysteines, aromatic residues and "boxes" of conserved sequence 
motifs which alternate with variable "blocks" of sequence. A schematic model of this 
framework is presented in Fig 3.5. 
Within each of twelve defined variable sequence blocks, individual 
variants can be assigned to "sequence subtypes" on the basis of their degree of 
homology to other variants. 
Variants assigned to the same sequence subtype for particular variable 
blocks are often highly divergent in other variable blocks. 
There is a considerable degree of DBL1 diversity encoded by 56 variant 
sequences obtained from 6 parasite clones isolated from a small geographical area in 
the Sudan over a relatively brief time interval of two months during the transmission 
season of 1989. 
Together, these conclusions suggest that the DBL 1 region of the var genes 
encoded by Sudanese P. falciparum parasites is highly dynamic. Widespread 
recombination between var loci resulting in a constant shuffling of sequence 
subtypes encoding the variable blocks of different variants is a plausible explanation 
for the observed variation. The conserved boxes which make up the conserved 
framework structure of DBL 1 may provide the pivot points for this recombination. 
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Chapter 4 
Phylogenetic analysis of Sudanese var genes and 
implications for population structure 
4.1 Introduction 
In recent years, the field of molecular evolution has produced powerful 
computerised tools for phylogenetic analysis of nucleotide and amino acid sequences. 
Hypotheses about evolutionary history of organisms and genes generated from 
sequence alignments are presented in the form of "trees". Each terminal node (i.e. 
branch end) in a tree represents a single sequence from the alignment, whilst internal 
nodes (i.e. where branches meet) represent hypothetical ancestral sequences. A wide 
variety of tree building techniques have been developed based on a range of 
philosophical and mathematical approaches. These techniques have important 
applications for the epidemiological study of infectious disease as means of 
monitoring the spread of particular pathogen "strains" and virulence genes within 
populations. Here, phylogenetic analysis is used to investigate relationships between 
Sudanese DBL 1 sequence variants and the implications this has for the structure of 
this P. falciparum population. If the population has clonal or "strain" structure, then 
var repertoires of different co-circulating parasites will have evolved in some degree 
of genetic isolation and thus should not be clustered together in phylogenetic trees. 
However, if the population is panmictic, then var sequences of co-circulating 
parasites will be related to each other through frequent recombination and shared 
ancestors. Thus trees should show clustering of variants from more than one parasite. 
4.2 Maximum Parsimony analysis of Sudanese DBLI 
sequences isolated from 6 different parasites 
Maximum Parsimony was used to analyse the region between F2 and RI 
primers (see Fig. 3.1) which is common to all cloned Sudanese DBL1 variants. The 
alignment in Fig. 3.3 was used to generate a phylogenetic tree (Fig. 4.1). Identical 
sequences isolated from multiple parasites are shown as single entries, as are SDI 05Q 
and SDI 05S which are identical over this region (see section 3.5.2). 
The tree generated (Fig. 4.1) is poorly resolved, with twenty-eight of fifty-six 
sequences unresolved, or falling into clusters with bootstrap value of less than 65%. 
A sequence remains unresolved when analysis discerns it to be no more closely 
related to any one sequence, than it is to any other in the data set. The remaining 
twenty-eight sequences fall into eleven statistically supported clusters (A-K, Fig. 4. 1), 
five of which (A-E) contain variants from more than one parasite. Cluster A contains 
variants from five different parasites with a bootstrap of 98%, including 
SD1O1A/SD1O2C itself isolated from two different parasites. Cluster B groups 
sequences from three different parasites with a bootstrap of 66%. Clusters C, D and E 
(bootstrap 66-85%) each consist of two sequences from different parasite clones. 
Cluster F groups three sequences from SD 102 with a bootstrap of 68%. Clusters G, 
H, I, J and K each contain two sequences from a single parasite with bootstraps of 92-
100%. 
Sequence alignment involves subjective decisions on minimisation of either 
mismatches or "gaps", which may influence the topography of trees generated by 
phylogenetic analysis. It was decided to test whether the relatonships described in Fig. 
4.1 were upheld when the sequences were re-aligned with gaps minimised at the 
expense of increased mismatches within variable blocks I and II. The realignment 
(Fig. 4.2) was again analysed using Maximum Parsimony and the tree generated (Fig. 








Fig. 4.1 A Maximum Parsimony model of the relationship between 56 Sudanese 
DBL1 sequence variants. The tree was generated by analysis of the alignment shown 
in Fig. 3.3. Statistical support is provided by the bootstrap resampling method (100 
resamplings). Bootstrap values are shown above branch lines. Branches with a 
bootstrap value of less than 50% are collapsed. Statistically significant clusters of 
variants from more than one parasite are boxed in red; statistically significant clusters 
of variants from a single parasite are boxed in blue. 
inn 
Variable Block I 	 I 	LLSI Box 	 I 	 Variable Block II 
70 	 2 	 30 	 40 	 50 	 60 
SD1O5P 	 NKNMFKMGRTSTTKHD 	 Il.I,D''MA "7N SAQSL 	 IRYHDKHQLTNEAflQI.IVI 
SOlOIB NKNM F. NMDflNNN GKAKHD 	lfll 	MAN 	 INSI -KTHYPIKYQTAYGNFPTII 	ll 
SD126K 	 H H S I I T N N T T S T T H K 	 A F L A S IN F. E S IN V F K Y K S V K I K K N 2 N P DON IN 
SDI05J II I-I N I I T I IN T T S K T S T D T A E I 	M IA N Y 	S 1 0 S L 	T R Q I-I V K If K I T N S D V N 	N I 	I V IN 
SDIO2J 	 1.1 SI N I T 	F T T S T T T N K 	 A S S M N A F A Q S L K N V H A Q V 5 (1 N N 1 0 IN N]N I V I 
SDI05R N K NM I KM 0 S 2 K I 	K N V I A L 	N A I. 	 S L 	V S K Y K V K Q F N N DDDrl) I 	El' 
SDI06C 	 V IS N I IN KM 0 T K K K N V 	 I N A K F (I 	I. K 0  HO Q H KG r N DUK I V 
SD 728G DQIIINFKINDYENITNDT IIVD 	IGAl 	FAISSIN 	KTVI1AQVQDKYPDSTEIM 	Ml 
SD106A 	 DQIILFFII K H D K I TRHN 	- 	 ADI FAIN S 1051 EKVISGQVQINNNSDVNI NI F 
SDIO5Q/SDIO5S 0 Q N I. F L I K P K N I T 	H N - I I 	I) S 	A 5 K F. A ESL 	K T V 0 (3 K V Q I T N II H F OIflN I 	I S I 
SDI05T 	 0 Il N I. Ii Q I K P Fl 'I I A 1 H N 	I I. V 0 V N Q 	F (I  IF. II I S 0 V Y P 0 V Q T K Y K D S IA S F I I V I 
SDI28E D Q N I I Q I IS P E Q I T 	T N N I I V D V 	A N Q F I. 	I. S 	S 0 0 N' IS Q V (3 N K Y D D S P 5 (3 I 	I M I 
5D1268/SDI28H A Il 5 1, F Q I F P I K I T N T II N - 	I V 0 V Q A A K 	I Ni (3 5 I F Q D N' P F V IS A I V N I) S P S K M I M I 
SDI26C 	 I) K 'I I S Q I K V F Q I S 	H N - - I I V D S 	Q A N F. I 	Q ii I 	H Y (3 S (3 V 	V Q N P (1 5 C, S (I 	I I 	I M I 
SDIO2G DKNIIQIIIPDKI TIJN 	 INIADG 1110, lADS! RGVYAINVD1QYPSSCNI IflI 
SDIO2A 	 D K N I (3 (3 I K A S Q I 	1 H N L IN A 0 5 	M A A N 	1. Q S I 	S H V H P (3 Y I) A 1 Y P G S 0 S F M 	I M I 
SDI05D DK!IQQIKIINIT(FIN 	 LIIDVIINAAK 01,1,51 KOYSILQYIVQYI'SSG'-IM Fl 
Sf7068 	 D1-1NIQQIKTLNI(SHN I,IIDA'INAAI. FC.QNI TGVHPQYIVQYPSSIA'IM I I 
Sf10213 HHNII -II I'TSMTTHD 	 IIIES MAAF INI.QSI RDYYPI'IQTKYNDVDSII VI 
5D102F2 	NH NI IT I DI KS(1 SOT - 	III 	MAIN I 13Q5 I 	TGYYPI YQTKYNDVDSTV 	I VI 
SD102F SSINIFSIDTKS((SDA 	 IILEI MAIN 5I.QSI TOYYFIYQIKYNDYDNPI' VI 
S0105L2 	II II A I F N I K V N N 	N D T I flI S 	M A A 	I "D IN 	I A V N P I V (3 1 K N' K 0 Ii S K I 	
:' 
flI 
SDI05L IIIINLINIKDVNNIDNDT 	 ljIN MAlAY IAESL SRYNPIVQIKVKDSGSSMIIINII. 
SD1OSU 	 VRNINIININDYSKINNKISN IIVI IAAK 01551 TGRYPQI-IQIINPDAKSQI'IVI 
S0105E S Fl N I I- S I (3 'I N N Y N S 0 N A K El 	I I V S S 	M A A K 	F 1, II S I 	K N Y Y P 
PQ 
	
V 13  0 r V P 0 1 N S Q I. I V IN 
513128.4 	 N I. S S I S 	N' N S N A IS H K 	I I DL  V M A A K F I' N S I N T H Y 1 	H 	(3 A N P 1) 1 K S (3 L 	I V I 
SO 128K II II 	L I- A I I) T T S M 1 II K 	 IN I IN P 	M .N N K 	F (I N S I 	F T V V T P 5 (3  II N N F 0 T A 	(3 1 I V I 
SDIO5C 	 S H N 1. I S I 0 T I S M 	II K I I I I A M A A K I A N S I 0 T II V P Q II  (3 S I N F D S P 5 (3 I 	I M IN 
Sf1056 S II N I. IN 5 I I) I C S M F SI K 	 I IN IN F A 	M A A K 	S (. N S I 	H I H V P Q II  Q IS 1 N F 11 S P N (3 I M I 
SD1O2H 	 IIIINII,TII'TCSITKHD II. DVIINAAI', (.Dll KTHVT YKSIKVC,DSA QIN VI 
5131026 IIlIN-LISCIISTS1TKIII)' 	SINADGI,IAK I',DSI 	KTHYTPYKHKYI.DSA'-OI.' IVI 
S0128D 	 DKNINFTISNDDSNAINIIK IIAS'IIMNNKFII,DI.l KTRYTIIIQATYODSAIAII 	VI 
5D126H II V N L Ii K M (I I K K N K A IS II N 	I I. A I- S fl N A 0. 	1 I, II S I 	T 0 IS N' R (3 Y  (3 A T V H D F CI 	N I I V IN 
SD 1281 	 S 	INS 	TIN 	TTSMTKFID INIAI,V'S(IK II.BTL TSVHPQVQFJTNPD'QI' 	VI. 
513105F NKNFPNMNSKDSIKAKND IINV D\I D NAK  ADLISL - IPYSID VKINTYGD Q VI, 
5131050 	 NKSPPNMNSKDSSKAKHD I,LVDV'MAAIC 15101 KVVHFQVIIVQVPSD(. FM SEll. 
513128!. DHIILSYMNAIAKTNTSDN 	ININLEVIMANQ FIIKAI SORYPQVVAKYHDIO IM SVI 
513105K 	 011115 SYMNAHKTNTTDN LI.LPS 	M A A Q F'. SI 	RHQHDKIIDI.DNNISDS'IQI 	SVl 
SD1O6F 0 Q II I, S II M N A H K I 74 I T D N 	1, IN I S N L A A K 	F A F S I V 1 K H K B F K K T H 14 0 	N I C I 
SD 06E 	 DQIILSHMKASKINSKDN I.LLLN''IlA 	Q 00551 	 VFKHKINI -KKTIINI) NIV]III 
S0128C D (3 II I 	El M D I N K I J; FN T H N 	L IN IN A I 	IN A S F, II F 03 Q S I T H N' N' I' K V F V (3 V P 0 S S I 	I 	I M IN 
S13126A 	 DQIII IIMKAFKI 	NKHN - I,INlFNlI.NAI10I0IQYI 	 AISQHII9YIITDHSc..r IVI 
SD1O5M DQIIISSIMKAFKIDN KHS4 	III,AV.IN4\l. 	0(1,51 KHYIIDKY1SA1VSI)SISSQI.'NVI 
513102E/s13126F IIL
RR 
N I F r I K N T T S 	1 5 5 D 'I 	I L A F N DA A N I I A F N I 	 K T V V l'Dll  (3 II K V 0 0 5 13 I ' I V I 
S01266 	 D'-.IFQIKPEIQITIISS 	 LADY INAAQHlN.QlI VKKINQEVDPNNVISISTI IVI 
Sf1060 I) NIl IN Q I D I' AK I 	I H N I I. 	D NI 	IN A N S. H F Ci F'TI 	 I D NY P SD 1111 N K 	0 	II
S0126M 	DNIF,IIIFPDQISHN 	l,IVDNIIIAANIIII-IDNI -- 	INNN'PDNRDKKKGIII[5J1 
SD 05A 1) V 	I 	K I 1 3 A N VI H N I I V D NUIL A A I. II I I, I) S IN 	- 	S K Y SI K II N P K I I P K S N V • I V I 
51312613 	 D K 1,  I, I' A I 1 V F N F Q N C D 0 	I IN CI N I 	V A A F 	F I Q S I - V N N V P D K N N S N N K S S I 	I A I 
5D126N D IS I S V I N N N NT ADS 51 D I, 1, CI N NV T I', F I 'D' I 	 V A K 	P K D I N 0 N K S S I I A I 
Sf10613 	 V Il N I. K N I ODIN 0 K I N N D T 	I. IN A I) V SLA 1.  J El F II 	K I F (3 1) V P K V Q A Q V A S I. CDP S Q I 	I M I 
SDIO5N VS,I ISNI SNYGKI NNDT I INAI)NIIAAI 111,11111 	SSDHHKYQF'I NNDVNANI ' IMI 
SDI26J 	 VI1',IFNISAINHKINNHT 	LIAD% 	SIST Hl,(,AAI SISNFIGI',IIQINTNSYSQI
Sf1260 V IS '5 1 IS N I S A IN SI K I N N H I I I. A 0 V 	A I II 	Cl A A I 	 S IS N H CI K II Q IN 1 N S N' S (3 IN
SDIO1A/SDIO?C VIS 	IN 	S A L D K I N 50 DI 	I I. A II A I HE A A I Il 0 D 	S 	V (3 IS 	N II 0 	Q IN ' NIl I II \ 131111, 'I I 
Fig. 4.2 Alignment of Sudanese DBL1 sequences with gaps minimised. The 
region aligned lies between the primers Fl/F2 (see Fig 3.1) and is common to all 56 
cloned variants. Conserved residues are boxed and shaded red on dark grey; 
conservatively substituted residues are boxed and shaded light grey. Cysteine 
residues are highlighted in red on yellow and conserved aromatic residues are 
highlighted in blue. Two blocks of variable sequence (I, II) are found within the 
aligned area and are delineated by red boxes. A semi-conserved sequence element, 
the LLSI box (see section 3.4.3) is delineated in blue. Three of the variants shown 
above (SD126B/SD128H, SD102E/SD126F, and SD1O1AJSD102C) were each 
isolated from two different parasite clones. Two of the sequences isolated from a 
single parasite clone (SD105Q and SD105S) are identical over the region portrayed 










Fig. 4.3 Maximum Parsimony analysis of "gap minimised" alignment of 56 
Sudanese DBL1 sequence variants. Tree based on alignment shown in Fig. 4.2. 
Statistical support is provided by the bootstrap resampling method (100 resamplings). 
Bootstrap values are shown above branch lines. Branches with a bootstrap value of 
less than 50% are collapsed. Statistically significant clusters are boxed in red where 
they contain variants from two or more parasite clones and in blue when they contain 
variants from a single parasite. 
Maximum Parsimony analysis of the re-aligned sequences has produced a tree 
(Fig. 4.3) that is very similar to that produced from the first alignment (Fig. 4.1). 
Clusters are boxed and assigned the same identifiers (A-K) as in Fig. 4.1. Again, 
clusters A-K are found in this tree with significant bootstrap support (65-100%). 
Cluster B however, has lost one sequence (SD128G) and now contains sequences 
from two different parasites. Resolution is again poor, with twenty-seven of fifty-six 
sequences unresolved, or having a bootstrap of <65%. 
Maximum Parsimony analysis seeks to minimise the total number of character 
changes (substitutions) necessary to account for the differences between members of a 
given data set, and involves generation of hypothetical ancestral sequences at each 
internal node. With this method, a certain bias is observed in that changes at relatively 
conserved positions contribute more to the final tree topography i.e. are more 
"phylogenetically informative" than changes at more variable sites. To investigate the 
extent to which the conserved LLSI box (see Fig. 4.2) has contributed to the 
topography of Maximum Parsimony trees previously generated, a further analysis was 
performed solely on this region (Fig. 4.4). The Maximum Parsimony tree generated 
from LLSI box alone is less well resolved with forty-five sequences failing to cluster 
with significant bootstrap support. There are only four clusters with a bootstrap 
above 65%, one of which (*, bootstrap 67% Fig. 4.4) containing sequences from two 
parasites is not found in any other Maximum Parsimony or Neighbour Joining (see 
section4.3) analyses. Cluster A is present, but here groups only five sequences from 
four parasites at bootstrap 75%, inclusion of the other sequence (SDI 06G) from Figs. 
4.1 and 4.3 lowers the bootstrap to 63%. Clusters I and J containing sequences from 
single parasites are retained in Fig. 4.4. In this tree cluster I contains a third sequence 
(SDI 05J) not present in other analyses. Differences between the tree based on the 
LLSI box alone, and those based on the full alignment show that changes at positions 
within variable blocks I and II contribute phylogenetic information towards the trees 
in Figs. 4.1 and 4.3. 
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Fig. 4.4 Maximum Parsimony Tree Based on LLSI Box. Tree generated from 
positions 21-36 in Fig. 4.2. Statistical support is provided by the bootstrap resampling 
method (100 resamplings). Bootstrap values are shown above branch lines. Branches 
with a bootstrap value of less than 50% are collapsed. Statistically significant clusters 
are boxed in red. 
43 Neighbour Joining Analysis of Sudanese DBLI 
sequences isolated from 6 different parasites 
The phylogenetic method chosen can influence tree topography. Therefore a 
second method (Neighbour Joining) was used to analyse the Sudanese sequences and 
investigate whether the relationships found using Maximum Parsimony were again 
supported. Neighbour Joining converts sequence alignment data into "pairwise 
distances" (i.e. the number of mismatches between pairs of sequence) and uses these 
values to generate a tree. As changes at individual positions are not taken into 
account, there is no bias in "phylogenetic information" between conserved or variable 
sites using this method. Analyses performed using Maximum Parsimony were 
repeated using Neighbour Joining for both alignments (see Figs. 3.3 and 4.2) and 
presented in Figs. 4.5 and 4.6 respectively. 
Resolution was better using this method, with seventeen and eighteen of fifty-
six sequences not assigned to clusters with bootstraps above 65% in Figs. 4.5 and 4.6 
respectively. Clusters A-K were again found in both Neighbour Joining analyses. Five 
additional clusters (L-P) were found, four of which contain sequences from different 
parasites, which did not occur with significant bootstrap using Maximum Parsimony. 
Cluster L (bootstrap 71% and 82% in Figs. 4.5 and 4.6 respectively) groups SDI 28K 
with two sequences from SD I 0 5 that form cluster H. Cluster L appears with a 
bootstrap of only 58% in Maximum Parsimony Fig. 4.3. Cluster M contains one 
sequence from each of three parasites (SD 102, 5D105 and SD 106) with bootstraps of 
78% and 89%. Cluster N contains SDI 05T and SD128E (bootstrap 75% and 80%), 
and occurs in the Fig. 4.1 with a bootstrap of 56%. Cluster 0 contains two SDI 05 
sequences with a bootstrap of 84% and 70%, and also occurs in Fig. 4.1 with a 
bootstrap of 62%. Cluster P (grouping one sequence from each of SD 102 and SD 105) 
is only found in the "gap minimised" Neighbour joining analysis (bootstrap 72%, Fig. 
4.6). Table 4.1 summarises clusters detected in these analyses and details the 




Fig 4.5 Neighbour Joining tree of 56 Sudanese DBL1 sequence variants. Tree 
generated from alignment in Fig. 3.3. Statistical support is provided by the bootstrap 
resampling method (100 resamplings). Bootstrap values are shown above branch 
lines. Branches with a bootstrap value of less than 50% are collapsed. Statistically 
significant clusters are boxed in red where they contain variants from two or more 
parasite clones, and in blue when they contain variants from a single parasite. Clusters 
which were not detected by Maximum Parsimony are boxed in green. 
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Fig 4.6 Neighbour Joining tree of 56 Sudanese DBL1 sequence variants. The tree 
was generated from the alignment in Fig. 4.2. Statistical support is provided by the 
bootstrap resampling method (100 resamplings). Bootstrap values are shown above 
branch lines. Branches with a bootstrap value of less than 50% are collapsed. 
Statistically significant clusters are boxed in red where they contain variants from two 
or more parasite clones, and in blue when they contain variants from a single parasite. 
Clusters which were not detected by Maximum Parsimony are boxed in green. 
Cluster P shown in black was not found in any of the other analyses. 
Table 4.1 Sequence clusters from phylogenetic analysis F1/2-111. 
Sequence Bootstrap values 
Sequences Subtype Mpa MP NJ'  NJ" 
Cluster Included Composition Fig. 4.1 Fig. 4.3 Fig. 4.5 Fig. 4.6 




B 105Q/105S h-i 66 71C 68 64/85C 
106A x-x 
128G x-x 
C 105R f-x 85 65 86 72 
106C f-x 
D 106D n-g 71 87 95 99 
126M n-g 
E 105K b-x 66 66 72 74 
128L b-x 
F 102F k-c 68 74 88 99 
102F2 k-c 
102D X-C 
G 102B e-e 100 96 100 100 
102H e-e 
H 105B m-d 100 96 100 100 
105C m-d 
I 105L 1-c 99 99 100 100 
105L2 1-c 
J 126D x-x 97 96 98 100 
126N x-x 
K 106E a-f 92 97 100 100 
106F a-f 
L  128K m-x <50 58 82 71 
M 102A f-b <50 <50 78 89 
1USD f-b 
106B f-b 
N 105T x-a 56 <50 75 80 
128E x-a 
0 105F d-x 62 <50 84 70 
105G d-x 
P 102J g-x <50 <50 <50 72 
Table 4.1 Lists clusters found in phylogenetic analyses of all cloned Sudanese 
sequences over their common region. For each cluster are listed sequences included, 
subtype composition and bootstrap values for each tree (Figs. 4.1, 4.3, 4.5 and 4.6). 
'Maximum Parsimony, "Neighbour Joining, 'Excludes SD128G, dalso  includes 
SD1O5B and SD1O5C from cluster H. 
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4.4 Phylogenetic analysis of 22 longer Sudanese DBLI 
sequences 
Phylogenetic analysis using both Maximum Parsimony (Fig. 4.7) and 
Neighbour Joining (Fig. 4.8) was also performed on an alignment of the longer cloned 
DBL1 sequences (positions 1-158, Fig. 3.4). Both trees are poorly resolved and 
contain only two clusters corresponding to clusters B and H in the previous analyses. 
























Fig. 4.7 Maximum Parsimony tree of 22 Sudanese DBL1 sequences. Based on 
positions 1-158 of Fig. 3.4. Statistical support is provided by the bootstrap resampling 
method (100 resamplings). Bootstrap values are shown above branch lines. Branches 
with a bootstrap value of less than 50% are collapsed. Statistically significant clusters 
are boxed in red. 
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Fig. 4.8 Neighbour Joining tree of 22 Sudanese DBL1 sequences. Based on 
positions 1-158 of Fig. 3.4. Statistical support is provided by the bootstrap resampling 
method (100 resamplings). Bootstrap values are shown above branch lines. Branches 
with a bootstrap value of less than 50% are collapsed. Statistically significant clusters 
are boxed in red. 
Cluster B (bootstrap 81% and 97% in Figs. 4.7 and 4.8 respectively) here 
contains three sequences, SID 105Q, SDIO5A and SD1O6A. Cluster H (bootstrap 100% 
in both Fig. 4.7 and 4.8) contains SID 105B and SID 105C. The remaining seventeen 
sequences fail to be resolved with significant support in either Fig. 4.7 or Fig. 4.8. 
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4.5 Conclusions 
Two alternative alignments of 56 Sudanese DBL1 sequences were analysed 
using two different tree building methods. Trees generated consistently include 
statistically supported clusters of sequences from more than one parasite. Cluster A 
(Figs. 4.1, 4.3, 4.5 and 4.6 and Table 4.1) contains sequences from five of six 
parasites in the study (bootstrap 81-98%). Cluster B contains four sequences from 
three parasites in three of four analyses (bootstrap 64-68%) and three sequences from 
two parasites in all four trees (bootstrap 68-85%). These three sequences also cluster 
in Maximum Parsimony and Neighbour Joining analyses of their downstream region 
(bootstrap 81% and 97%, Figs. 4.7 and 4.8 respectively). Three other clusters (C-F) 
containing sequences from two parasites are found in all trees. Thus clustering of 
sequences from different parasites was consistently seen. 
There are a further seven clusters (F-J, 0 and P) which consisted of sequences 
from a single parasite; two multiparasite clusters (A and B) both included two 
sequences from single parasites. Highly related sequences are more likely to have 
originated from a single parasite than from different parasites. 
Neighbour Joining analyses gave greater resolution of the data set, discerning 
a further three multiparasite clusters (L-N) and two single parasite clusters (0 and P) 
which were absent from the Maximum Parsimony trees. However, all trees produced 
were incompletely resolved, meaning that no single tree was found that best 
represented the relationships between all sequences in the data set. This lack of 
resolution may be explained by widespread recombination between var genes 
resulting in many sequences having no single closest relative". This is consistent 
with the hypothesis that recombination between var genes is a major mechanism in 
the generation of new variants. 
These observations, together with the isolation of three DBLI variants from 
more than one parasite, do not fit the predictions of strain and clonal population 
models that var gene repertoires should be non-overlapping. Rather this analysis 
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supports the traditional panmictic model with widespread sexual recombination in this 
P. falciparum population. 
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Chapter 5 
Analysis of sequence diversity within the global population 
of var genes 
5.1 Introduction 
Multigene families are characterised by rapid evolution and in the case of var 
genes, this may be accelerated by immune selection pressure. This process could be 
sufficiently fast to result in differences between var gene pools in P. falciparum 
populations from geographically distant areas. It was therefore decided to analyse 
the evolutionary relationships between DBL 1 sequences from the "global 
population" of var genes. 
5.2 Analysis of DBLI sequences from the "global population" 
Two regions of DBL 1 as shown in Fig. 5. 1, from a cohort of sequences 
originating from a range of geographical areas, were studied. Table 5.1 lists and 
identifies the geographical origin of non-Sudanese sequences. Deduced animo acid 
alignments of these regions are presented in Figs. 5.2 and 5.3. 
Area aligned In Fig. 5.2 	 Area aligned in Fig. 5.3 
- 
GACA Variable LLSI Variable LARSFA[)IG Variable LEIF Variable KAFTC 
Box 
F 
Block I Box Block II Block Ill Box BIocklV Box 






U - S 
Fig. 5.1 Schematic showing regions analysed. Positions of conserved cysteines are 
indicated below the model. Conserved sequence "boxes" are shown in pink and 
variable "blocks" in blue (see section 3.4). 
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Table 5.1 Identification of non-Sudanese sequences analysed in study 
GenBank 
Accession Geographical Identifier Subtype 
Number Origin in Trees composition' 
Z94751 3D7Ab 3D7A-2 h-i 
Z94750 3D7Ab 3D7A-3 n-x 
Z94749 3D7Ab 3D7A-4 f-b 
Z94748 3137A  3D7A-5 n-x 
Z94747 3137A  3D7A-6 
Z94746 3137A  3D7A-1 Jx 
Z94745 Vietnam Vietnam-3 
Z94744 Vietnam Vietnam-i 
Z94743 Vietnam 
Z94742 Kenya Kenya-6 
Z94741 Vietnam Vietnam-4 
Z94740 Vietnam Vietnam-7 
Z94739 Vietnam Vietnam-6 
Z94738 Vietnam Vietnam-5 
Z94737 Vietnam Vietnam-2 
Z94736 Vanuatu 
Z94735 Vanuatu Vanuatu-2 
Z94734 Vanuatu 
Z94733 Vanuatu 
Z94732 Vanuatu Vanuatu-i a-x 
Z94731 Kenya Kenya-3 
Z94730 Kenya Kenya-i 
Z94729 Kenya Kenya-4 a-x 
Z94728 Kenya Kenya-2 
Z94727 Kenya Kenya-5 
Z94726 Kenya 
Z94725 Kenya n-x 
Z94724 Kenya 
Y13408 Brazil Brazil-2 
Y13407 Brazil Brazil-7 
Y13406 Brazil Brazil-6 
Y13405 Brazil Brazil-8 
Y13404 Brazil 
Y13402 Brazil Brazil-3 
U31083 Brazil Brazil-5 
U67960 Gambia Gambia-i 
U67959 Gambia Gambia-3 
U53324 3D7Ab 
L42636 Indochina Indochina-1 
L40608 Indochina Indochina-2 
L40609 Gambia 
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Table 5.1 (Continued) 
GenBank 
Accession Geographical Identifier Subtype 
Number 	Origin 	 in Trees 	Composition' 
L42247 Brazil Brazil-4 
L42246 	Brazil 
L42245 Brazil 	 Brazil-i 
AF050740 Papua New Guinea PNG-1 
AF050739 Papua New Guinea 
U27338 Malaya Malaya-1 
U27339 Malaya Malaya-2 
AF061155 Gambia 
AF003473 Gambia Gambia-2 
AF152572 3D7A' 3D7A-9 
AF152573 3D7Ab 3D7A-10 
AF152574 3D7A" 3D7A-7 
AF152576 3D7Ab 3D7A-14 
AF152578 3D7Ab 3D7A-8 
AF152579 3D7A' 3137A-12 
AF152580 3137A  3D7A-ii 
AF152581 3D7Ab 
AF152582 3D7Ab 3D7A-15 
var lc 3D7Ab 
var2c 3D7A' 
var5c 3D7A' 
var 6c 3D7Ab 
var7c 3D7A' 3D7A-13 
var-9' 3D7Ab 
var lOc 3D7Ab 
var l2c 3D7Ab 
var l4c 3D7Ab 
var l5c 3D7Ab 
varl7c 3D7A" 
var37C 3D7Ab 
var-38' 3D7Ab 3D7A-16 
var 46 3137A  3D7A- 17 
Table 5.2 Identification of non-Sudanese sequences analysed in study. Accession 
numbers and geographical origin of sequences included in Figs. 5.2 and 5.3. Where 
appropopriate subtype composition and identifier used in trees (Figs. 5.15-5.18) are 
given. aSee  section 3.5 b  3137 was isolated from a patient in Holland, origin of 
infecting parasite is unclear. C  Unpublished sequences isolated from 3D7A by G. 
Clottey (personal communication). 
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An alignment of 102 DBL1 sequences from the "global population", 
including 56 from Sudan, covering the region from variable block I to variable block 
II is shown in Fig. 5.2. A second alignment, Fig. 5.3 contains 69 sequences (22 
from Sudan), incorporating the region from variable block III to the conserved 
KAITC box. All sequences aligned have the same basic stuctural framework as 
described in section 3.4. Eight of forty-six non-Sudanese sequences included in Fig. 
5.2, have identifyable sequence subtypes as previously defined for the Sudanese 
sequences (in section 3.4.3) over variable block I. Of these, four also have a 
discernable sequence subtype for block II. However, for variable blocks III and IV 
where few Sudanese sequences were assigned to a subtype, again, no non-Sudanese 
sequences could be fitted into previously defined subtypes. Table 5.1 shows the 
sequence subtypes of non-Sudanese sequences. 
The regions aligned incorporate three conserved cysteine positions (C6-C8, 
section 3.4.1). Table 5.2 lists substitutions occuring at these positions. Cysteine 6 
(position 29, Fig. 5.2) is substituted in 21 of 102 variants, in 19 cases being replaced 
by Leucine and once each by phenylalanine and serine. Cysteine 7 (position 62, Fig. 
5.1) is replaced in only one of 102 variants. Cysteine 8 (position 92, Fig. 5.3) is 
substituted in only one of 69 variants. 
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Table 5.2 Substitutions at conserved cysteine positions within DBL1. 
Sequence Area of Origin Substitutions 
Z94745 Vietnam Leucine for Cysteine 6 
Z94740 Vietnam Leucine for Cysteine 6 
Z94739 Vietnam Leucine for Cysteine 6 
Z94738 Vietnam Leucine for Cysteine 6 
Z94736 Vanuatu Leucine for Cysteine 6 
Z94732 Vanuatu Leucine for Cysteine 6 
Z94728 Kenya Leucine for Cysteine 6 
Y13408 Brazil Leucine for Cysteine 6 
Y13407 Brazil Leucine for Cysteine 6 
Y13406 Brazil Leucine for Cysteine 6 
Y13404 Brazil Leucine for Cysteine 6 
Y13402 Brazil Leucine for Cysteine 6 
SD126N Sudan Leucine for Cysteine 6 
SD126M Sudan Leucine for Cysteine 6 
SDI26D Sudan Leucine for Cysteine 6 
SDIO6D Sudan Leucine for Cysteine 6 
SDI05A Sudan Leucine for Cysteine 6 
L42247 Brazil Leucine for Cysteine 6 
L42245 Brazil Leucine for Cysteine 6 
L40609 Gambia Leucine for Cysteine 6 
SD128E Sudan Serine for Cysteine 6 
SD126C Sudan Phenylalanine for Cysteine 6 
SD106E Sudan Tyrosine for Cysteine 7 
AF050739 Panua New Guinea Phenylalanine for Cysteine 8 
Table 5.2 Identification of DBL1 variants from global population which contain 
substitutions at conserved cysteine residues. 
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7 
507266 I K N I. P 5 I 	V - 	8 0 1 - 	- - 	1 	7. I, 	N - 	S II 	5 1) 0 	I 0 0 8 0 	V 0 V P 0 N N 	S T ' 5 IPL 
$072687501280 I H S I, F 0 I P - - I K I - - - I I II N L V H N' 5 S I N I II 0 1, I 	0 A 	- P 	 A I Y N -- S S P - K 	' I M I 
507264 	 QHI,NIIM A 	EKI 	N 	HI? 	I,? LEVI IS I1)II NQSI 0 HG lIT - - 	.I)GNVsT I' 	Vi 
507065 N L I N I 	A L - 0 K I N - A 7, I 9? S 	L I I L II F 15 0 N I F 0 A 	P 	0 A 0 Y A N S P S F -' 0 M I. 
507067 	 SIlLS H M A 	OK 	N 	- 	]- D 	I I I F -' I - 	1, 	I.E N L 	EKIIK 8 KKTH N 	05 	N I ' I I I 
501061 IQIILSIIM'A - EKI 5K- - D II 1. I' 	LI 15 1115851 P111K 	-IS 	HKTHN- ON - N 1911? 
507060 	 SN 61 0 I 	P - - AK I - - - TITT5 	I 	V 5' - I ' -' 1411 	sE N I I H N 	P 5 - DHHNK ES I ' IflI 
50106C 5111: KM S -- TI I - - K1NV I I 77E ,'fT' -- ', I fl.', L 	N -11 Dfl HG TN PD -- I1K I I II 
501066 	 NIQQ? 'T- -EN! 	
RA 
I IIl, 	,1L 	, ,,SlIG 	lIFIi 	SOAP 	
N PG 
71 IM? 
501064 QIl I F H I 	H - - DI I -
I T 1 i,9I1 
' N I A F N I 	K N 	0 L - SN - SO N I N I ' 191 
SOIO5U 	 N I, I N I 0 Y - N K I 	N 	- 	- I I V 6 -' 	I U - 	I I E - I S H 	P H 	6 EN P - DR S 0 	' F V F 
0070SF I S N L 1 0 I 	P - - II T I - - A I I, V II 1 Y ' - 5 ' 	K ', I - 0 A - P 	- 0 1 K A H 	A N S S T I 1' I' V I
SD7O M I. KM S - 	TI I - - K V 	1 96 ' 	Y '-I'. K S L 	6 K 	- - F K Q - - P N ND N 0 ID 1 1 F
N070567501055 	EQS I I. L I 	F - - K N I ---— I I V II I I I .1. I. 	50 6 S L - 1 8 	GIl 	Q L TN 	- HO P H TN I I iEIL 
50705P NMLK H - - - - 	5 - T0 	I I I II , 	NI - 1 'H, AS S I I 	H 	HO - Li N - .EOSQ 1Ff VL 
507000 	 N 1 L H I 	NY - OK N - - - 	N 1 1 	5, S L I I L'I 	,. 	I S DII G - - 0 8 IN N - - DON A N I I IM I 
507059 QIIL.HM'A -8K? N..K9 LL1'I'l LEA ',,-SI 0 HA 	AFYS -D 5  FiSK 
5010012 	H IN L I 5 I ' A S - N N I 	N - - 0 F I. I flE S ' M A 'I. A 	' -.9-, 1 i 	S 	N P I 	0 T K Y K -- H S A S K I I - I 	K 
507051 HI1)I,ENI 	DV -NNI N 	..-.DFlIJE'- 	615,5 LI,E"L -H NP 	I TKYK 	OSANT 	IF 
507051 	 II It I, S Y M A - 	S K A N - A T - 0 	I. ' I V I M A S 	F I. 5 N I 	0 0 II S ' K L 0 N N N N S S 0 1' 1 V I 
007051 H 1 I, I i I -------S K T N A - A 1 1 98 N ' M S A 1 N 6 S L 1 1 0 H V - I K L T 	5 5 0 V N I N I I I V I 
$07050 	N NFFNM SK-ANN - - -KAKIID 	IIVIVI M,IA - I -SINE - 	V 	HE 	VQYP - 	A 	551 	II El. 
5070SF N N F P N M S K - H S 	- - - K A K N A I I V I' 5' I 	A K L 	1 s L I - P II 0 L T Y 	--- D N 0 I A 	I 
SO SE 	s N 	S I 	T N - N S S S N A K 11 	I I V 11 V I H A K F I N V 	P 	Q H T V I' DflN I Q I I V I 
507050 - N I 55 I ' i 	8 140-----II - 1 5 L Ii S -- L 1 ,S K 	F -,,, I. 	N IT I - V 0? P 	5 N A 6 1 	'196 
501051 	 5 	NIFNI 	- - 	TTNIII -THS 	IIIEVIMII: ' 	NIl 16 	P -SETS EANPNQI'IMI 
501058 5 ISLES I - - - ITEM -IRK I.LLES, Ms 	- 	- Ns I 	16 - F 	II R T N 	- IDSFSQI LIME 
50705A 	 1)11-K! ----TAANSTN1II 	 VrLj '..11''ASLS K 	'ENPKI--- IPKSN FYI 
507021 H NI,EI I ---- ---ITS T T I NI LL OS 	'-I 	- N HA 	HA - ?ENTDLNTN I' IS? 
507026 	 5 L 1 I I 	- 	- I I H - I TflII S 	I I 	N D - I ' I II 	T P - - K H K V A - - N S A S 0 - I I V I 
007020 '1)1801 P .DK----TffII- IL IlV)S'I I'D 1105 A--L TQYP .NNSSTIIFflI 
5070272 	5 1 5 L R I I ---- -------I T 0 - 1 1 1 5 , 61','i, ' 	 - 5, V - P 7 	T K I N - 0 A S I --FVE 
50702F S11)1.111 	- - - - TKS 	ITSAFI.I,LEI IMISU, 	I'VQS 	IVY 	- P 	I QTKYN - - DYSIP 111511 
507028,1501267 11I N N I I I N - 	- - T S SM IT IS 0 I. L9E V IQs '. -41, I F ' - I 5' p9 SKY 	0 - A SQ L I I V I 
507020 	 N 	1. I, 8 1 I 	- - - T I S 	1? 0 - I L L 8 N I M I - 	' 	I 	LI I 	- P - I 	0 T K V N - 0 5 0 .ST I - I V S 
507028 III 5 1. 8 T I --- - ------1 1911 A I L A 0 N I' 7. 1 -- I - --I IT I P - - K H K V 0 - - 0 1 A IQ 	I V I 
00102A 	 111)100? 	A 	101- ---1111 	LL 	1151 Ms - - 	110 	- 0- 	HP 	ATYP - .GSOIIT 'NI' 
501076 - 'NNIENM T SN 	0.KA,IID IL SEVSM.55' I 	ES I'll? P - lAYS - 	N 	PrE 	, 
V 	N N 6 N I 	A L - H K N 	- S 	I A II V ' L S I 	II I I' - I 	0 A H S 	- 0 6 T S 8 - of-SO I - 
142636 	 ,LPSI -- - ST. 	ILL 65 MI,), F_N_i THT - 0816 ID9AjQL 101 
142247 8 II 1.8 5' L - I N - - IN TN - - Till H 	I LI[L]V I I I, 	1 I'D 	I 	SN H 	PDK - 	N S SON - - 	K,V I 	9, 
142246 	 N SLIT I 	I 	OK? 	N - K K 	- L LVI ' L S S 1, 1 I- 8 I - EN - P - KT TAO - 5FF FE L ' I V I 
L42245 1 H S L 1 0 I P - A K I - - T 1 
1. 15 
L L V 0 V L L S S 	6 1 I I D N - P 5 	H H H --- N K F 0 I 	91 
140609 	~'R SLEL I I- --HEN 	TSTHN 	ILVEFLLT LII?) --III 	KR 	96 IKKN 	85151 V
140600 NLIQI P- - 7K! - rSls- I,LVHN Ml II, , ,-QS I 00 -P-K QATYGN'Q
I500740 	 NLET I TN -NY SN -N 	1- 	LLVHVSMA IN I 	I 'TA i--H QHKY 	
.01 
SQL' IV I 
o5050739 'LEKM - 	- -HIS -IlK A LL EVIMASE FIlIAl)! 'TH 	P-K 	IQYPGSGS I 	'EM? 
o0803473 	 ' 	N 	SN DON - - -KAKIIA- LLAERCMAAK F lIN I ill - P K S K Y P G 	LjDFP I'AMI 
I I 	 Ill 	LL.OS'C.&-.',  
Fig. 5.2 Alignment of 102 DBL1 sequences from around the world. Region 
aligned incorporates variable blocks I and II (see Fig. 5. 1), delineated by red boxes. 
Conserved residues are boxed and shaded red on dark grey; conservatively 
substituted residues are boxed and shaded light grey. Cysteine residues are 
highlighted in red on yellow and conserved aromatic residues are highlighted in blue. 
SM 
Variable Block Ill Variable Block IV 
10 20 30 40 50 
1TDLWJNKEETDT - - 	-  R[TtyTrI GEl 
af061 155 I V K C K C I L C K K K K T Q M 0 K N K K K K F R N  F K DLI K I H D E V - R K 0  
140609 IVISGKDI. LOYDDEE KLKISKQI FKLKKF OKIHDDVMKTSGRTNO 
af050739 IVRFDI L G Y D D K E - KNRRKQI.DDKI.KDI A I KIYDNLM  - EDLTND Q 
vat-5 I 	VRGKL)I. iThYDDEE - KNRRKKIrQKLKV I OH I YEE - - 	- - - 	L K K H K 
sdlO5u I I RCKI)I RIGD- TEE 	- - KKKRKKI 1 ELKT I flji YDELKNOKT - - 	- - 
var2 I 	I K OK I) 	I, E G Y 	D Q  K D K C - 	- Q K V K 	I. I N ElF K D 	I KJNIS Y N EL -- T S T N OK K 
af152574 Ii RGKDF I G  D K K D R V QKKKI Q DS I IKNI DNIIYNEL -- - - - TT SO 
sdlOSm I 	I K (S K I) F I G  D K K D 	R V Q K K K I. Q D slI K N 	I QJI Y N E F -- -- - T T 5 0 
142636 I V K C K I) I. I. G  - D N K E K E - Q N K K I F 0 Ku1,  K D I K K I H K C 
var37 I 	V 	K (I 	K II 	I. L C Y - 	- p p E K 0 K I D I 	I. 	D KjI. K D 	I K Q I H D D V I N 0 
varl7 I VRGKIII (i- N K K K K Q T 1-ISEKIl NjNFKT I K  HSDV 
varl4 I 	V K (S K I) L I N S V E S A - Q IS r  F NI 	K T 	I H S E 
------TKSO 
V-------I T 
af152578 IVRGRDI, NPQCSA- QISKIDEKILKEI 
11, 
KJJIHSDVM ---- --(SO 
sdlOSe IVROKDI LG NPQEST-- IIIN IKDI AIK I HSDVM - - 	- - - 	(SO 
y13405 I 	RISKIII LI]- NPQCSA - KQI 	ID IRKI NIKI YKEL ----- -SSRN 
u67959 I I RGKI)F I 	F MPQE SA- 
URR 
ROl I DNIRKI EI YKEL --- I SSRN 
u31083 I 	R(IKI)F LII NEON SA- KQI 	I DNI.RKI DIJI YKEL- -- I S SRN 
y134O6 I IRGKI)L JQ- NODY - KKVSNNLKTI KKIYDJsL- - 
sd705k IIRGRISI. It  - 	DKG - LLKKLFKNIKEI KNIYNEL -- 
varl2 I 	V N C K I) I sI - N - 	- K K K F 	K I 	S Q N I 0 K I K IS 	I Y D K F 
sd101A II ROKISI RIG NN 	- - 	KRISQQI I NNFKI I K K I Y D N L - 	- . - 	V 
var9 I 	I R(]KJ)5 JG NNG - - KDKII I 	NI 	NT I (SKI H E a L 	- - K  
140608 I VRDRDI. ID NPQC KQIIQ 1.1 NNFICT I DKI YCKI. 
af152572 IVISDKI)I (DY DDPIKKQIIDFIIENLKTI KNIYDNI 
sd705r 1VR(K1II jJGY DDFEKK ISDIIIENIKII KNIYONL -- -- 
u27339 IVRDNLII, L(SY DDKEKDEISKKLINNF[IEI KKIHENL - 
u27338 I 	V H C K II I L C Y 	- - 	- D D K E K D E IS 	K K 	I. I- N N I[i F K K I H E N I. 
af152581 VVRDRDI (I N K K E N K 	IIEKIILNJRKI IYEGL 
sdl05a IIll(.KI)I VII N R K E 	-- KIKLKLQKNLKNI 
sdlO5c LYIIGNISI Y16-NSKE - KSKISDLI,I'INLKTI GKIHFKL 
1 VRGKI)F H- NSQE 	- - KEKRDEI,ITNFKT I DEl HEEL 
- - 
V--------- - 
sf152573 I V N C K IS F RIG - 	N 	- D IS E - - - 	K K K IS D I I. F K N I. K T 	I 0 K 	I II 	S K F 
------T 
sdlO5i I VRGROI / J(. N- DEE - - KKKRDEFI ENLIST I (lEt H IRE - 	- 	- - - 
sd726b II 	RCKDF LG -NKKKNEN - 	KRI KEKI FNl IIFY 
vat-53 I VKGKI}F DYNQ - 	- - - KDRKFKI QI QNJJLKY[III KR I H E K L 
sdlO6c I V RD K 	II ]D NT Q N ST - - Q S I 	El 	I K F K LII KI H N DL - 	- 	- 
sf050740 IVRCKI)F YJG NTQIS 	- KFKRLDIlNJLKDjI KKIHSGL 
Y73404 IVRCKI)I LO H K Q --------RKKNIFI-IN1.RNLI 
/42245 I 	I K 	(I K I) I. N K Q 	- - - F K D K F Q DIQ I 	K K Y K IS L H N N F 
sd126c II RDKDI I CNN - - - 	- KISDKI IKLQI Q K Y KKIYDKI - 	-- - - - - - DO 
u67960 I V H H K I) F I 	(S - N K 0 	- - - 	- - -- - - I 	I EJJF K Q Y K K I Y N C L - - 	- T K 0 N 
sdlO6a I 	V K Si K I) I C N - D K E - - - - -- D 
- 
K I F EIN I 	K KLI K K I Y D N 
AKISISOL........ 
F 
sdl05s 1 RON 1)1 RID N N - K 	E - - - - 	- - 
-K 
DR I 	F DIN 	I IS ElI K Q L Y IS E F 	-- - - - - T K N 
sdlOSq I 	I K C K IS I RID N N K E - - - - 
-K 
K D K I I D[I K KLL K Q I. Y IS E 
FKIYNSI........... 
F -- - - - - I K N 
u53324 IVRGRD[ RJDNN - --  -RENDKIEKJçjFKEY KKIYDNL -- - - - - - VE 
vat-79 IVR(SISI)I L(NN -- - 	 KLKKQIIEINI.KKI f]IYDKL 
KNIHOGI----------- 
- 	-- - - - -DOK 
/42246 I 	I N DR I) I. l, N N - - 	- - K K IS - 	- - - E 	It 
-K 
Q Q F F EL5I 	K K I A Nil Y E E 
- 
L - - - 	S R T P 1 K 
van I I N C K I) F I 	C K K K K K T E - I) Q 	I I S 	Eli K K I U D  V N E 
sd101b I V KG K I) I C K K E N - - - K IS K Q LED DjjI. KR I oji 
- 
- 
var6 IIRGKDI, Lr;DIKKKQNOKKTFISrICILEL3_IKRI 
- 
- 
 -- - 	- - - 	- TN 
af003473 I 	I K 17 R 	I) L L (I N K K K K Q N 0 K E T Ii N F K L N QJJL K IS 	I K K I 	H 0 N I 
I.........T 
y13408 I I RCKI;F I 	(I NKKYNET EREKEKIQRjNLIY I KK1 











- - - - - - - 




af152580 IIIS(SKDM K 	R N 	------------ KHDNIIKDIIREV KKIYEGI.---------- 
af152579 IVI1GKI)M 
I V R G R D M 
K S N DNVFN0FV KKIYEOF --------- 
y13402 KPNDADKV - - 	- CKGFQVVFGKIN S LPSP 	- - - - - - - - - - 
/42247 I VRGROM K P N D A D K V - - - - - - 	EKOI QVVFGIEI 13JL PS P ---------- 
yl34O7 I 	I RGKDF Ei 	N 	- - 	- - KKKE[KEKI LKNI 	K  I K  I 	YE 	- - - - - 	- - - 	- - - 
sdI26a I I R 0 NI) I ILR N ---------RjK DR I. 	I K N L K K I J/çI KG - - - - - - - - - - N 
var7 IVRGKDL L(I I HK Q  -- - - - - 	- -IREKEFI KKLVEM KINIQO - - - - - - - - - - N 
sd726m I 	I N C K D I L (S H 	Q 	--------1K K K Y F F A K F IS Q M KIN I R 	N IS 	---------N 
sf152576 I V R C K I) F L U H N Q - - - 	- - - - -I K K K F F C K LIE Q M KIN I T H S - - - - 	- - - 	- - N 
sdl05f I VRGNOI LGHNQ - - - - - - 	- -IJKKKI R R K I RTNVKJNITHS - - - - - - - - - N 
var38 II 	RGKDI. LGKKKKKQNOKETEIISEKLI DYI KIll ENI EKE 	- - - - - - - - - N 
var46 IVRGRDI RG -JRKKNETKTJREKIDDKFKEI E N I 	R K E - - - - 	- - - 	- - N 
sd105d IVRCRDS ODSKKE - 	- - - - 	- EIKISK LDDKFKKI E N I K K E 	- - - - - - - - - N 
af152582 I VRGKDL YGNTYE ST - - - - -IQRKVFDDNLKT I EN I K K S ---------0 
sdlO5j IVRGKDL I 	VEIlED! U 







Fig 5.3 (Page 1) Alignment of 69 DBL1 sequences from around the world. 
Alignment incoroporates variable blocks III and IV (see Fig. 5. 1), delineated by red 
boxes. Conserved residues are boxed and shaded red on dark grey; conservatively 
substituted residues are boxed and shaded light grey. Cysteine residues are 
highlighted in red on yellow and conserved aromatic residues are highlighted in blue. 




L T C 
A I 'V C 
K A I T[F 
K A I T C 
K A I T C 
iA 	T C 
SIA I T I' 
SJA I T C: 
K A L[iJC 
I T C 
Ej A K T C 
K A I T c' 
K A I 'V C' 
K A I T C 
K A MI C 
K A MI I 1C 
K A M I C 
K A I T C' 
K A I T C 
K ' I. I' I' 
K A I K C 
K A I K 
K A I •F ( 
K A I T C 
KI T C 
K A I T C 
K A I T C 
K A I, S C 
K A M 'V c 
I All' 
I A I T C 
I A I T C' 
I A I 'I' C 
K A I T C 
K A M T C 
K A I T C 
K A I T C 
K A I T C 
K A IC 
I T C 
K A L T 
K A I 'I' C 
K A I T C 
K A I T C 
K A I T C 
iJA I T C 
I T C 
K A I T C 
K A I T C. 
K A I T C 
lA NI -r c 
JA L T C 
K A I T C 
K A M T (•' 
K A I T C 
K A I T C 
I T C 
XJA I T C 
K  I T  
I T C 
K A L T C 
K A L T C 
K A M T C 
K A I T C 
K A I T C 
K A I T C 
V •K A I T C 
D Q V 
A T V 




A K V 
E K V 
E K V 
I T V 
I-I T V 
AT! 
I T V 
D Q V 
D Q V 
L D I 
I D I 
L D I 
D Q V 
1 1 V 
H T V 
IT V 
I T V 
ET V 
R Q V 
R Q V 
S T V 
S r V 
H Q V 
A K V 
A T V 
AT V 
D Q V 
I) Q V 
A T I 
A T I 
I-I T V 
E T V 
AT V 
L D I 
K M V 
QE I 
Q -r V 
QE V 
QE V 
Q D V 
K K V 





L D V 
E T V 
D Q V 
D Q V 
KR V 
KR V 
Q Q V 
E M V 
D Q V 
I M V 
D Q V 
D Q V 










































































Variable Block IV 
60 
- R D I AFT KJK K - S D A K H L - 
GEALKFI -ATJVIKE 
KKSAEAQKR N -DATG - - - 
TKKDGA KR NGDGD- - - - 




GKKQALQAR Q -I)DGSG - - 
KNVDKAI<AR N -DPKGD - 
 
- 
KNVDKAKAR N-DPKGD- - 
MKTNGAQER I - D D A K G G D 
KNKDALKTR H -DDAKGGH 
N N K D A L ER QKDEKDG - - 
TNGEAAEAR N -DTK - - - - 
SNGRALQKR K -DTD- - - - 
SNGRAL 	1<1 K- DTD- - - - 
GKTNGAEE PTKMEVE lIT - 
GKTNGAEER K- DGSG - 
 
- 
GKTNGAEER K- DGSG - - 
-  -KDTVKET 	K -DDP - - - - 
TTKNGTKER N -DTD - - - 
- -  - 
 
NGAKDH QKDGDK - - - 
IQKPQARER NGDGD - - - - 
G K T N G I E E R 	GNJ)PD - - - - 
- -  - 
 
NGAEAR GNDPE - - - 
- - - - 
 
D K K D R - - EGDTK - 	- 
- - -  -DKKDR 	- - EGDTK - - 
- GTQDAKDH KKDEE - - - 
- GTQDAKDII KKDEE - - - 
- SNNGVKAR QGDKE - - - - 
-TKKGAEAR K - DNDE - - 	- 
K D K E G A E T R GSDTT - - - - 
K D K E G A E T R G S D T T - - - - 
-  - 
 
TKDAQNY-EDNDTDK - -
- -TKDAQNY -EDNDTDK- -
- -ESSIKSN 	-- NNDTK - - - 
- - DSEAQTR NGATC -- - - - 
- - DGEAQAR NGDT 	- - - - 
- - TGGVI<AR 	K- D T T - - - - 
-  - 
 
TNGAEAR NDDTGD - - 
-  - 
 
ESEAKNY NDI)TKK - - 
KKKKEAKDY QDRT- - - 
IKRQEA KR QDDKYE - - 
-NDAHVLEH QDDDKGTK - - 
NKNEAIKTH QDDDP - - - - 
NKNEAIKTH QDDDP - - - 
KKKEEAETD KDL)APD - - - 
N G K K T L Q E R KGDTT - - - 
NGQKSAKDR GQI)SP - - - - 
NGRNGVKNH Q - DDNGG - - 
SGRNGAEAR KKDEDG - - - 





- KDKEAQKR NGDEDP - - 
- -NAKAKEY 	SDDKSG- - 
- - P L K A K N Y TKEKjP. - - 
- KNNGAREH K - EVKNG - -
-LDKGAREH K - EVKNG - 
 
- 
%QKH AHHDGSG - -
A Q K 	AHI)DGSG - - 
KLGHLSTE- -
NR--KLSTL---D nD ---- -
NS - - KLRTL - - - - SLN - - - 
NN - - KLRRL - - - SIR - - - - 
AA - - KLSVL - 	SSKE - - - - 
AA - - K 	S V L - S S K E - - - - 
N S - - KLK S 	- - T G 	- - - - 
NS - - KLKSL - - TDD - - - - 
N- - EKLKSL - 	- TDD - - - - 
T K L T K L - - - - - - NDE - - - - 
T K L T K L - - - - - - NDE- - - - 
A. 	.• 	D 
Fig 5.3 (Page 2) Alignment of 69 DBL1 sequences from around the world. See 
previous page for legend. 
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5.3 Analysis of similar variants from different geographical 
regions 
In a number of cases, variants from distant geographical locations were found 
to be highly similar in sequence. In particular two parasite clones, SD 105 and 3137A 
(probably, but not certainly, of African origin) have yielded a number of variants 
with highly similar sequences. Variants SID 1O5J and AF152582 (from 3137A) were 
identical at nucleic acid level, whilst another pair from the same parasites (SD 105M 
and AF 152574) contained only a single synonymous substitution. Several other 
variants isolated from 3D7A and SD 105 were found to be highly similar over all or 
part of the region sequenced (see Figs. 5.4-5.7). 
Variable Block Ill 
10 	 20 	 30 
sdl05I 	I V R G R D L F R G N D F E K K K R D E L E K N L K T I F G K IH S R L T 
0152573 I V K G R D L F R G N D F E K K K K D F L F K N L K T I F G K I H S R L T 
I V R G R D L F R G N D E E K K K R D E L E K N L K T I F G K I HS R LT 
40 	 50 	 60 	 70 
sdlO5I K D A Q NY Y F D ND T D K N Y Y Q L R F D WW KY N R D Q V WE A I T C 
af152573 K D A Q N Y Y E D N D T D K N V Y Q L R E D WW K V H R D Q V W E A I T C 
K D A Q N Y Y E D N D T D K N Y Y Q L R EI)WWKV RDQVWEA I T  
Fig. 5.4 Pairwise alignment of two highly similar sequences from SD105 and 
3D7A. Variants SD105L and AF152573 (from 3137A) have identical variable block 
III regions and differ at only one position within variable block IV. 
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Variable Block Ill 
10 	 20 	 30 
0152572 IVRGKDLYLGYDDEEKKQRDELEENLKT I F K N I Y G NJ  
sdlOSr 
	
	I VRGKDLYHGYDDEEKKQRDELEENLKT I F K N I Y G N 
IVRGKDLY GYDDEEKKQRDELEENLKTIFKNIYGN 




Fig. 5.5 Pairwise alignment of two highly similar sequences from SD105 and 
3D7A. SDI05R and AF152572 (from 3D7A) differ at one position in each of 
variable blocks III and IV. 
Variable Block lii 
10 	 20 	 30 
af152576 I V R G K D L F L G H N Q R K K K L B B R L E Q M FK N I I H S N A A j  
sdl05f IVRGKDLFLGHNQR KKK IRRKIRTN\KNITHSNAA 
IVRGKDLFLGHNQRKKK. 	 KNJTUSNAA 
40 	 50 	 60 
fl 52576 KLSVLSSKEIREYWWALNRDQVWKALTC 
sdlO5f KLSVLSSKEIREYWWALNRDQVWKALTC 
KLSVLSSKEIREYWWALNRDQVWKALTC 
Fig. 5.6 Pairwise alignment of two highly similar sequences from SD105 and 
3D7A. Variants SD I 05 and AF 152576 (from 3D7A) have identical variable blocks 
III and IV, but highly divergent LEIF boxes, 
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Variable Block Ill 
10 	 20 	 30 
sd105e IV R G K D L Y L G N P Q E S T Q RJ I I L K N N L K D1A K11 HS D 
af152578 I VRGRDLFJIGNPQES AQRKVLDEKLKE I F K E I HS D 
I V R G DL. 	G N P Q E S . Q 	. L . 	L 	. IF 	I H S D 
40 	 50 	 60 	 70 
sdlOSe VMSTSGSNGRALQKRYKDTDNYYELREDWWALNRD 
af152578 IVMS TS GS N G R AL Q K R Y K D T D N Y Y EL RE D WWAL NRD 
V M S T S U S N U N A I. ( K N V K U T D N Y Y K L N K 1) W W A I. N R D 
sd105e QVWKAITC 
af152578 Q V W K A I T C 
QVWKAITC 
Fig. 5.7 Pairwise alignment of two highly similar DBL1 variants from SD105 
and 3D7A. SDI 05 and AF 152578 (from 3137A) differ in only the first two positions 
of variable block IV, but have highly divergent variable block III and LEIF box 
sequences. 
One other Sudanese variant (isolated from both SD 126 and SD128) was 
highly similar to a sequence from 3137A (see Fig. 5.8). 
Variable Block I 
10 	 20 	 30 
Z94750 	I)RNLEQIDPAK I TATHNLLVDVCQAAKFEGQS I T  
SD126B/SDI28H DRNLEQIEPIKIT NIT HNLLVDVCQAAKFEGQS I T Q 
D R N L E Q I . P KIT THNLLVDVCQAAKFEGQSITQ 
Variable Block II 
40 	 50 
Z94750 	DYPKYLATYNDSPSQICTML 
SDI2613/SDI28H DVPKY RAT YNDSPSKMCTML 
D Y P K Y ATYNDSPS. .CTML 
Fig.5.8 Pairwise alignment of highly similar DBL1 variants from SD126/ SD128 
and 3D7A. Alignment contains SD126B/SD128H, isolated from two different 
Sudanese parasites, and Z94750 from 3137A. Each of variable blocks I and II contain 
three differences between these sequences. 
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Other cases where variants from distant geographical regions were found to 
be closely related over all or part of the sequenced region are shown in Figs. 5.9-
5.13. 
Variable Block I 
10 	 20 	 30 
y1.3402 D R N L E Y L I N K N T N T T H D L L G N V L V T A K Y E G D S !VN 
L42247 D R N L E Y L I N K N T N T T H D L L G N V L V T A K Y E G D S I V N 
SD126N D R N L E V L[1 	INTAT T H D L L G N V L V T A K Y E GJ7flS i v[ 
I) R N I. K V I. I N K N T N T 'r i-i 1) L L U N V 1. VI A K V H G D S I V N 
Variable Block II 
40 50 
y 1340 NHPDKNSSGNKSS I C T A L 
L42247 N H P D K N S S G N K S S I C T A L 
SD126N K 	 D I H P I-i K N I G N K S I C T A L 
N II I' D K N S S G N K S S I C T A L 
Fig.5.9 Alignment of highly similar DBL1 variants from Brazil and Sudan. Two 
Brazilian variants, Y13402 and L42247, are identical for this region and have a 
highly similar variable block Ito SD126N, differing at only three positions. Variable 
block II of the Brazilian sequences diverges from SD126N at seven positions. 
Variable Block I - 
10 	 20 	 30 
SD1O5A I D Y N L E K I T D A N V T N T H N L L V D V L L A A K H E G -ID IS L S K 
y1.3408 D V N L E K I T D T NTITNTHN L L V D V L L A A K I E G N S L S K 
DYNLEKITD.N TNTHNLLVDVLLAAK KG S L S K 
Variable Block II 
	
40 	 50 
SDI 05A nYMKENPKI IPKSNVC TVL
y13408 N E N Fl G T V P K S N V C T V L 
Y 	EN 	 PKSNVCTVL 
Fig. 5.10 Pairwise alignment of two highly similar DBL1 variants from distant 
geographical regions. SD105A is from Sudan and Y13408 from Brazil. These 
sequences differ at two positions in Variable Block I and five in Variable Block II. 
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Variable Block I 
10 20 	 30 
af003473 NKNFPNMNSIDSSKAKHDLLUEVCMAAKYEGES  1K 
SD1O5G NKNFPNMNSKDSSKAKHDLLVDVCMAAKYEGESLK 
SD1O5F N K N F P N MN S K D S [iRK A K N D L L V D V CHA  A K Y EJT]E S L[T 
N K N F P N M N S K D S S K A K H D L L V D V C M A A K V E G P S L K 
Variable Block II 
40 	 50 
af003473 THYF - KYDSKYPGS D  PMCTML 
SD1O5G 	- VYHEQYEVQYPSSOSTMCTL 
SD1O5F -PYHD YKLTY-G-DSQVCTVL 
Y II 	Q V . . . Y P G S 1) S 	M C 	L 
Fig. 5.11 Alignment of three highly similar DBL1 variants from distant 
geographical regions. SD105F and SD105G were isolated from the same Sudanese 
parasite, AF003473 is from Gambia. All three sequences have highly similar 
variable block I regions, but diverge in variable block II. 
Variable Block I 
10 20 	 30 
SDIO1A/SDI02C V R N L E N I S A L D K I N N D I L L A D V C L A A L H E G A A I R Q 
SD126G 
SD126J 
V R N L E N I S A L 





N NFIIJ T L L A D V C L A A L H E G A A 
N N H I L L A D V C L A A L HG A A 
I 
I 	S RI 
SD105N S N Y G K I N N D T L L A D V C L A A L H E G A A I S S 
SDI06G 
V R N L 
ELNI 
V 	N L E 	S AL D K I N N DI L L A DV CL A AL HE GJT3]S IT  Q 
Z94741 V R N L  S N Y E K I NfiZ1D T L L A D V C L A A L HE GIQIS I T Q 
V R N L E N I SAL K I N N D T L L A D V C L A A L H E G A A I 	. 
Variable Block II 
40 	 50 
SDIOIA/SD102C DHGQYQETNE - - - - GSQLCTML 
SDI26G 	 N H G K H Q L T N S - - - - V S Q L C TM
E 
L 




SD106G Y P K Y Q A  Q  Y A S S F S P S Q I C T M L 
Z94741 	P K Y Q A Q Y T F S F S P S Q1 C T M L 
DHGKYQ TN. 	 SQ. CTML 
Fig. 5.12 Alignment of a Vietnamese variant with variants from five Sudanese 
parasites. Z94741 from Vietnam aligned with five sequences from the Sudan. All 
have similar variable block I. Z94741 is most like SD105N in variable block I, but 
most like SD106G in variable block II. 
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Variable Block I 
	
10 	 20 	 30 
u67959 SHNLES!QTNNYDSSKAKHNLLAEVCYAAKFEGES 
01083 IS H N L E S I Q T N NYDSSKAKHN LLAEVCYAAKFEGES 
SHNL IL S  OTNNYD S S K A K H N LLAFLVCYAAKFEGE S 
Variable Block II 
40 	 50 	 60 	 70 
u67959 	I V K N Y E Q L G H H T T E G I C T A L A R S FAD I GD! I RGKD 
01083 I V K N Y E Q LGHHTTE G I C T A L A R S F ADIGDIIRGKDI  
V K N Y E Q L G H H T T E G I C T A L A R S F A D I G D I I R G K D 
Variable Block Ill 
80 	 90 	 100 
u67959 LYLGNPQESARRKQLEDNLRKIFEKIYKELTSSRN 
u31083 LYLGNPQESARRKQLEDNLRKIFDFIYKELTSSRN 
L Y L G N P Q E S A R R K Q L E D N L R K I F 	I Y K E L T S S R N 
110 	 120 	 130 	 140 
u67959 GKTNGAEERYKDGSGNYYKLREDWWNANRLDIWKA 
01083 GKTNGAEERYKDGSGNYYKLREDWWNANRLDIWKA 
G K T N G A F FL F. Y K D U S U N Y Y K I. R FL I) W W N A N F. L D I W K A 
Variable Block V 	 Variable Block VI 
150 	 160 	 170 
u67959 MICKAPGNAPYFRNTCSNGEKPTGEKCQCIDGTVP 
01083 M I C K A P G N A Q Y F R N T C S N G £ KPTGEKC Q CIDGTVP 
MICKAPGNA YFRNTCSNGEKPTGEKCQCIDG'I'VP 
Variable Block VII 	
Variable Block VIII 
180 	 190 	 200 	 210 
u67959 TNLDYVPQYLRWFEEWAEEFCRKRNLKLQNAIKNC 
01083 T N L D Y V P Q Y L R W F E £ W A E E F C R K R N L K L Q N A I K N C 
Variable Block IX 
220 	 230 	 240 
u67959 RGMDDDGKEKYCSRNGYDCTKT!RS I D K Y S M N R E C 
01083 H G M D D D G K E K Y C S R N G Y D C T K T I R S I D K Y S M N R E C 
.GMDDDGKEKYCSRNGYDCTKTIRSIDKYSMNREC 
250 	 260 
u67959 TKCLYVCDPYVKWIDNKKKE 
01083 1 TKCLYVCDPYVKWIDNKKKE 
T K C L Y V C D P Y V K W I D N K K K E 
Fig. 5.13 Alignment of two highly similar DBL1 variants from Gambia and 
Brazil. U67959 and U31083, isolated from the Gambia and Brazil respectively are 
highly similar throughout the region from variable blocks I-XH, differing at only 4 
out of 265 compared amino acids. 
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DKN t QQ I KTEN I TTHNLLLDVCLAAKY EGE SL 
D K N I Q Q I K T E N I T T H N L L L 0 V C L A A K F E G Q S I 
D K N I Q Q I K T E N I T T H N L L L D V C L A A K F E G Q S I 
D K N 1 Q  I KT EN! TT 11  L EL D V C L A A K Y E G E S L 
D K N I Q Q I K T F N I T T II N L L L I) V C L A A K F 0 	S 






40 	 50 
SD105D H F Q Y E V Q V P S S G S T M C T E L 
SD106B H P Q V E V Q Y P S S G S T M C T M L 
u67960 HPQVEVQYPSSGSTMCTML 
Z94749 HFQYEVQVPSSGSTMCTEL 
I-I 	QYEVQY I'S SOSTMCT 	T- 
(b) 
Variable Block I 
10 	 20 	 30 
u67960 DKN!QQIKTENITT!INLLLDVCLAAKFEGQSITGY 
SDIOSD DKNIQQIKTE N I T T H N L L L D V C L A A K V E G E S L K G Y 
D K N I Q Q I K T E N I TTIINLLLDVCLAAK. hO. S 	G  
Variable Block II 
40 	 50 	 60 	 70 
u67960 HPQYEVQYPSSGSTMCTMLARS FAD IGDIVRGKI)L 
SD105D H E Q Y E V Q Y P S S GS TMCTEILARS FAD 1 G D I V R G R 0 L 
H 	Q Y E V Q Y P S S G S T MET LARSFADIGDIVRG. DL 
Variable Block Ill 
80 	 90 	 100 
u67960 YIGNKGEI(KKLEEKLKQYFKKIYNDLTKDNIKRQE 
SDIO5D YGGSKKEKEKRKQ- LDDKLKKIF EN! KKENN - - - £ 
Y G K E  K 	 L 	 KKI. 	 K.N 	 E 
110 120 	 130 140 
u67960 	AQKRYQDDKYENYYQLREDWWIANRQEIWKALTCD 
SD1O5D K L K S 	L T 0 D--------Q I R E Y W W T A N R F T V W K A I T C D 
K DD Q. RE 	WW 	ANR. 	.WKA TEl) 
Variable Block V 	 Variable Block VI 
150 	 160 - 	 170 
u67960 	APN- -GDVNYFIKTCSMGQS - - -HVNDKCTCANGD 
SDIO5D N N N K L G G V L Y F R 0 T C U D N E K S V T Q A R D K C N R K K K 0 
N U 	Y F R 	T  D K C 	 D 
Variable Block VII 
180 
u67960 	- - - - - - -P T'NIii 
SD7O5D N T P D D Q1V P TIY[j 
V P T F 
Fig.5.14 Alignment of four similar DBL1 variants from geographically distant 
areas. 
Two pairs of identical sequence are shown (SD105D/Z94749, from Sudan and 
Gambia respectively; and SD106B/U67960, from Sudan and 3D7A). 
Longer alignment of SD105D and U67960 showing mutual divergence after the 
LARSFADIG box. 
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5.4 Phylogenetic analysis of DBLI sequences from around 
the world 
Alignments of "global" DBL1 sequences (Figs. 5.2 and 5.3) were analysed 
using Maximum Parsimony and Neighbour Joining. Relationships between Sudanese 
sequences found in chapter 4, were generally maintained when the data set was 
extended to include non-Sudanese variants. As in chapter 4, trees were poorly 
resolved indicating that no single tree best represented the relationships between all 
variants. Multiple clusters containing variants from distant geographical regions 
were identified in all trees and generally found to be consistent using both methods 
of analysis. 
Maximum Parsimony analyses (Fig. 5.15) of the alignment Fig. 5.2, included 
12 clusters (A-L) containing variants from distant geographical regions. Cluster A 
contained five Sudanese variants (from five different parasite clones) and one 
Vietnamese variant with bootstrap support of 96%. Cluster B contained one variant 
from each of two Sudanese parasites, 3137A and a Gambian isolate, with bootstrap of 
86%. Cluster C consisted of two identical sequences from SD 105 and 3D7A 
(bootstrap 100%). Cluster D contained two sequences, one from Sudan and another 
from Kenya (bootstrap 70%). Cluster E contained SD105Q and SD lOSS (identical 
over this region) plus a sequence from 3137A (bootstrap 83%). Cluster F consisted of 
a sequence isolated from two Sudanese parasites plus one from 3D7A (bootstrap 
92%). Cluster G contained two sequences from SD 105 plus another from Gambia 
(bootstrap 74%). Cluster H contained a Vietnamese and a Sudanese variant with a 
bootstrap of 84%. Clusters I -K each contained sequences from Sudan and Brazil 
with bootstrap supports of 97-100%. Cluster L grouped a Gambian and a Brazilian 
sequence (bootstrap 100%). One further group (cluster M), consisted of three 
sequences from Vietnam (bootstrap 100%). 
128 











































































Fig 5.15 Maximum Parsimony analysis of 102 DBL1 sequences from around the 
world. Tree generated from alignment Fig. 5.2. Statistical support is provided by the 
bootstrap resampling method (100 resamplings). Bootstrap values are shown above 
the branch lines. Branches with a bootstrap of less than 50% are collapsed. 25 
Sudanese and 26 non-Sudanese sequences did not resolve into statistically 
significant clusters and are omitted from the diagram. Accession numbers of non-
Sudanese sequences are given in Table 5.2. 
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Neighbour Joining analysis (Fig. 5.16) of the same alignment found many of 
the same clusters with significant bootstrap support. Cluster C contained two 
additional sequences (SD106C and 3D7A) using Neighbour Joining, bootstrap 85%. 
Cluster D contained an additional sequence from Vietnam (bootstrap 71%), and was 
grouped together with cluster E with bootstrap of 69%. Cluster F had additional 
sequences from Indochina and Kenya (bootstrap 83%), and cluster I contained an 
additional sequence from the Sudan (SDI 26M). Cluster G however, contained only 
two Sudanese sequences and cluster H was absent from the Neighbour Joining tree. 
Five further clusters (N-R) containing variants from different geographical areas 
were found using Neighbour Joining. Cluster N contained one variant from Vanuatu 
and two from different Sudanese parasites (bootstrap 77%) Cluster 0 consisted of 
one sequence from 3137A and another from Kenya (bootstrap 98%). Cluster P 
grouped a variant from Sudan with another from Papua New Guinea with 81% 
bootstrap. Cluster Q contained one sequence each from Kenya and Vanuatu 
(bootstrap 74%). Cluster R conatined one Sudanese and one Vietnamese sequence 
with bootstrap 80%). Table 5.3 compares bootstrap values obtained using Maximum 





NJ Bootstrap global short 
Fig 5.16 Neighbour Joining analysis of 102 DBL1 sequences from around the 
world. Tree generated by analysis of alignment shown in Fig. 5.2. Statistical 
support is provided by the bootstrap resampling method (100 resamplings). 
Bootstrap values are shown above the branch lines. Branches with a bootstrap of less 
than 50% are collapsed. 16 Sudanese and 13 non-Sudanese sequences did not resolve 
into statistically significant clusters and are omitted from the diagram. Accession 
numbers of non-Sudanese sequences are given in Table 5.2. 
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Table 5.3 A comparison of phylogenetic analyses of 102var gene sequences 
(Figs. 5.15 and 5.16). 
Bootstrap values 
Sequences MPa NJb 
Cluster Included Fig. 5.15 Fin. 5.16 
A SD1O1A/102C 96 69 
SD1O5N 
SD1O6G 
SD 1 26G 
SD126J 
Vietnam-4 




C SD105R 100 100/85c 
3D7A-1 
SDI 06C (NJ only) 
3D7A-6 (NJ only) 
SD1O6A 70 
Kenya-i 
Vietnam-2 (NJ only) 
Ee SD105QI105S 83 100 
3D7A-2 
F 5D12613/1281-1 92 
3D7A-3 
Indochina-2 (NJ only) 
Kenya-6 (NJ only) 
G SD105F 74 659 
SD1O5G 
Gambia-2 (MP only) 
H SD126E 84 
Vietnam-3 
SD1O6D 97 100,  
Brazil-i 
SDI 26M (NJ only) 
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Table 5.3 (continued) 
Bootstrap values 
Sequences MPa 	NJ' 
Cluster Included Fig. 5.15 	Fig. 5.16 
J SD105A 99 	97 
Brazil-2 
K SD 126N 100 	71 
Brazil-3 
Brazil-4 
L Brazil-5 100 	100 
Gambia-3 
M Vietnam-5 100 	99 
Vietnam-6 
Vietnam-7 
N SD105T 77 
SD 1 28E 
Vanuatu-2 
0 Kenya-5 98 
3D7A-5 
P SD105E 81 
PNG-1 
Q Kenya-4 74 
Vanuatu- 1 
R SD128G 80 
Vietnam-i 
Table 5.3 Maximum Parsimony and Neighbour Joining bootstrap values for 
identified sequence clusters. aMaximum  Parsimony,  bNeighbour  Joining. 'Includes 
SD106D and 3D7A-6. dIncludes  Vietnam-2. 'NJ analysis groups D and E together at 
bootstrap 69%. 'Includes Indochina-2 and Kenya-6. 9NJ cluster is missing Gambia-2 
'Includes SDI 26M. 
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Phylogenetic analysis performed on an alignment of 69 DBLI sequences 
(from variable block III to KAITC box; Fig. 5.3), produced almost identical trees 
using both Maximum Parsimony (Fig. 5.17) and Neighbour Joining (Fig. 5.18). 
Both trees are incompletely resolved, and contain a number of clusters of sequences 
of diverse geographical origin. Clusters A-G are common to both trees with 
bootstrap values 93-100%. Of these clusters A-E and consist of one variant from 
each of SDI 05 and 3D7A. Cluster F contains two variants from 3D7A and one from 
each of 5D105 and SD 126. Cluster H is only found by Neighbour Joining and 
contains two variants from 3D7A and one from SD 105. This appears at first sight to 
suggest that the var repertoires of 3D7A and SD 105 are rather similar, although it 
should be borne in mind that the data set is heavily biased towards these parasite 
clones, which account for twenty-six and fourteen of sixty-nine sequences 
repectively. Cluster G, the only grouping of sequences from different regions not to 
contain Sudanese or 3D7A variants, appears in both trees and consists of two 
variants from Brazil and one from Gambia (bootstrap 99-100%). Both trees also 
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Sd 1051 
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Fig 5.17 Maximum Parsimony analysis of 69 "global" DBL1 sequences. Based 
on Fig. 5.3. Statistical support is provided by the bootstrap resampling method (100 
resamplings). Bootstrap values are shown above the branch lines. Branches with a 
bootstrap of less than 50% are collapsed. 9 Sudanese and 32 non-Sudanese 
sequences did not resolve into statistically significant clusters and are omitted from 
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sd 1 05c 
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Fig 5.18 Neighbour Joining analysis of 69 "global" DBL1 sequences. Based on 
Fig. 5.3. Statistical support is provided by the bootstrap resampling method (100 
resamplings). Bootstrap values are shown above the branch lines. Branches with a 
bootstrap of less than 50% are collapsed. 9 Sudanese and 29 non-Sudanese 
sequences did not resolve into statistically significant clusters and are omitted from 
the diagram. Accession numbers of non-Sudanese sequences are given in Table 5.2. 
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5.5 Conclusions 
Two alignments of DBL 1 sequences, containing a total of 120 variants, from 
around the world were analysed and the following observations made: 
DBL1 variants from distant geographical areas apparently have the same 
basic structural framework as Sudanese variants. 
variants from different geographical areas contained stretches of 
sequence that were highly similar within the "variable blocks". 
sequence subtypes of variable blocks I and II as defined for the Sudanese 
variants (see section 3.4.3), could be identified in parasites isolated from distant 
regions of the world. 
phylogenetic analyses using both Neighbour Joining and Maximum 
Parsimony resolved variants from different geographical areas together at high 
bootstrap values. 
Sudanese variants which co-resolved in the phylogenetic analyses 
presented in chapter 4, again clustered together when the data set was extended to 
include non-Sudanese sequences. 
the parasite clones 31)7A and SDI 05 contain a number of similar DBL1 
variants, suggesting their overall repertoires may be similar. However, this could be 
an artifact of their relative over representation in the sample of sequences analysed. 
From these observations, it is clear that the geographical origin of a P. 
falciparum isolate cannot be determined from DBL1 sequences. Variants from 
distant geographical regions were often found to be more alike than variants from a 
single village, suggesting that there is a finite number of var gene variants. A likely 
explanation is that the rate of gene flow between different P. falciparum populations 
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may be sufficient to prevent pronounced differences between different var gene 
pools. This is consistent with a recent study which found that only 7.8% -12.8% of 
polymorphisms present in two surface antigen genes (PvMSP1 and PvAMA1) of P. 
vivax were due to differences between populations (Figtree et al., 2000). An 
alternative explanation is that the existing global population of?. falciparum is 
descended from a small ancestral population. One study has proposed that the 
current P. falciparum population is dervied from a single strain!  within the last 
50,000 years (Rich et al., 1998). However, the theoretical basis for this time-scale, 
based on silent substitution rates, has been questioned (Hey, 1999). Further, the 
extended hypothesis of clonality proposed by Rich and co-workers (Rich et al., 1997 
& 1998) is incompatible with the observertion that genetically distinct, co-circulating 
parasites have overlapping var repertoires (Chapter 4, this thesis). 
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Chapter 6 
Expression of DBLI fusion proteins 
61 Introduction 
Recombinant DBL 1 peptides were expressed as Glutathione-S-transferase 
(GST) fusion proteins in E. co/i host cells with the aim of using them as antigens in 
immunoassays (ELISA) using Sudanese sera. The GST-fusion system developed by 
Smith and Johnson in 1988, utilises recombinant proteins linked to the C-terminus of 
the Schistosomajaponicum enzyme GST, which can then be collected by affinity 
binding to glutathione coated agarose beads. GST-fusion peptides have been 
successfully produced for a range of malarial proteins including the rhoptry 
associated protein 1 (RAP 1) and merozoite surface protein 1 (MSP 1), both of which 
have been used in seroepidemiological studies in the Sudan (Cavanagh et al, 1998; 
Fonjungo et a!, 1999). PfEMP1 domains have also been expressed as GST-fusion 
proteins (Baruch et al., 1995 & 1997), making this system a promising candidate for 
production of recombinant DBL1 antigens for use in ELISA experiments. 
6.2 Preparation of GST-fusion proteins 
Sudanese DBL1 variant sequences were subcloned into pGEX-4T1 and re-
sequenced to check for correct reading frame and nucleic acid sequence. Fusion 
protein expression was initiated by the lac operon inducer isopropyl-J3-D-
thiogalactoside (IPTG) in E. co/i DH5a and BL21 cells. Bacterial cell lysates were 
extracted and fusion proteins purified from the slurry, examined by denaturing 
polyacrylamide gel electrophoreses (SDS-PAGE) and compared to protein molecular 
weight markers. It was found in all experiments that fusion proteins showed some 
level of degradation or production of truncated protein in both host cell lines, 
including a visible band corresponding to the size of unmodified GST. 
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Figs. 6.1 and 6.2 show representative SDS-PAGE gels of DBLI-GST fusion 
proteins expressed in DH5u cells harvested four hours post-induction at 37°C. Fig. 
6.1 shows fusion proteins of different lengths from four DBL1 variants. In this 
experiment, extraction of equal amounts of bacterial lysate gave different yields of 
fusion protein for each variant. The proportion of full-length product obtained also 
differed due to the degree of degradation or truncation of the fusion proteins 
produced. In Fig. 6.1, SD1O2B-GST shows the lowest overall expression and a full 
length fusion protein visible at -37.5kD; SD126B-GST and SD126C-GST are both 
efficiently expressed and show different proportions of full length (61 .7kD) to 
truncated protein; SD1O1A-GST (expected length 52.5kD) was expressed at an 
intermediate level, but shows the least amount of degradation of full length product. 
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Fig. 6.1 SDS-PAGE of D115a lysates expressing DBL-1 fusion proteins. 
Fusion protein expression was induced for four hours at 37°C. L= crude lysate of 
harvested cells. W= wash fluid run-off from glutathione agarose beads. Br 
glutathione agarose beads with bound fusion protein. Lane 13 = molecular weight 
markers (size indicated in kD at side of gel). Purified fusion protein bound to 
glutathione agarose beads was run in lanes 3, 6, 9 and 12; bands corresponding to 
expected size of full-length product are indicated with arrows. All preparations 
contain significant amounts of truncated or degraded fusion protein corresponding to 
bands of lower molecular weight and including a -29.5kD band equivalent in size to 
unmodified GST indicated by stars. 
Fusion protein preparations from a further seven variants expressed under the 
same conditions are shown in Fig. 6.2. Four show visible bands corresponding to the 
size of the respective full-length fusion proteins (SD128K-GST and SD105G -GST 
both 37.5kD and SD105M-GST and SD105L-GST both -61.7kD). The remaining 
three preparations despite similar levels of expression overall did not show visible 
full length bands (SD 1O5N-GST and SID 105T-GST both 37.5kD and SID 105J-GST 
--6 1 .7kD). All seven preparations contain bands of lower molecular weight 
indicating truncated or degraded products. Plasmids isolated from each culture were 
checked and found to contain the relevant insert in the correct reading frame. 
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Fig. 6.2 SDS-PAGE of DBL-1 fusion proteins expressed in DH5a cells. Fusion 
protein expression was induced for four hours at 37°C. Lanes 2 and 9 contain 
molecular weight markers (size indicated in kD at side of gel), all other lanes contain 
purified fusion protein bound onto glutathione-agarose beads. Lane 1 SD 128K, lane 
3 SD105G, Lane 4 SD105J, lane 5 SD105T, lane 6 SDJ05M, lane 7 SD105N and 
lane 8 SD105L. Bands corresponding to predicted full length product are indicated 
by arrows, each preparation contains lower weight bands of degraded or truncated 
forms of the fusion protein indicated by stars. 
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Several experiments were undertaken to address the problems of low level 
expression and degradation and improve the yield of full length fusion proteins. To 
investigate whether a shorter induction time would decrease degradation, a series of 
time course experiments were carried out with samples taken at 1, 2, 3 and 4 hours 
post-induction. The experiments were performed in both DH5a and BL21 cells at 
different temperatures, 30°C and 37°C; different concentrations of IPTG, 0.05niM 
and 0. 1mM, were used for induction; and purification performed with and without 
the addition of protease inhibitors (0. 1mM tosyl-L-lysine chromomethyl ketone, 
1mM phenylmethylsulfonyl fluoride, 0.5% w/v aprotinin, 504g/ml pepstatin and 50 





Fig. 6.3 SDS-PAGE of DBL-1 fusion proteins expressed in DH5a cells. Four hour 
time course of SD1O2B-GST fusion protein expressed in DH5a cells at 30°C. Fusion 
protein expression was induced by adding IPTG to 0.05niM. The expected size of 
the fusion protein was 37.5kD, protease inhibitors (0. 1 m tosyl-L-lysine 
chromomethyl ketone, 1mM phenylmethylsulfonyl fluoride, 0.5% w/v aprotinin, 
50j.iglml pepstatin and 50 j.ig/ml leupeptin) was added during purification. 
(a) Crude cell lysates. Lane 1 molecular weight markers (size indicated in kD at 
side of gel), lane 2 pre-induction, lanes 3-6 respectively 1, 2, 3 and 4 hours post-




Fig. 6.3 SOS-PAGE of DBL-1 fusion proteins expressed in D115a cells. Four 
hour time course of SD1O2B-GST fusion protein expressed in DH5a cells at 30°C. 
Fusion protein expression was induced by adding IPTG to 0.05mM. The expected 
size of the fusion protein was -37.5kD, protease inhibitors (0. 1 m tosyl-L-lysine 
chromomethyl ketone, 1mM phenylmethylsulfonyl fluoride, 0.5% w/v aprotinin, 
50.xg/ml pepstatin and 50 j.tg/ml leupeptin) was added during purification. 
(b) Washed glutathione-agarose beads with bound purified fusion protein. 
Lane 1 molecular weight marker (size indicated in kD at side of gel), lanes 2-5 
respectively show 1 hour, 2 hour, 3 hour and 4 hour post-induction. Full length 
fusion protein is indicated by black arrow and truncated products by white arrows. 
Degradation of fusion protein was evident from 1 hour post-induction across 
all these expression conditions (data not shown), and no differences were observed 
between host cell lines. Addition of protease inhibitors during purification failed to 
lower the level of degradation, suggesting that the fusion proteins were either 
translated in truncated form, or degraded inside the host cell prior to purification. 
A series of longer time course experiments was then performed over a wider 
range of induction temperatures. Cultures of transformed DH5a and BL2 1 E. coli 
host cells were induced overnight at 18°C, 20°C, 25°C and 37'C, and samples taken 
every two hours from 2-18 hours post-induction. DH5cz and BL2I host cells lines 
again gave indistinguishable results over this range of conditions. A representative 
gel, Fig. 6.4 shows 18 hour time course experiments for the fusion protein SDI 2613-
GST expressed in BL21 cells at four different temperatures. Similar results were 
obtained using two other variants, SDIO5M and SD128K (data not shown). 
Degraded or truncated fusion protein was present at all time points for all three 
fusion proteins throughout the temperature range tested. 
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Fig. 6.4 (a) 18°C 
Fig. 6.4 SDS-PAGE of SD126B-GST expression in BL21 cells over an eighteen 
hour time course at a range of temperatures (18°C - 37°C). 
(a) 18°C. M= molecular weight markers (size indicated in kD at side of gel). 
Numbers above lanes indicate hours post-induction. All sample lanes contain 
glutathione-agarose beads with bound purified fusion protein. Bands corresponding 
to full length product are indicated by white arrow. All preparations show stronger 
lower molecular weight bands corresponding to degraded or truncated protein, 
indicated by black arrows. 
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Fig. 6.4 (b) 20°C 
Fig. 6.4 SDS-PAGE of SD126B-GST expression in BL21 cells over an eighteen 
hour time course at a range of temperatures (18°C - 37°C). 
(b) 20°C. M= molecular weight markers (size indicated in kD at side of gel). 
Numbers above lanes indicate hours post-induction. All sample lanes contain 
glutathione-agarose beads with bound purified fusion protein. Bands corresponding 
to full length product are indicated by white arrow. All preparations show stronger 
lower molecular weight bands corresponding to degraded or truncated protein, 
indicated by black arrows. 
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Fig. 6.4 (c) 25°C 
Fig. 6.4 SDS-PAGE of SD126B-GST expression in BL21 cells over an eighteen 
hour time course at a range of temperatures (18°C - 37°C). 
(c) 25°C. M= molecular weight markers (size indicated in kD at side of gel). 
Numbers above lanes indicate hours post-induction. All sample lanes contain 
glutathione-agarose beads with bound purified fusion protein. Bands corresponding 
to full length product are indicated by white arrow. All preparations show stronger 
lower molecular weight bands corresponding to degraded or truncated protein, 
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Fig. 6.4 (d) 37°C 
Fig. 6.4 SDS-PAGE of SD126B-GST expression in BL21 cells over an eighteen 
hour time course at a range of temperatures (18°C - 37°C). 
(d) 37°C. M= molecular weight markers (size indicated in kD at side of gel). 
Numbers above lanes indicate hours post-induction. All sample lanes contain 
glutathione-agarose beads with bound purified fusion protein. Bands corresponding 
to full length product are indicated by white arrow. All preparations show stronger 
lower molecular weight bands corresponding to degraded or truncated protein, 




Best yields of full length product were obtained at 18-20°C, 8-10 hours post-
induction, although extensive degradation was still observed. Fusion proteins from a 
range ofDBL1 variants were subsequently expressed under these conditions. Fig. 
6.5 (a)-(c) shows examples of these expressed variants on SDS-PAGE. 
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Fig. 6.5 (a) 
Fig. 6.5 (a) SDS-PAGE of DBLI variants expressed fusion proteins expressed at 
20°C for 8-10 hours. Lane 1 molecular weight marker (size indicated in kD at side 
of gel), lane 2 SID 1O5G, lane 3 SD 105J, lane 4 SD1O5L, lane 5 SID 1O5M, lane 6 
SID 1O5N, lane 7 SID 126B, lane 8 SID 126C, lane 9 SD126E, lane 10 SD128C, lane 11 
SD128D, lane 12 SID 128E and lane 13 GST. White arrows indicate bands 
corresponding to full length fusion proteins. 
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Fig. 6.5 (b) 
Fig. 6.5 (b) SDS-PAGE of DBL1 variants expressed fusion proteins expressed at 
20°C for 8-10 hours. Lanes 1 and 2 SD126H, lane 3 SD126E, lane 4 GST, lane 5 
molecular weight marker (size indicated in kD at side of gel). Arrows indicates 
expected size of full length fusion proteins. Star indicates size of unfused GST. 





Fig. 6.5 (c) 
Fig. 6.5 (c) SDS-PAGE of DBL1 variants expressed fusion proteins expressed at 
20°C for 8-10 hours. Lanes 1-2 GST, lanes 3-4 SD105N, lane 5 molecular weight 
marker (size indicated in kD at side of gel), lanes 6-9 SDI 26E, lanes 10-11 5D128A, 
lanes 12-13 SD128D, lanes 14-15 SD128E. White arrows indicate bands 
corresponding to full length fusion proteins. 
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Using the same experimental conditions, some DBL1 variants were poorly 
expressed compared to others e.g. SDIO5J-GST and SD126C-GST in Fig. 6.5 (a) 
lanes 3 and 8, therefore several recombinants were induced for each variant to 
increase the chances of obtaining sufficient fusion protein suitable for use in ELISA. 
Ten DBL1-GST fusion protein preparations were selected for use in a pilot ELISA 
experiment against a cohort of Sudanese serum samples. The antigens selected for 
use in the ELISA, and the yields obtained from 1 L of induced culture are shown in 
Table 6.1. Total protein for each preparation was estimated by Bradford assay and 
this figure adjusted to take into account the proportion (obtained by visual inspection 
of SDS-PAGE) of unfused GST present. These fusion protein preparations 
containing products of varying lengths were then used to coat 96 well microtitre 
plates at a standard concentration of Sng per well. Control wells were coated with the 
same amount of GST alone (negative control) and MSP 119  (positive control, kindly 
donated by Dr. D Cavanagh, University of Edinburgh). 
Table 6.1 Yields of fusion proteins used in ELISA. 












aEstimated by Bradford assay and adjusted to take into account unfused UST 
present in sample. 
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63 ELISA reactivity of Sudanese serum against DBLI 
recombinant antigens 
Other malarial antigens e.g. MSP 1 and RAP 1 prepared as GST-fusion 
proteins, containing a proportion of truncated products have been successfully used 
in ELISA with human sera (Fonjungo, 1998; Dr D Cavanagh, personal 
communication). Admittedly the preparations used in this study showed a relatively 
high proportion of truncated products, however it was decided to use a selection of 
these DBL1 fusion proteins in a pilot experiment to investigate whether there was 
any discernible reactivity against these variant antigens using sera known to be 
reactive against other malarial antigens. 
A range of 10 DBL1-GST fusion proteins (see Table 6.1) were tested against 
a cohort of six paired serum samples from adult Sudanese patients, one taken pre-
transmission season (and presumably pre-infection), the other after onset of clinical 
infection. A pooled sample of Ghanaian sera of high reactivity against malarial 
antigens was used as a positive serum control. Baseline reactivity of each antigen for 
human serum was determined using serum samples from four malaria-naïve adult 
European donors tested in duplicate and cut-off values obtained. MSP1 19  is known 
to react with antibodies from cases of recent P. falciparum infection and was 
therefore used as positive control. Standard assay conditions (test serum dilution, 
incubation times, concentration of secondary antibody, wash regime etc.) developed 
in this institute, for MSP1 were adopted for this experiment. For each antigen, 
serum samples were tested in duplicate and the observed reactivities (Optical 
Densities at 492 nm) were adjusted by subtraction of corresponding GST control 
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Results are shown in Table 6.2. MSP1 19 antigen reacted strongly, as 
expected, with all dilutions of the Ghanaian pooled sera and all post-infection 
Sudanese samples. However, four of six Sudanese pre-infection sera also reacted 
against MSP 1 l9 , although in two cases the reactivity was close to cut-off. D7 and 
2A7 pre-infection sera show unexpectedly high reactivity, which may be due to 
recent sub-clinical infection. Antibody to MSP 1 is known to be of short duration and 
it is therefore unlikely to be antibody from the previous transmission season 
(Cavanagh et al., 1998). In general, positive control antigen shows increased titre of 
reactivity with post-infection samples. 
Five of the recombinant DBL1 antigens showed little or no reactivity with 
the European donors and produced cut-offs similar to MSP 1 9 . Of the other five, 
four had cut-offs 3-5x the MSPI 19  value; however, SD105L2 reacted strongly with 
two of four European donors to produce a cut-off 40x that of MSP I 19.  This 
unexpected result could be a non-specific reaction, yet two European donors and two 
Sudanese pairs S4 and D7 are non-reactive. Alternatively the reactivity may be due 
to cross-reactive antibodies to cellular or other non-malarial antigens present in the 
serum of some individuals. In the four Sudanese serum pairs reactive with SDI 05L2, 
levels of reactivity were the same pre- and post-infection. 
None of the recombinant DBL 1 antigens showed levels of reactivity against 
the Ghanaian pooled sera or Sudanese samples comparable to that of MSP 119 
antigen, although some reactions were above the calculated cut-off values for those 
particular antigens (shown in bold in Table 6.2). It may be that, during infection, 
antibody levels against particular DBL 1 variants do not reach the levels obtained by 
antibodies against the conserved MSP 119  antigen encountered at each malaria 
episode. Further, it is possible that antibody reacting against DBL 1 variants may 
have been raised against related but non-identical DBL 1 encountered during 
infection, and therefore bound with less avidity. To address this the experiment 
should have been repeated using increased concentrations of DBL 1 antigen and 
decreased test serum dilutions. 
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There is only one DBL 1 antigen (SDI 28A) which may be regarded as 
showing specific reactivity, albeit low level, against the pooled Ghanaian sera. 
SD128A was recognised at all dilutions, but at a much lower level than MSP1 19. 
SDI 05N was recognised by one mid-series dilution of the Ghanaian serum pool, 
likely to be a non-specific reaction. Four DBL1 antigens showed differential 
reactivity between pre- and post-infection samples from particular Sudanese donors 
(indicated in italics in Table 6.2). These variants (SD 128A, SD1O5N, SD 128H and 
SDI 26E) all show a post-infection reactivity, above cut-off and at least 3x pre-
infection levels for certain pairs of sera. Although these differential reactivities were 
low, they were not seen with all Sudanese samples and not in the Ghanaian pool, 
suggesting that they are genuine specific reactions. 
6.4 Conclusions 
In these experiments, the expression of full length DBL 1-GST fusion 
constructs proved difficult, with all preparations containing a high proportion of 
truncated or degraded peptides. Other workers have experienced similar problems 
with DBL 1 expression using this system (Baruch, personal communication; Fagan, 
1999). Degraded or truncated fusion protein was present from 1-2 hours post-
induction across a range of experimental conditions and was not affected by the 
addition of protease inhibitors during the purification process. Two E. co/i host lines 
were used, BL21 and DH5a, and found to give similar levels of expression and 
degradation of fusion proteins. 
A pilot ELISA performed using a range of DBL 1 recombinant antigens 
against a cohort of Sudanese patients' sera, showed differential recognition, albeit at 
low level, of DBL 1 variants by four of six pairs of pre- and post-infection samples. 
Further, the fusion protein SDI 28A-GST was recognised by a Ghanaian serum pool. 
Admittedly the level of sensitivity of the system is unknown (and untestable in the 
absence of variant specific anti-DBL 1 antibodies); the validity of the differential 
reactivities is in doubt due to their low levels. However, this is well within the range 
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of reactivities noted for early infections with Human Immunodeficiency Virus (HIV) 
and Hepatitis C Virus (HCV) in standard diagnostic assays (NEQAS, 1997), 
therefore these low level reactivities may be of clinical significance and certainly 
merit further study. Thus it appears that these DBL1 antigen preparations are 
recognised by antibody in serum from malaria patients, although at a lower level 
than MSP1 19.  This lower reactivity may be due to the quality of the antigen 
preparation, or may indicate that biological levels of antibody to particular DBL 1 
variants are produced at a lower level than antibodies to the conserved MSP1 19 
antigen encountered at each infection. An alternative possibility is that the antibody 
detected was raised against a related DBL1 variant binding with a lowered affinity to 
the test antigen. 
This ELISA experiment was only successfully performed once due to 
constraints of time. It would have been of interest to repeat the experiment with a 
lower serum dilution and with a higher concentration of antigen coating on the test 
wells, and to have optimised incubation times etc. This would have allowed 
investigation of whether the differential reactivities observed in paired pre- and post-
infection sera were antigen specific responses by amplifying the detected signal. It 
had been hoped to perform a longitudinal study of anti-DBL 1 responses of Sudanese 
sera similar to that performed for MSP 119  (Cavanagh et al., 1998), and further 
looking for seroconversions to DBL 1 antigens over the course of chronic 
asymptomatic infections between transmission seasons. However, it was decided not 
to use many samples from a valuable serum collection on antigens as yet 




7.1 Why study PfEMPI? 
The PfEMP1 family of proteins encoded by var genes may prove to be one of 
the most important molecules in the biology of P. falciparum infection. PfEMP1 
mediates two major aspects of infection, adhesion phenotype and antigenic 
variation. Adhesion of parasites to venular endothelium is central to the pathology of 
P. Jalciparum infection, with heavy concentrations of sequestered parasites in 
particular organs implicated in clinical complications such as cerebral and placental 
malaria (MacPherson etal., 1985; Fried & Duffy, 1996). Adhesion probably 
functions as an immune evasion mechanism, permitting the parasite to avoid lysis 
by splenic macrophages, allowing higher parasitaemias to develop than are observed 
in other Plasmodium species causing human malaria (David et al., 1983). Whilst, 
several other parasite-derived molecules including sequestrin (Ockenhouse et at., 
1991b), clag (Holt et al., 1999), rosettins (Heimby etal., 1993), and parasite-altered 
host molecules such as band 3 protein (Crandall and Sherman, 1994 & 1996) have 
been implicated in adhesion reactions, to date only PfEMP 1 has been shown to 
determine isolate specific binding phenotype (Baruch etal., 1997; Rowe etal., 1997; 
Scherfet al., 1998; Reeder etal., 1999). PfEMP1, by mediating specific binding 
phenotypes plays a major role in the presentation of clinical malaria in a given host 
and as the major variant adhesion antigen on the surface of erythrocytes is 
responsible for the avoidance of specific host immune responses, thus extending the 
duration of individual infections and potential for transmission. 
Epidemiological studies have shown that agglutinating antibody responses, 
thought to be primarily targeted against PIEMP 1, were associated with immunity 
(Marsh et al., 1986). Further, new clinical infections have been found to be caused 
by parasites corresponding to "gaps" in the agglutination antibody repertoire of 
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patients (Bull etal., 1998 & 1999). Immune responses to PfEMP1 are therefore 
important in the development of isolate specific immunity and may contribute to the 
eventual onset of clinical immunity through development of extensive repertoires of 
anti-PfEMP1 responses to locally circulating variants. 
7.2 Why study DBLI? 
The extracellular portion of PfEMP 1 is very variable in sequence, but 
incorporates a number of identifiable domains containing conserved motifs. These 
include the DBL domains which are homologous to identified erythrocyte-binding 
domains on the DBA and EBA-175 proteins of certain Plasmodium species (Su ci 
al., 1995), and the CIDR domain which lies immediately 3-prime to the first and 
most highly conserved DBL domain (DBL I). Both DBL and CIDR domains have 
been implicated in binding phenotypes of PfEMP1 (Baruch etal., 1997; Reeder et 
al., 1999). DBL1 has been implicated in the rosetting (i.e. binding of non-parasitised 
erythrocytes) of a cloned parasite line (Rowe etal., 1997). DBL1 has been found in 
all var genes characterised to date, in contrast to the other DBL domains which are 
absent in some variants, suggesting DBL1 is necessary for some aspect ofPfEMP1 
structure or function. Thus DBL 1 is a region of particular interest within PfEMP 1. 
This thesis analyses sequence variation in the DBL1 domain of var genes and 
presents a model of the structure of this region of PfEMP1. The observed patterns of 
sequence variation are assessed in terms of the probable mechanisms for generation 
of new PfEMP1 variants, and the implications for the population structure of 
Sudanese and global P. falciparum. Finally the role ofanti-PfEMP1 immune 
responses in the development of clinical immunity is discussed. 
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7.3 Sequence diversity and structure of DBLI domain 
A PCR based cloning strategy was used to isolate and sequence 56 DBL I 
variants from a cohort of six Sudanese parasites; in three cases, the same variant was 
isolated from two different parasites. Comparative sequence analysis was performed, 
firstly, among Sudanese variants alone (Chapter 3) and then with additional DBL 1 
sequences submitted to GenBank from geographically diverse regions (Chapter 5). 
Most PfEMP1 sequences in GenBank are DBL1 variants, reflecting the biological 
importance of DBL land the relative ease of study e.g. amenability to primer design. 
The DBL 1 sequences examined were highly diverse, but closer inspection revealed 
that this diversity is subject to a number of constraints, with well conserved motifs 
punctuating the length of DBL 1, and identifiable patterns discernible within the 
more variable stretches of sequence. 
Multiple and pairwise sequence alignments of DBL 1 variants allowed the 
construction of a generalised model for the DBL1 domain (Fig. 3.5, reproduced as 
Fig. 7.1 below). The model shows a number of alternating conserved and variable 
sequence elements. Conserved elements or "boxes" incorporate a number of highly 
conserved cysteine and aromatic residues. Variable elements or "blocks" were 
found to contain identifiable sequence "subtypes" defined on the basis of partial 
sequence homology within that variable block. Each variant, therefore could be 
described as a series of consecutive subtypes. 
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Fig 7.1 Schematic model of DBL1 structure. DBL 1 can be divided into alternating 
regions of conserved and variable sequence. Conserved sequence "boxes" are 
outlined in red, and variable "blocks" in black. The order of these sequence blocks, 
their sizes, and primer annealing sites are shown. The positions of conserved 
cysteines are indicated in yellow. With the exception of the Cysteine-Rich Variable 
Block, all the conserved cysteines lie within the conserved boxes . These conserved 
boxes are rich in aromatic residues, notably the KAITC and FEEWAED boxes 
which contain 5 and 8 aromatics respectively. 
DBL 1 contains eighteen conserved cysteine residues present in almost all 
variants sequenced (see Table 3.2). Disulphide bonds formed between pairs of 
cysteine residues are important elements in determining secondary and tertiary 
structure of many mature extracellular proteins. Such bonds may form between 
cysteines distant in the primary sequence, but brought together in the three 
dimensional structure of the folded protein. Digestion of NEW 1 in situ using 
sequence specific proteases has shown that some of the disulphide bonds occurring 
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in PfEMP 1 link pairs of cysteines located within different domains of the molecule 
(Fagan, 1999). The three dimensional structure of DBL 1 is currently unknown but it 
is possible that variants lacking one or more cysteine residues (9/56 Sudanese 
variants) would fail to adopt the correct conformation for effective biological 
function of PfEMP 1, or perhaps such variants would mediate unusual phenotypes. 
One Sudanese variant (SDI 26D) has a cysteine residue "displaced" 8 positions 
upstream possibly with implications for the structure of this variant. The conserved 
sequence boxes of DBL1 are also rich in conserved aromatic amino acid residues, a 
feature shared with the related EBA- 175 and DBA erythrocyte-binding molecules 
with which PfEMP1 forms the proposed superfamily of "Duffy-binding like' 
proteins (Su et al., 1995). The functional role of these bulky aromatic residues is 
unclear, but they are perhaps important structurally. The aromatic amino acids, 
tyrosine and phenylalanine are frequently substituted for each other in comparisons 
of DBL 1 variants, whereas tryptophan residues are absolutely conserved in all 
variants (see Table 3.3). Whilst the conservation of cysteine and aromatic residues in 
DBL 1 is particularly striking due to the large number of such residues, it should be 
remembered that these amino acids, particularly tryptophan and cysteine, are 
generally the most conserved residues in any comparisons of related proteins. 
Again, tyrosine and phenylalanine are substituted for each other far more frequently 
than for any other amino acid. Table 7.1 lists the relative frequencies of amino acid 
substitutions in comparisons of related proteins. The conservation and substitution of 
cysteine and aromatic residues in DBL1 is as expected from Table 7.1 
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Table 7.1 
Cysteine I Aromaticl Hydrophobicl Basic I Acid-amide I Hydrophilic 
i c 	W 	Fly L 	M 	R H 	ED N 	APT SI 
I 	 I 	 I 	 I 	 I 
C 1 12 	-8 0 -4 12 -6 -2 -5 I -S - - 1-5 - 	 -3 2 -3 -2 0 
I 
W 	1 -8 
I 
117 0 0 
I 
-6 -2 -5 -4 
I 
1-3 2 -3 
I 
I -S -7 -7 -4 
I 
-7 -6 -6 -5 
I 
-2 
Y 1 	0 1 	0 10 7 -2 -1 -1 -2 -4 -4 0 1-4 -4 -4 -2 1-5 - - -3 -3 	I 
F 1 -4 1 0 7 9 1 -1 2 1 0 -5 -4 -2 -5 -5 -6 -4 -5 -4 -5 -3 -3 
V 	1 -2 -6 -2 -1 I 	4 2 4 2 -2 -2 -2 -2 -2 -2 -2 1 -1  0 -1 0 -1 	I 
L 1 -6 -2 -1 2 1 2 6 2 4 1 -3 -3 -2 1 -2  -3 -4 -3 -4 -2 -3 -2 -3 
I 	1 -2 -5 -1 1 1 	4 2 5 2 -2 -2 -2 1-2 -2 -2 -2 1 -3  -1 -2 0 -1 
M 1 -5 -4 -2 0 1 2 4 2 6 I 	0 0 -2 -1 -2 -3 -2 1-3 -1 -2 -1 -2 	I 
I 
K 	I -5 
I 
-3 -4 -5 
I 
1-2 -3 -2 0 
1 
I 	5 3 
I 
0 	1 1 0 0 1 
I 
1-2 -1 -1 0 
I 
0 
R I - I 	2 -4 -4 1-2 -3 -3 0 I 3 6 2 1 1 -1 -1 0 I- -2 0 -1 0 
H 	I -3 - 0 2 1 -2  -2 -2 -2 1 	0 2 6 	1 3 1 1 2 -2 -1 0 -1 -1 	I 
I 
Q 	1 - 
I 
-5 - -5 
I 
1-2 -2 -2 -1 
I 
1 	1 1 3 
I 
1 	4 2 2 
I 
1 	I-1 0 0 -1 -1 
E 1 - -7 - -5 1-2 -3 -2 -2 I 0 -1 1 1 2 4 3 1 1 0 0 -1 0 0 	I 
D 	I -5 -7 -4 -6 1-2 -4 -2 -3 I 	0 -1 1 1 	2 3 4 2 	1 1 0 -1 0 0 I 
N I 	- -4 -2 -4 1-2 -3 -2 -2 1 1 0 2 I 1 1 2 2 I 0 0 -1 0 1 	I 
I 
G 	I -3 
I 
1-7 -5 -5 
I 
I-i -4 -3 - 
I 
1-2 -3 -2 
I 
1 -1 0 1 0 I 	5 1 -1 0 1 
A I 	-2 1-6 -3 -4 1 	0 -2 -1 -1 1 -i  -2 -1 I 	0 0 0 0 I 1 2 1 1 1 	I 
I -3 1-6 -5 -5 -1  -3 -2 -2 I-i 0 0 I 0 -1 -1 -1 1 -1  1 6 0 1 I 
T 	I -2 1-5 - -3 1 	0 -2 0 -1 1 	0 -1 -1 I-i 0 0 0 I 	0 1 0 3 1 
S I 0 -2 -3 -3 1 -1  -3 -1 -2 1 0 0 -1 I-i 0 0 1 1 1 1 1 1 2 	I 
Table 7.1 Relative frequencies of amino acid substitutions in pairwise 
comparisons of related proteins. For each pair of amino acids the matrix gives the 
ratio of the frequency at which the pair is observed in pairwise comparisons of 
proteins to that expected due to chance alone, expressed as a "log odd". Amino acids 
that regularly replace each other have a positive score, amino acids that rarely 
replace each other have negative scores. Replacements most often occur among 
chemically related amino acids (shown in bold). The relative frequency for cases of 
identity are underlined. (Adapted from Page & Holmes, 1998). 
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The sequences of the variable blocks follow certain patterns, with many 
showing variations on basic themes and characterised as subtypes!.  Subtypes 
describe groups of similar sequences for particular variable blocks, some of which 
can be further subdivided, and are defined in Table 3.4. Thus DBL1 variants can be 
described as a series of variable block subtypes ("subtype composition", see Table 
3.5). Interestingly, many variants which share sequence subtype for a particular 
variable block or series of blocks are divergent elsewhere in their sequences, which 
has implications for generation of new variants and development of immunity 
(discussed in sections 7.4 and 7.7 respectively). Different levels of sequence 
diversity are found in each variable block, reflected in the proportions of variants 
which could be assigned to a subtype (range 14% - 93%), shown in Table 7.2. 
Table 7.2 Number of identified subtypes and proportion of Sudanese DBL1 
variants assigned to a subtype for each variable block 
Proportion 
Number of 	of Variants 
Variable Subtypes Assigned to Length of 
Block Identified Subtypes Variable Block 
Not Studied Not Studied Not Studied 
I 14 34/56 (61%) 15-20 amino acids 
II 9 22/56 (39%) 13-19 	amino acids 
III 2 5/22 (23%) 8-15 amino acids 
IV 2 4/22 (18%) 15-29 amino acids 
V 4 12/22 (55%) 6-10 	amino acids 
VI 2 7/22 (32%) 15-29 amino acids 
VII 4 9/22 (41%) 5-15 	amino acids 
VIII 3 9/14 (64%) 6 amino acids 
IX 1 2/14 (14%) 5-9 	amino acids 
X 2 13/14 (93%) 6 amino acids 
XI 2 4/14 (29%) 12 	amino acids 
XII 1 2/14 (14%) 12 amino acids 
aThe 5 variable block lies upstream of the region sequenced 
Since all 56 variants contained variable blocks I and II, a larger number of 
subtypes could be defined for these regions. In contrast, variable blocks II - VII (22 
variants) and VIII-XII (14 variants) have fewer subtypes defined. Variable blocks 
III, IV, IX, XI and XII contain the highest degree of sequence variation. Blocks IV 
and VI are most disparate in terms of length (15-29 amino acids), but have 18% and 
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32% respectively assigned to subtypes reflecting sequence variability. Taking into 
account variation in both length and residue identity, the most variable region of 
DBL I is the stretch from block ITT-TV. The region IX-XII whilst containing 
considerable diversity in residue composition (and the shortest conserved boxes, see 
Fig. 7.1) is of relatively constant overall length, suggesting that the size of this 
region is restricted by selection pressure. 
Thus it appears that diversity in DBL1 whilst extensive, is subject to a 
number of constraints, including cysteine and aromatic residues which are common 
and highly conserved and the presence of a dozen identifiable stretches of conserved 
sequence boxes. Even the variable blocks show evidence of underlying order, in that 
18%-93% of DBL1 variants in this study could be classified into subtypes grouping 
related sequences. This suggests that DBL 1 sequence diversity is not limitless, but 
rather variation on a basic scheme, dependent on both sequence substitution and the 
length of certain variable stretches of sequence as constraints. 
The subtype scheme described in this thesis is a preliminary attempt to 
classify DBL 1 sequences. The general pattern of alternating variable and conserved 
cysteine and aromatic amino acid-rich sequence elements can be seen in the other 
DBL and CTDR domains of published var sequences (although the level of 
conservation is less than that observed in DBL I). It is possible that such domains 
may also incorporate identifiable sequence subtypes within their variable regions. 
Variable blocks in DBL1 and other domains may encode and define variant specific 
aspects of binding and seroreactivity. To date, no association has been found 
between sequence data and variant specific function or serology, however an 
extended subtype classification scheme covering all domains of PfEMP 1 could 
provide a useful way of matching phenotype to sequence data and perhaps identify 
sequence elements common to variants sharing particular phenotypic properties. 
It is probable that conserved elements of DBL and CIDR variants play a major role 
in determining the secondary and tertiary structures of PfEMP 1, generating correct 
conformation for biological activity. Further, other non-variant specific functions of 
PfEMP1 may be dependent on conserved elements; e.g. CD36-binding is common to 
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all parasite isolates and appears to be at least partially mediated by PfEMP1 (Smith 
el at., 1998) perhaps through the conserved portions of the molecule; whilst variant 
specific functions e.g. seroreactivity may be determined by the variable blocks. 
74 Evidence for widespread recombination between DBLI 
variants 
Alignments of Sudanese DBL 1 variants suggest that recombination is a 
major mechanism in evolution of new PfEMP1 variants. Analysis of the alignments 
produced revealed many instances of shared stretches of sequence between variants 
which are divergent elsewhere, either up or downstream. This suggests that DBL 1 
variation may be generated by "shuffling" of the variable blocks through 
recombination events. Figs 3.8 (a)- (i) (see Chapter 3) show examples of Sudanese 
DBL1 variants exhibiting this phenomenon. In Fig. 3.8 (a) SD105S and SD105Q are 
identical for the first 215 of 263 amino acid residues (and for the initial 646 of 789 
nucleotides) after which the sequences abruptly diverge within the CT box. These 
sequences share the same subtype for 12 out of 14 variable blocks. In Fig. 3.8 (b) 
SD1O5C and SID 1O5J are divergent from Variable block Ito the YC box, after which 
they are identical sharing the same subtypes for blocks X-XII. This abrupt 
divergence of two highly homologous variants and equally abrupt convergence of 
two previously divergent variants within the same small region of DBL 1 may be 
indicative of a hot spot for recombination at the region of variable block X and the 
CT box (see Fig. 7.1). Figs. 3.8 (c) - (i) show comparisons between a number of 
variants which share high level sequence identity in a mutually exclusive manner in 
one of two variable blocks, I or II. This suggests that the LLSI conserved box which 
lies between blocks I and II might be another recombination hotspot. Two of such 
variants (SD 1 05M and SD 1 26A) aligned over all twelve variable blocks, show a 
pattern of alternating homology and divergence. They are homologous in blocks I. 
VIII and IX, (a single substitution within blocks I and IX) but divergent over the 
other nine variable blocks. 
Together, these alignments (Figs 3.8 (a)-(i)) reveal an apparent shuffling of 
sequence subtype blocks among DBL 1 variants, and constitute a body of 
circumstantial evidence for wide spread recombination between different var loci. 
Further, of the nine examples of putative recombination events observed, six include 
variants isolated from different parasites, lending weight to this shuffling being a 
general mechanism for generation of DBL I diversity. Further, phylogenetic analysis 
using two different methods failed to resolve a significant proportion (34% - 48%) of 
DBL1 variants. This observation is consistent with the widespread occurrence of 
recombination within the data set (discussed further in section 7.6). 
The findings of this study are in agreement with those described in the 
literature which suggest recombination is an important source of var gene variation. 
Many var genes are found associated with the rep20 repetitive DNA element in the 
subtelomeric regions of P. Jàlciparum chromosomes (Rubio etal., 1996; Thompson 
et al., 1997), which are known to undergo frequent homologous and heterologous 
recombination (de Bruin etal., 1994; Hinterbeg etal., 1994 ; Scherfet al., 1996). 
One such study found highly homologous var genes present at the ends of 
heterologous chromosomes, and at both ends of a single chromosome within a 
laboratory clone of P. falciparum, suggesting that recombination between both 
heterologous and homologous chromosomes plays an important role in the 
generation of new variants (Deitch etal., 1999). Further, the same study has shown 
spontaneous recombination between var genes within a centrally located cluster on 
chromosome 12. All these studies however have concentrated on var genes within 
single parasite genomes; in this study, there is evidence from comparisons between 
DBL 1 sequences isolated from multiple parasites that widespread recombination has 
occurred between the var loci of different parasites (Figs. 3.8 (c) -(e) and (g)-(i)). 
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7.5 Evidence for gene duplication in the generation of new 
PfEMPI variants 
A second mechanism allowing generation of new PfEMP1 variants may be 
gene duplication. Gene duplication, i.e. the creation of duplicate copies of a gene on 
the same chromosome which may, over time, diverge from each other through 
mutation etc., resulting in a series of related linked genes linked, is a major 
contributing factor in the evolution of gene families (Holland etal., 1994 ). In this 
study certain patterns of DBL 1 sequence homology have been noted which could be 
explained by this process. There are several examples of highly homologous 
Sudanese DBL1 variants which differ by only a few residues (Figs. 3.6 and 3.7, 
Chapter 3). Such variants are found more commonly within individual parasite 
clones than from more than one parasite clone, suggesting that there may be multiple 
cases of genetically linked var loci within individual genomes encoding highly 
related DBL 1 variants. This fits a scenario of gene duplication followed by point 
mutation, resulting in related loci on the same chromosome. There are two pairs of 
such highly related variants isolated from each of SD 102 and SD 105 and one pair 
from SDI 26 (Fig. 3.6 (a)-(e)). All of these related pairs were cloned using the same 
forward primer. There is only one example where three such highly homologous 
variants were isolated each from a different parasite (SD 102, SD 105 and SD 106, 
Fig. 3.7). One previous study has reported the presence on chromosome 7 of Dd2, 
highly related pseudogenes downstream of a var gene cluster, suggestive of gene 
duplication events (Su etal., 1995). 
Further investigations allowing localisation of the Sudanese DBL1 sequences 
within the genome would be of interest in determining whether highly homologous 
and identical variants within and between genomes were located on the same 
chromosome. It would also allow detection of cases where variants were found at 
more than one locus within a single genome. Determination of which variants were 
located to telomeric and central loci would also be of interest as it has been 
suggested that the centrally located var genes may be more conserved than telomeric 
var genes (Fisher etal., 1997). It may be that those DBL1 variants isolated from 
more than one parasite (SD101A/SD102C, SD102E/SD126F and SD126B/SD128H) 
are found in central loci, lending support to this hypothesis. 
These processes of recombination and gene duplication followed by 
mutation, have been proposed as major mechanisms in evolution of new PIEMP1 
variants by a number of authors (Deitsch et al., 1999; Rubio et al., 1996; Fisher et al 
1997) and the observations discussed here are consistent with these hypotheses. 
Recombinative and duplicative mechanisms are known to be important in the 
biology of the vsg variant antigen genes of African trypanosomes, associated with 
switches in expression (Borst etal., 1998). While such chromosomal 
rearrangements have not been found associated with var gene switching, it appears 
likely that they play a major role in the generation of new var variants. 
7.6 Phylogenetic analysis of DBLI variants 
Sequence alignments of DBL I variants were analysed using two different 
phylogenetic techniques, Maximum Parsimony (MP) and Neighbour Joining (NJ). 
Trees generated by these techniques represent hypothetical reconstructions of the 
phylogenetic relationships between members of a given data set. The range of 
possible trees for a data set increases rapidly with the number of sequences e.g. for a 
data set of 10 sequences there are >34 million possible trees; assessment of all 
possible trees for data sets larger than this is beyond the power of contemporary 
computers. Phylogenetic techniques either examine a sample of all possible tree 
topologies in an attempt to make an approximation of the "best" possible tree as 
defined by chosen criteria (searching methods), or they use an algorithm to generate 
a tree, starting with a few members of the data set and adding the others one at a time 
(clustering methods). MP is an example of a search based method of tree building 
which selects a tree which minimises the total number of substitutions necessary to 
account for the observed variation in the data set (Eck and Dayhoff 1966). As it is 
not possible to examine all possible trees a sample of the possibilities is examined 
and the "shortest" tree (usually more than one) saved as an approximation of the 
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theoretical optimal tree; it should be noted that the "optimal" tree, even if found, is 
still merely a hypothesis about a possible evolutionary history. MP generates 
hypothetical ancestral sequences for each of the internal nodes of every tree 
examined during the search procedure and places high demands on computer power. 
Repeated MP analysis of a given data set will sample different trees from the 
essentially limitless range of possibilities and thus produce different "shortest" trees 
for each search. The bootstrap method of resampling with replacement is commonly 
used to lend statistical support to relationships between sequences represented in 
trees generated by MP analysis (see chapter 2). NJ is a clustering method of tree 
building that begins by converting the sequence data to a "distance matrix" 
consisting of pairwise differences between all combinations of sequences in the data 
set. NJ then uses these distance values to construct a tree beginning with three 
sequences and adding further sequences one at a time until the tree is complete 
(Saitou and Nei, 1987). The advantage of this method is that it is much quicker than 
MP and generally generates a single tree. Disadvantages are, the order in which 
sequences are added during tree building can greatly influence the final topography, 
and the loss of data inherent in conversion from discrete sequence characters to 
pairwise distances prior to tree building. The bootstrap method can again be used to 
obtain statistical support for relationships proposed by NJ analysis. Phylogenetic 
techniques cannot take account of recombination within the data set. High levels of 
recombination in data result in a large proportion of unresolved sequences i.e. 
sequences not assigned to clusters. 
MP and NJ analysis performed on a range of alignments of the Sudanese 
variants produced largely consistent results, although NJ resolved a greater 
proportion of variants than MP. Variants from genetically different co-circulating 
parasites repeatedly clustered with a high level of statistical support (Figs.4. 1 and 
4.2-4.8). MP placed 15 out of 56 variants into five clusters derived from more than 
one parasite. NJ resolved these 15 plus a further 10 sequences 25 into nine such 
clusters. One cluster found in all analyses contained variants from five of six 
parasites included in the study (cluster A Figs. 4.1, 4.3 and 4.6). The high homology 
observed between variants from different parasites in sequence alignments 
170 
(discussed in 7.3), the isolation of three variants from two different parasites and the 
consistent clustering of variants from multiple parasites, suggest that var genes from 
the six parasites studied have not evolved in isolation but rather have recombined 
freely. Further, MP and NJ failed to resolve 26 and 15 out of 56 variants 
respectively, indicating that they have no single "closest' relative identified in these 
analyses. This lack of resolution is consistent with widespread occurrence of 
recombination between DBL1 sequences. 
7.7 	Population structure of Sudanese P. falciparum 
The phylogenetic analysis performed in this study describes a population of 
freely outcrossing parasites undergoing widespread meiotic (and mitotic) 
recombination and having overlapping repertoires of var genes. This is consistent 
with previous studies of genetic variation of Sudanese P. falciparum (Babiker et al., 
1997; Arnot, 1998; Babiker, 1998), and despite the relatively low level of malaria 
transmission in the Sudan, fits the traditional panmictic view of P. falciparum 
populations (Walliker, 1991). The analysis does not support the largely discredited 
clonal theory (Tibayrenc et al., 1990), nor the more recent strain theory (Gupta & 
Day, 1994 a & b) of P. falciparum population structure, both of which predict non-
overlapping repertoires of var genes between different "clones" and "strains" 
respectively. 
Overlapping of parasite var repertoires is shown clearly in Fig. 7.2, an 
unrooted MP tree of the Sudanese DBL1 variants (based on alignment shown in Fig. 
3.3). Variants are shown in colours specific for the parasite of origin. The resulting 
"bouquet-like" spread of colours throughout the tree illustrates the interrelationships 










/ 	 \ 
Fig. 7.2 Unrooted tree of Sudanese DBLI variants. Tree generated by MP analysis 
of alignment shown in Fig. 3.3. Variants from the same parasite clone are 
highlighted in the same colour. The spread of colours throughout the figure indicates 
the overlapping nature of the var gene repertoires of these parasites. 
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Strain theory is based on the hypothesis that immune pressure exerted on the 
variant antigens will select for non-overlapping repertoires of those antigens and it 
has been argued that strains may be based on a subset of relatively conserved and 
immunodominant var genes located in central positions of some chromosomes (Day, 
personal communication). However, defining strains on the basis of a progressively 
smaller subset of loci from a single multigene family, makes the concept of "strain" 
of limited practical relevance. 
An objection which could be raised to this analysis is that the sequences 
studied have been cloned from genomic DNA and thus take no account of 
expression. They may have originated from pseudogenes or rarely expressed var 
genes, or may not include important immunogenic epitopes, therefore not subject to 
immune selection pressure which acts to generate "strains". Whilst these objections 
are justified, in this analysis the sequences are used merely as markers for 
investigation of genetic relationships between var genes of different parasites and 
questions of expression and exposure to immune response does not affect the 
conclusions. 
7.8 Diversity of DBLI sequences in the global population 
The Sudanese DBL 1 variants were compared to a total of 64 overlapping 
DBL 1 sequences from other geographical areas in two alignments (Figs. 5.2 and 
5.3). One alignment (Fig. 5.2) includes variable blocks I and II and the second (Fig. 
5.3), blocks III and IV. Table 7.3 presents a summary of the geographical origin of 
sequences included in each alignment. 
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Table 7.3 Geographical origin of sequences used in analysis. 
Area of Number' of Number' of Total 
Geographical Variants in Variants in Number 
Origin Fig. 5.2 Fig. 5.3 of Variants 
Sudan 56 22 56 
3D7A 7 26 30 
Gambia 4 5 5 
Kenya 9 0 9 
Indochina 2 2 2 
Vietnam 8 0 8 
Papua New Guinea 2 2 2 
Malaya 1 2 2 
Vanuatu 5 0 5 
Brazil 9 10 10 
Total 103 69 120 
Table 7.3 Geographical origin of sequences used in analysis. 
a  Some variants 
appear in both alignments. 
Non-Sudanese DBLI sequences conform to the proposed model shown in 
Fig. 7.1, with the same conserved cysteines, aromatic residues and conserved 
sequence elements. In a number of cases, variants isolated from geographically 
distant locations share high levels of sequence similarity (see Figs. 5.4-5.14). Of 
particular note is a pair of long sequences from Brazil and Gambia (GenBank 
accession numbers respectively U67959 and U31083) which differ at only 4 of 265 
amino acid positions in an alignment incorporating variable blocks I-XII (Fig. 5.13). 
Sudanese variants share notable levels of homology with variants from Brazil, 
Gambia, Vietnam and the 3D7A cloned line (probably of African origin). SDI 05 
and 3137A, in particular, show a high number of homologous variants (Figs. 5.4-5.7), 
however this may have been influenced by sample bias since 19 and 30 variants 
respectively were included in the analysis. It was again observed that certain 
variants, obtained from distant locations, showed homology over some stretches of 
sequence, yet diverged in other regions (Figs. 5.7, 5.10 - 5.12 and 5.14 (b)). 
Sequence subtypes, previously defined from Sudanese sequences, could be 
identified in 8 of 46 (18%) of non-Sudanese variants for variable block I, but in only 
four (9%) for block II (all of which also had identified block I subtypes) . No 
subtypes were identified in 47 non-Sudanese sequences for variable blocks III and 
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IV; this compares with the two subtypes identified for Sudanese sequences in each of 
these latter two blocks, confirming the high variability of this region of DBL 1. That 
subtypes can be identified in sequences from geographically distant locations lends 
weight to the validity of this classification system. 
Phylogenetic analysis using MP and NJ was performed on the "global" 
sequence alignments. Both methods resolved sequences from diverse geographical 
regions into clusters with high bootstrap support, summarised in Table 7.4. Sudanese 
sequences clustered with variants from Vietnam, Gambia, Kenya, Brazil, Indochina, 
Papua New Guinea, Vanuatu and from 3D7A in these analyses. Relationships 
between Sudanese sequences previously discussed were found in general to be 
robust when the data set was extended to include non-Sudanese sequences. Once 
again the trees were incompletely resolved. 
Sud 3D7A Gain Ken 	Ich 	VN 	PNG 	Van 	Bra 	Mal 
Sud + + 	+ + + + + + + - 
3D7A + + + + 	+ 	- 	- 	- 	- 	- 
Gain + + 	- - - - - - + - 
Ken + + - - 	- 	+ 	- 	+ 	- 	- 
Ich + + 	- + - - - - - - 
VN + - - + 	- 	+ 	- 	- 	- 	- 
PNG + - 	- - - - - - - - 
Van + - - + 	- 	- 	- 	- 	- 	- 
Bra + - 	+  
Mal - - - - 	- 	- 	- 	- 	- 	- 
Table 7.4 Co-resolution of variants isolated from diverse geographical regions 
in phylogenetic analysis. Sud = Sudan, Gam = Gambia, Ken = Kenya, VN = 
Vietnam, PNG = Papua New Guinea, Van = Vanuatu, Bra = Brazil and Ma! = 
Malaya. A plus sign indicates that variants from two regions cluster with a high 
bootstrap support using phylogenetic analysis. A minus sign indicates where no 
variants from a pair of regions were found in the same cluster. (See Figs. 5.15-5.18). 
The data set is biased towards those areas which contribute larger numbers of 
sequences, further, not all geographical areas are represented in both alignments e.g. 
Kenya, Vanuatu and Vietnam have no sequences in the alignment Fig. 5.2. 
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Nevertheless, from this table it can be seen that variants from diverse geographical 
regions are closely related. Both direct sequence comparison and phylogenetic 
analyses show that sequences from locations distant geographically and temporally 
can be more alike than those isolated from one village during a single transmission 
season. It is therefore not possible to determine the geographical origin of a P. 
falciparum isolate from its DBL 1 sequence. This is in contrast to surface antigens of 
other pathogens e.g. chronic infections with hepatitis B virus, produce individuals 
carrying viral surface antigen (HB5Ag) with sequence patterns characterised by 
ethnicity of the host (Norder etal., 1992; Magnius & Norder, 1995). Evolutionary 
changes in sequence of HBsAg can be matched to the migration of host populations 
(Sastrosoewigngo etal., 1991; Basuni etal., in press). 
This finding of highly similar var sequences across a wide range of 
geographical regions suggests that the global pool of var genes is finite, and is 
consistent with immunological data showing the ability of serum taken from malaria 
exposed individuals in one geographical area to agglutinate parasites from distant 
regions (Aguiar et al., 1992). There are a number of possible explanations for this 
restricted variation and the observed relationships between DBL1 variants from 
distant regions. Firstly, the current global population of P. falciparum may have 
evolved from a relatively small ancestral population of parasites; indeed it has 
recently been suggested that this has occurred within the last 50,000 years (Rich et 
al., 1997 & 1998). This time-scale and the authors!  companion hypothesis of 
clonality has been called into serious question as it is based entirely on substitution 
rates and linkage disequilibrium observed in a set of 25 sequences from a single 
copy, polymorphic antigen gene (csp) and does not take into account the occurrence 
of recombination within other genes (Conway et al., 1999; Hey, 1999). Secondly, 
gene flow between distant geographical areas may be high enough that new 
variations in var genes generated locally could be spread rapidly throughout the 
global population. Thirdly, particular var genes or stretches of var sequence, 
conferring beneficial phenotypes may be conserved among gene pools of different 
populations. It may be that motifs mediating such phenotypes are shuffled about 
between var genes through recombination but themselves remain in the gene pool. It 
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has been shown that the CSA-binding phenotype of parasites from placental malaria 
cases is blocked by antibodies from multigravid females from distant geographical 
regions (Fried et al., 1998). This suggests that var genes or epitopes on var genes 
that confer particular phenotypic properties may be common to parasites in different 
areas of the world. Despite this, it has not proven possible to date, to identify 
sequence elements common to CSA-binding var genes which appear to be 
heterologous in primary sequence (Buffet et al., 1999; Reeder et al., 1999). It is 
possible that CSA-binding is mediated by one or more variable blocks of PfEMP I 
which may be distant in the primary sequence, but come together in the folded 
protein. An extension of the subtyping scheme (to include the rest of the 
extracellular portion of PfEMP 1) could be utilised to help identify sequence 
elements associated with phenotype such as CSA-binding. 
The existence of homology between variants from around the world and 
shared sequence subtypes for variable blocks, together with the reactivity of 
agglutinating antibodies against geographically diverse parasites, suggests that 
potential PfEMP1 vaccine components may be found useful beyond local 
populations. 
7.9 Immunity to PfEMPI and malaria 
PfEMP1 is a major variant antigen on the surface of infected erythrocytes, 
and thought to be the main target of the agglutinating antibody response (Baruch et 
al., 1995; Giha et al., 1999a). There is evidence that variant or isolate specific 
immune responses are important in immunity to P. falciparum; agglutination 
antibody responses, were the only immune responses associated with protection in 
an extensive epidemiological study in Africa (Marsh et al., 1989); asymptomatically 
infected individuals have a wider repertoire of agglutinating antibodies than 
clinically infected individuals living in the same area (Forsyth et al., 1989; Giha ci' 
al., 2000); new infections have been associated with parasites expressing variant 
antigens not agglutinated by pre-infection sera (Bull ci' al., 1999 & 2000). Therefore 
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it appears that anti-PfEMP1 antibodies play a major role in isolate specific 
immunity. The role of such responses in the development of clinical immunity is, 
however, less obvious. 
7.9.1 How variant specific is the agglutination response? 
The extent of cross reactivity of agglutinating antibody responses directed 
against variant antigens is the subject of debate. Early studies characterised these 
responses as predominantly variant specific and non-cross reacting (Newbold et al., 
1992). These observations provided the basis for the strain theory of malaria 
transmission (Gupta & Day, 1994a & b). Other studies, however, have found 
extensive cross-reactivity in agglutination reactions (Giha et al., 1998 & 1999a). 
These apparently conflicting reports in the literature may be explained by differences 
in study methodology. Studies which have used the mixed agglutination (or co-
agglutination) test have found little evidence of cross-reactivity, whereas use of the 
microagglutination test has demonstrated widespread cross-reactivity. In the mixed 
agglutination assay, two parasite isolates are stained with differently coloured non-
reactive dyes, and reacted simultaneously with an immune serum (or serum pool), 
followed by examination for dual-coloured agglutination. The agglutination response 
is considered cross reactive only if parasites stained with both dyes co-agglutinate. 
The microagglutination assay tests each parasite separately against a series of 
immune sera (or serum pools) and records agglutination patterns of individual 
isolates which are then compared for cross-reactivity. In practice, these methods 
define cross reactivity differently; microagglutination scores as cross reactive 
parasites which are agglutinated by the same test sera, each parasite however, may 
be agglutinated by a different subset of antibodies present in the sera; in contrast, 
mixed agglutination only scores as cross reactive those parasites which are 
agglutinated by the same subset of antibodies, see Fig. 7.3. 
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Fig. 7.3 Agglutination responses to PfEMP1. P1, P2 and P3 represent the 
repertoires of target epitopes for agglutination antibodies present on three parasites 
expressing related PfEMP 1 antigens. These 3 parasites are reacted with serum raised 
in response to P1. The range of agglutinating antibodies present in this serum is 
depicted by red, black and blue "Y" s, reacting against different epitopes on P1. 
shows the reactivity of test sera against P1. 
and (c) show the same serum tested against two different parasite isolates, P2 and 
P3 each of which share some target epitopes (pink colour) with P1. P2 and P3 can 
each be separately agglutinated by antibodies present in the test serum, but as no 
subset of antibodies can recognise both P2 and P3, they cannot be co-agglutinated 
by the test serum. P2 and P3 would be scored as cross reactive using the 
microagglutination assay, but as non-cross reactive using the mixed agglutination 
assay. 
In the context of widespread recombination between var genes of different 
parasites, agglutination epitopes will frequently overlap as shown in Fig. 7.3 and 
thus isolates will often be scored as cross reactive using microagglutination, but as 
non-cross reactive using mixed agglutination. Therefore the aforementioned 
conflicting studies can be reconciled. A recent study has employed both 
methodologies to test for agglutination cross reactivity of Sudanese isolates. These 
isolates exhibited cross reactivity using the microagglutination assay, but failed to 
cross react using the mixed agglutination test (Giha et al., 2000). These agglutination 
patterns may be explained by parasites expressing different PfEMP1 variants which 
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share some epitopes which are targeted by agglutinating antibodies. This is 
consistent with the hypothesis of widespread recombination between the var genes 
of different Sudanese P. falciparum isolates. 
Mixed agglutination detects the presence of antibodies which cross react 
against the same epitope on two parasites and may be useful for fine mapping and 
detailed analysis of closely related isolates in the laboratory e.g. the ITO clonal tree 
(Smith etal., 1995). Microagglutination detects the presence of antibody capable of 
separately agglutinating individual isolates and is likely to be of greater clinical 
utility in measuring breadth of immune responses. It should be noted that parasites 
can be agglutinated by immune sera from distant locations, indicating that the global 
repertoire of PfEMP1 contains many epitopes common to isolates from different 
regions. It is argued here that these epitopes are unlikely to be encoded by conserved 
regions of the molecule (or all isolates would cross-react). This again suggests that 
the global range of PfEMP 1 diversity may be finite, and highlights the potential 
importance of subtype sequences of variable regions. The cross-reactivity of 
agglutination antibodies suggests that anti-PfEMP1 intervention strategies such as 
vaccination, may be feasible, particularly if cross reactive epitopes can be associated 
with aspects of infection or pathology e.g. placental malaria. 
7.9.2 The role of variant specific responses in the 
development of clinical immunity 
The role of anti-PfEMP 1 responses in the development of clinical immunity 
observed in long-term residents of hyper- and holoendemic areas of malaria 
transmission is unclear. Clinical immunity develops slowly over a number of years 
exposure and presumably numerous infections. There are three interpretations of the 
observed patterns of clinical immunity (i) clinical immunity may be effected 
primarily via accumulation of specific responses to a comprehensive range of variant 
and polymorphic antigens present in the local parasite population, notably PfEMP 1; 
(ii) immunity may result, following repeated exposure, from the slow development 
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of responses to poorly immunogenic conserved epitopes (which may lie on variant or 
polymorphic antigens); (iii) the onset of clinical immunity may be due to a shift in 
the nature of the immune response e.g. towards cytophilic IgG subclasses (Aribot et 
al., 1996), perhaps associated with the age of the host (Baird et al., 1998). In the 
latter hypothesis, responses to PfEMP1 and other immunodominant antigens, whilst 
important in controlling individual infections prior to onset of clinical immunity, 
may act as a "smokescreen" which prevents the immune system from recognising 
cross-protective conserved epitopes, thus delaying the onset of clinical immunity 
(Druilhe & Perignon, 1997). It is not currently possible to decide between these 
competing hypotheses and it is likely that they are all partially true. Putative 
PfEMP 1 vaccine components in any event, appear most likely to be of use in 
protecting against particular sets of cross-reacting var genes, possibly sharing a 
common clinically important phenotype e.g. placental adhesion, rather than in 
protecting against all parasite isolates. 
7.9.3 Seroreactivity against DBLI antigens 
In a pilot ELISA ten Sudanese DBL1 variant antigens were tested against a 
cohort of paired pre- and post-malaria infection sera from Sudanese patients, and a 
pool of Ghanaian sera (Chapter 6). One of the Sudanese variants reacted with the 
Ghanaian pool, again indicating that PfEMP1 epitopes are recognised by serum from 
distant locations and suggesting either the existence of variants common to Ghana 
and Sudan, or of shared epitopes perhaps related to subtypes. A number of low level 
reactivities suggestive of seroconversion were observed in the paired Sudanese 
samples. However, the validity of these results is in doubt due to the low level of 
reactivity measured. The experimental system was not optimised and the sensitivity 
was unknown. Factors which may have affected sensitivity included the quality of 
expressed DBL1 antigens, and other assay parameters. Further, low level reactivity 
may have been inevitable due to inherent low level antibody specific for test antigens 
present in the serum, or low avidity binding of antibody raised against related but 
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non-identical DBL 1 variants. Unfortunately due to time constraints the ELISA was 
not followed up and optimised. 
7.10 Expression of DBLI in heterologous systems 
Attempts to express DBL1 constructs using the GST fusion system in E. co/i 
hosts encountered a number of technical problems. All expressed variants included a 
large proportion of degraded or truncated protein product. This occurred over a range 
of expression conditions and was found from early sampling times. Addition of 
protease inhibitors failed to reduce this degradation, which apparently occurred 
inside the host cells prior to the purification process. The problems may have been 
due to the reducing environment of the E. coil host cell preventing correct folding of 
the fusion product due to inhibition of disulphide bond formation, rendering the 
product unstable. Further, the cloned DBL1 fragments did not include the entire 
domain, which may also have reduced stability. A deficit of the required AT-rich 
tRNAs in the expression host could also have resulted in truncated products. Other 
P. falciparum proteins, including PfEMP 1 domains however, have been successfully 
expressed using this system (Cavanagh et al., 1998; Fonjungo et al., 1999), making 
codon bias an unlikely explanation for the difficulties encountered. Other workers 
have experienced similar problems in expressing DBL 1 -GST fusion proteins (Fagan, 
1999). The laboratory which first expressed DBL1 as GST-fusion constructs has 
been unable to reproduce this success with subsequent DBL1 variants and has since 
abandoned this system (Baruch, personal communication). Recently in our 
laboratory, PfEMP1 expression work has switched to using the budding yeast Pichia 
pastoris. It is hoped that this eukaryotic host will allow expression of PfEMP 1 
constructs with a conformation more like the native protein. Emphasis has shifted 
somewhat to DBL3 which has been linked to CSA-binding (Reeder et al., 1999) with 
a view to developing a vaccine component to protect against placental malaria. 
Attempts are focusing therefore on cloning full length DBL3 domains for expression 
using this system with the additional aim of investigating the structure of the peptide 
using nuclear magnetic resonance. 
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7.11 General summary 
DBL 1 sequence diversity contained in six parasites isolated from one 
Sudanese village during a single transmission season was found to be extensive, 
though constrained in several ways by the DBL 1 structure. 
A model of DBL 1 structure has been proposed with several conserved 
sequence "boxes", rich in cysteine and aromatic residues, alternating with variable 
"blocks" of sequence. Many of the variable "blocks" of sequence which lie between 
conserved boxes contain "sequence subtypes", defined on the basis of partial 
homology. Identification of these sequence subtypes provides the basis for a 
classification system of PfEMP 1 variants which may highlight small but 
phenotypically important areas of similarity within variants otherwise divergent in 
primary sequence. 
Comparison of DBL1 variants in sequence alignments suggests that 
recombination and possibly gene duplication are important mechanisms in the 
evolution of new var gene variants. Recombination appears to be widespread and 
involve the shuffling of variable blocks between variants. The region of sequence 
between variable block X and the CT box is a potential hotspot for recombination, as 
is the LLSI box which separates variable blocks I and II. 
Phylogenetic analysis of DBL 1 sequences supports the traditional 
panmictic population model for Sudanese parasites. Sudanese var genes appear to be 
freely recombining between and possibly within parasite genomes and are not 
structured into non-overlapping sets of variants. This finding is incompatible with 
the clonal model of population structure and with the "strain" theory of P. 
falciparum transmission. 
DBL1 sequences from distant geographical regions are frequently found to 
be more homologous than those isolated from a single location, suggesting that 
whilst sequence variation in local populations is large, the global pool of var genes is 
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finite. This is consistent with the observation that agglutinating antibodies from 
residents of one endemic area frequently react against parasites from distant areas. 
6- The GST-fusion system of heterologous protein expression in the E. coil 
host was not found to be an ideal system for the production of recombinant DBL 1 
peptides. 
7.12 Future work 
Further work to extend the findings of this study could include: 
P. faiciparum contains an estimated 50 DBLI variants (Thompson et al., 
1997), Only 2-19 variants have been isolated from the six parasites in this study. 
More extensive sequencing of a greater number of variant sequences would 
eliminate the current sample bias towards particular parasite isolates and var loci. 
Sequencing of other DBL or CIDR domains may allow the extension of 
subtype classification to other regions of DBL1 and perhaps verify the validity of 
this system. Investigation of possible links between phenotype and subtype 
composition of variants would be of interest and require the extension of the 
subtyping system to other domains of PfEMP1. 
Localisation of variants within the genome would reveal whether closely 
related variants lie on the same chromosome, perhaps supporting the hypothesis that 
gene duplication is a major mechanism in the evolution of new variants. Localisation 
of variants to telomeric or central positions within chromosomes would also be of 
interest in determining whether centrally located variants are better conserved and 
whether telomeric variants are more homologous due to frequent recombination. 
The Sudanese variants were cloned from genomic DNA, it would be of 
interest to re-culture some or all of the parasites and use RT-PCR based cloning to 
detect which variants are expressed in culture. 
Results of the expression work were disappointing. Future work could involve 
trying alternative expression systems such as Pichia pastoris which is particularly 
suited to producing protein for structural analysis. 
It had been hoped to perform a seroepidemiological study using recombinant 
DBL 1 antigens in ELI SA tests. Better quality, well characterised fusion proteins 
could be used in such a project. 
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Appendix: GenBank accession numbers and nucleotide 
sequences of Sudanese DBLI variants 
Variant 	ACC No 	Nucleotideseguences 
SD101A AF127272 OTTAGAATT TAGAAAATAT AAGTGCATTG GATAAGATTA 
ATAATGATAC ATTATTGGCA GATGTATGTC TTGCAGCTCT 
ACATGAAGGG GCGGCAATAA GAGGTGATCA TGGACAATAT 
CAACAAACTA ATGAGGGTTC TCAATTATGT ACTATGCTGC 
CACGAAGTTT TGCACATATA GGAGACATTA TACGAGGAAA 
GGATCTGTAT CGTGGTAATA ATAAGAGAAG ACAACAATTA 
GAAIATPATT TGAAAACAAT TTTTAAAAAA ATATATGACA 
ATTTGGTTAT ACAGAAACCG CAAGCAAGAG ZACGCTACAA 
TGGTGACGGT GATAATTTTT TTAAATTAAG AGAAGATTGG 
TGGTATGCTA ATCGAGAAAC AGTATGGAAA GCTATAAGGT 
GTTGTGCGCC AAGGGATGCT GATTATTTTA TAAGAACAGC 
CTGTGGTCAA GGAAATGAI\A CACATGGTTA CTGCCGATGT 
ATTTCTGGAG ATGTCCCCAC ATATTTT 
SD101B 	AF127273 	AACAAAAATA TGGAAAACAT GGACACAAAT AATAATGATG 
GTAAAGCTAA ACATGATTTG TTGGCAGACG TGTGTATGGC 
AGCAAAATAT GAAGGAGAT CAATAAAAAC ACATTATCCA 
AAATATCAAA CAGCATATGG TAATTTTCCT TTTGAATTAT 
GTACAGCGTT AGCACGAAGT TTTGCAGATA TAGGTGATAT 
CGTACGCGGC AAAGATCTAT ATAGTGGTAA TAAGAAAGAA 
AACAAACAAA GAAAACATT AGATGATAAG TTGAAAAGAA 
TTTTCGGGGA TATATATAAG GACGTGACGA GCGGGAGGAA 
TGGCGCAGAA GCACGCTACA AAAAAGATGA ACACGGAPT 
TATTCTAAAT TACGAGAAGA TTGGTGGACG GTTAACCGCG 
CCACAGTATG GAAAGCCATA ACATGTAGCG ACGAGCTAAC 
AGGTGCTTCA TATTTTCATG CAACGTGCAG TATGAATGGA 
AGTGGACCCC AAGCTAATCA CTACTGTCGA TGTAAThACG 
ACCAGCCAAA TGCCGACAAG GCAAATACCC ATCCCCCAAC 
CTATTTC 
SD102A 	AF127274 	GACAAAAATA TCCAACAGAT AAAAGCGGAA CAAATAACAA 
CACATAATTT GTTGGCAGAT GTGTGTATGG CAGCAAAATT 
TGAAGCACAG TCAATATCAG GTTATCATCC ACAATATGAT 
GCAACATATC CTGGTTCTGG TTCTACAATG TGTACTATCT 
TA 
SD102B 	AF127275 	CATCATAATT TGGAACTAT AGAAACAACG TCGACGACGA 
AGCATGATTT GTTGGCAGAT GTATGTCTTG CAGCCAIATA 
CGAAGGGGAC TCAATAkAAA CACATTATAC ACCATATAAA 
CACAAATATC GTGATTCTGC TTCCCAATTA TGTACACTAT 
TA 
SD102C 	AF127276 	GTTAGAAATT TAGAAAATAT AAGTCCATTG GATAAGATTA 
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Appendix: GenBank accession numbers and nucleotide 
sequences of Sudanese DBLI variants (continued) 
Variant 	ACC No 	Nucleotideseguences 
SD1 0 2C (cont.) AF12 7276 	ATAATGATAC ATTATTGGCA CATGTATGTC TTGCAGCTCT 
ACATGAAGGG GCCGCAATAA GAGGTGATCA TGGACAATAT 
CAACAAACTA ATCAGGGTTC TCAATTATGT ACTATGCTG 
SD102D 	AF127277 	CATCATAATT TGGAAACTAT AGAAACAACG TCGATGACGA 
CGCATGATTT GTTGTTAGAG GTGTGTATGG CAGCCAAATA 
TGAAGGACAA TCAATAAGAG ATTATTATCC AATATATCAA 
ACAAAATATA ATGATTATGG TTCTACAATA TGTACGGTGT 
TG 
SD102E 	AF127278 	CATCATAATT TGCAAACCAT AAAGAATACA ACGTCGATGA 
CGACGACTAC TGACACGTTG TTGGCAGAAG TGTGTTATGC 
AGCAAAAGAG GAAGGGGAAT CAATAAAAAC ATATTATCCA 
CGACATCAAC ACAZATATGA TGCTTCTCAA CTATGTACCG 
TGTTG 
SD102F 	AF127279 	AGTCATAATT TGGAAACTAT AGACACA.AAG TCGACGACTA 
GTGACACGTT GTTGTTAGAG GTGTGTATGG CAGCCAAATA 
TGAAGGACAA TCAATAACTG GTTATTATCC AATATATCAA 
ACAAAATATA ATGATTATGG TTCTCCAATA TGTACAGTAT 
TG 
SD102F2 	AF127280 	AGTCATAATT TGGAAACTAT AGACACAAAG TCGACGACTA 
GTGACACGTT GTTGTTAGAG GTGTGTATGG CAGCCAAATA 
TGAAGGACAA TCAATAACTG GTTATTATCC AATATATCAA 
ACAAAATATA ATGATTATGG TTCTACAGTA TGTACCGTGT 
TG 
SD102G 	AF127281 	GACA?AAATC TCGAACAAAT AGAACCTGAT AAAATAACAA 
CACATAATTT ATTGGCAGAT GTATGTCAGG CAGCAAAATA 
TGAAGGGGAT TCAATAAGAG GCTATTATGC ACTATATGAT 
ACACAATATC CTTCTTCTGG TTCTACAATA TGTACTGCCC 
TT 
SD102H 	AF127282 	CATCATAATT TGGAAACTAT AGGAACAACG TCGACGACGA 
AGCATGATTT GTTGGCAGAT GTATGTCTTG CAGCCAAATA 
CGAAGGGGAC TCAATAAPAA CACATTATAC ACCATATAAA  
CACAAATATG GTGATTCTGC TTCCCAATTA TGTACAGTAT 
TA 
SD102J 	AF127283 	CATCATAATT TGGAAACTAT AGAAACAACC TCGACGACGA 
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Appendix: GenBank accession numbers and nucleotide 
sequences of Sudanese DBLI variants (continued) 
Variant 	ACC No 	NucleotideseguenceS 
SD102J (cont.) AF1272 83 	CGAATAAGTT GTTGGCAGAA GTATGTATGG CAGCAAAATA 
CGAGGCACAG TCATTAAAAA ATTATCATGC ACAATATCGA 
GGAAATAATA CTGATTTGAA TACCAATATA TGTACCGTTT 
TA 
SD105A 	AF127284 	GATTATAATT TAGAAAAAAT AACTGACGCC AATGTAACGA 
ATACTCATAA TTTATTGGTA GATGTGTTAC TTGCAGCAAA 
ACATGAAGGA GACTCCTTAT CTAAATATAT GAAAGAAAAT 
CCTAAAATTA TTCCAAAATC TAATGTATGT ACCGTTTTAG 
CACGAAGTTT TGCAGATATT GGACACATTA TAAGAGGAAA 
AGATCTTTAT CTTGGTAATA GAAAAGAAAA AGAAAAACAG 
AAATTACAAA AGAATTTGAA AAATATTTTC GCGAAAATAC 
ATAGTGGATT GACGAAGAAA GGCGCAGAAG CACGCTACAA 
AGATAATGAC GAAAATTATT ATCAATTACG AGAAGATTGG 
TGGGAAGCTA ATAGAGCAAA AGTATGGGAA GCCATGACAT 
GTAGCGTACA AGATGCTTAT TATTTTCGAC AAACATGTGG 
TGGAGAAAAA ACTGCGAGTA CTAACAAATG TAGATGTGTA 
AATACCCATC CCCCAACCTA TTTC 
SD105B 	AF127285 	AGTCATAATT TGGAATCTAT AGACACAACG TCGATGACGC 
ATAAGTTGTT GTTAGAGGTG TGTATGGCAG CAAAATACGA 
AGGAAACTCA ATAGGTACAC ATTATCCACA ACATCAACGA 
ACTAATGAGG ATTCTCCTTC TCAAATATGT ACTATGTTGG 
CACGAAGTTT TGCAGATATA GGTGATATTG TAAGAGGAAA 
AGATTTATCT CATGGTAATA GCCAAGAPA AGAAAAAAGA 
GATCAATTAG AAACCAATTT GAAAACAATT TTCGGGAAAA 
TACATGAAAA ATTGAAGGAT AAGGAAGGAG CAGAAACTCG 
TTACGGAAGT GATACTACAA ATTATTATCA ATTACGAGAA 
GACTGGTGGT ATGCGAATCG CGCCACAGTC TGGGAACCTA 
TCACGTGCGA CGTTCATGGT TCTGACTATT TTCGACAAAC 
ATGTGGTGAT AAACAAACCA CTCCAACTCG GCTTAAAGAC 
AAATGCCGCT CTAAGGACCA AAACGGCAAA AAGCCCGGCT 
CAAATGCCGA CCAAGTCCCC ACATATTTT 
SD105C 	AF127286 	AGTCATAATT TGGAATCTAT ACACACAACG TCGATGACGC 
ATAAGTTGTT GTTAGACGTG TGTATGGCAG CAAAATACGA 
AGGAAACTCA ATAGATACAC ATTATCCACA ACATCAACGA 
ACTAATGAGG ATTCTCCTTC TCAAATATGT ACTATGTTGG 
CACGAAGTTT TGCAGATATA GGTGATATTG TAAGAGGAAA 
AGATTTATTT TATGGTAATA GCAAAGAAAA AGAAAAGA 
GATGAATTAG AAACCAATTT GAAAACAATT TTCGGGAAAA 
TACATGAAAA ATTGAAGGAT AAGGAAGGAG CAGAAACTCG 
TTACGGAGT GATACTACAA ATTATTATCA ATTACGAGAA 
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Appendix: GenBank accession numbers and nucleotide 
sequences of Sudanese DBLI variants (continued) 
Variant 	ACC No 	NucleotideSeguences 
SD1 05C (cant.) AF1272 86 	GACTGGTGGT ATGCGAATCG CGCCACAGTG TGGGAGCTA 
TCACGTGCGA CGTTCATGGT TCTGACTATT TTCGACAAAC 
ATGTGGTGAT I½AAGAAACCA CTGCAACTCG GGTTAAGAC 
AAATGCCGCT GTAAGGACGA AAACGGCAAA AAGCCCGGCT 
CAAATGCCGA CCAGTCCCC ACATATTTTG ACTACGTGCC 
GCAGTATCTT CGCTGGTTCG AGGAATGGGC AGAGACTTT 
TGTAGGAAAA AAAAAAAGAA ATTAGAAAAG TTGGAACAAC 
AGTGTCGCGA TTACAAPCAA AATTTATATT GTAGTGGTAA 
TGGCTACGAT TGCACAkAAA CTATATACAP APAGGTAAA 
CTTGTTATAG GTGAACATTG TACAAACTGT TCTGTTTGGT 
GTCGTCTGTA TGAATCT 
SD105D 	AF127287 	GATAAAAATA TCCAACAGAT AAAAACTGAA AATATAACAA 
CACATATTT ATTATTAGAT GTGTGTCTTG CAGCAAAGTA 
TGAAGGAGAG TCCTTAAAG GTTATCATGA GCAATATGAA 
GTACAATATC CTTCTTCTGG TTCTACAATG TGTACTGAGT 
TGGCACGAAG TTTTGCAGAT ATAGGAGATA TTGTCAGAGG 
AAGAGATTTG TATGGAGGTA GTAAAAAAGA AAPAGAAAAA 
AGAAAACAAT TAGATGATAA GTTGAAAAAA ATTTTCGAAA 
ACATTAAGAA AGAGAATAAT GAAAAACTTA AATCCCTTAC 
AGATGACCAA ATTAGGGAAT ATTGGTGGAC TGCAAATCGA 
GAAACAGTAT GGAAAGCTAT TACTTGTGAC GAAGAGAACA 
AGCTAGGGGG TTATTTATAT TTTCGAGGAA CATGTGGTGA 
TAATGAAA AGTGTAACTC AGGCTAGAGA CAAATGCCGC 
CGTAAGAAGA AAGACAACAC CCCCGACGAC CAGGTCCCCA 
CATATTTC 
SD105E 	AF127288 	AGTCATAATT TGGAAAGTAT ACAAACAAAT AATTATATA 
GTGGTAATGC TAAACATAAT TTATTGGTAG ATGTGTGTAT 
GGCAGCCAAA TACGAAGGGG ACTCAATAAA AAACTATTAT 
CCAAAGTATC AAAGAACATA TCCTGATACT AATTCTCAAT 
TATGTACCGT GTTGGCACGA AGTTTTGCTG ATATAGGAGA 
TATCGTACGC GGTAAAGATC TGTATCTCGG TAATCCACAA 
GAAAGTACAC AAAGAATAAT ATTAGAAAAT AATTTGAAAG 
ATATTTTCGC GAAAATACAT AGTGACGTGA TGTCAACGAG 
CGGGAGTAAT GGGAGGGCGC TACAAAAACG CTACAAAGAT 
ACTGATAATT ATTATGAATT GAGAGAAGAT TGGTGGGCAC 
TTAATAGAGA CCAAGTATGG AAAGCTATCA CATGCAATGC 
TGGGGGTGGT AATAGATATT TTCGACAAAC ATGTGGTTCA 
GGAGAATGGG CTAAAGACAAATGCCGGTGT AAGGACGACA 
AGGTCCCCAC ATATTTT 
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Appendix: GenBank accession numbers and nucleotide 
sequences of Sudanese DBLI variants (continued) 
Variant 	ACC No 	Nucleotidesequences 
SD105F AF127289 AACAAAATT TTCCAAATAT GAATAGTAAG GATAGTTTGA 
AAGCTAAAAA TGATTTATTG GTAGATGTGT GTTATGCAGC 
AAAATACGAG GCAGAGTCAT TAATACCTTA TCATGACCAA 
TATAAATTAP CTTATCGTGA TTCTCAAGTA TGTACTGTAT 
TAGCCCGAAG TTTTCCAGAT ATAGGTCATA TTGTCAGAGG 
AAAAGATCTT TTCCTTGGTC ATAATCAAAG AAAAAAAAAA 
ATTAGAAGAP AGATTAGAAC AAATGTTAAG AACATTACGC 
ATAGTAATGC GGCTAPJCTA AGTGTACTTT CP,AGCAAAGA 
AATTAGGGAP TATTGGTGGG CTCTTAJTAG AGACCAACTA 
TGGAAAGCAC TAACATGTGA CGAGAGAAC AAGCTAGGGG 
GTAATGCATA TTTTCATGCA ACGTGCACTG ACGTAATGG 
AGGTTGTTCT CAAGCTCATG AAAAATGCAG GTGTCCCATG 
ACAAGTGATG GCAAGCCCAA TGACCAAGTC CCCACGTATT 
TT 
SD105G 	AF127290 	AACAAAAATT TTCCAAATAT GAATAGTAAG GATAGTTCGA 
AAGCTAAGCA TGATTTATTG GTAGATGTGT GTATGGCAGC 
AWTATGAA CGGGAGTCCT TAAAAGTTTA TCATGAGCAA 
TATGAAGTAC AATATCCTTC TTCTGGTTCT ACAATGTGTA 
CTGAGTTG 
SD105J 	AF127291 	CATCATAATT TOG?AACTAT AGAAACAPCG TCGAAGACGT 
CTACTCACAC ATTGTTGGCA GAGGTGTGTA TGGCAGCATA 
CTATGAAGGA GAATCTTTAA CAAGACAACA TGTCAAACAT 
AAPCTAACTA ATTCTGATGT CAATATCAZT ATATGTACCG 
TTTTAGCACG AAGCTTTGCA GATATAGGGG ATATCGTTAG 
AGGAAAAGAT CTATTTTATG GTAATACATA TG?AGTACA 
CAAAGAkAAG TATTAGACGA TAATTTAAAA ACAJTTTTCG 
AAAACATTAA GAAAAGTGAT ACAAAACTAA CTAAGCTTAA 
TGATGAACAA ATTAGGGAT ATTGGTGGGA AGCCAATCCA 
GAACAGTAT CCAAAGCCAT AACATGTAGC GACGACCTAA 
AAAATTCTTC ATATTTTCGA ACAACAGCGT GTGCAGGAC 
CCCGACTAAT GACAAATGCC GCTGTACCAA GTCAAGTGGC 
GCAAAGGTCG ACGACCAAGT CCCCACATAT TTTGATTATG 
TGCCGCACTA TCTTCGCTGG TTCCAGGAAT GGGCCGAPGA 
CTTTTGTACG AAAAAAAATA AAAAATAAA AGATGTTAAA 
ACAAATTGTC GTGATGAAAA AG1AAATAT TGTAGTGGTA 
ATGGATATGA TTGCAGAAPA ACTATATACA AAAAAGGTAA 
ACTTCTTATA GGTGAACATT GTACAAACTG TTCTGTTTGG 
TGTCGTCTGT ATGAAAAA 
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Appendix: GenBank accession numbers and nucleotide 
sequences of Sudanese DBLI variants (continued) 
Variant 	Acc No 	NucleotideSequences 
SD105K AF127292 GATCATCATT TATCATACAT GAATGCTGGT AAAACTAATA 
CCACAGATAA TTTATTCTTA GAGGTGTGTA TGGCAGCACA 
ATATGAAGGA CAATCAATAA GAGGTCAACA TGACAAACAT 
AAACTAGACA ATAATAATTC TAGTTCTCAA TTATGTACCG 
TTTTAGCACC AAGTTTTGCA GATATAGGTG ATATTATAAG 
AGGAAGAGAT TTGTATCGTC GAGATAAAGG AGAAGAGAAA 
AAATTAGAAA AGAATTTGAA AGAAATTTTC AAGMTATAT 
ATAATGAGTT GACGACGAAA AATGGCACAA AAGAACGCTA 
CAATGATACA GATAATTATT TTCAATTACG AGAAGATTGG 
TGGGAAGAAA ATACAGAAAC AGTATGGAAA GCTATCACAT 
GCCACGTTGT GAGTGGTAAT AATTATTTTC GACACACATG 
TACTGATGAA kACCATCCAA CTGCGACTCA AGGTAACTGC 
CCATGTATAG CCGCATCAGT TCCCACATAT TTC 
SD105L 	AF127293 	CATCATAATT TGGAAAATAT CAACCATGTT AATAATATTG 
ATAATGATAC GTTGTTGGCA GAAGTGTGTA TGGCAGCATA 
CTATGAACGA GAATCTTTAA CACGTTATAA TCCAATATAT 
CAAACAAAAT ATAAGGATTC TGGTTCTACA ATGTGTACTG 
AGTTGGCACG CAGTTTTGCA GATATAGGAG ATATTGTGAG 
AGCAAGAGAT CTATTTCGTG GTAATGATGA AGAAAAAAAA 
AAAAGAGATG AATTAGAAAA GAATTTGAAA ACAATTTTCG 
GGAAAATACA TAGTCGATTG ACGAAAGACG CACAAAATTA 
CTACGAAGAT AATGATACTG ACAAAAACTA TTATCAATTA 
AGAGAAGATT GGTGGAAGGT CAACAGAGAT CAAGTATGGG 
AGCCATAAC ATGTGAACCA AAAAGCGATG ATAAATATAA 
TGTAATAGGT CCAGATGGCA AAATAACAGA ATCTAATAAG 
GGACAATGTA GATGCTTTAG TGGAGATCCT CCTACTAATA 
TGGACTACGT TCCTCAGTTT CTTCGCTGGT TCGAGGAATG 
GGCAGAAGAC TTTTGTAGAT TAAGCAAACA TAAATTAAA 
GATGCTATAG ACAAATGTCG TACACCAAAG GGTAAAGAAA 
AATATTGCGA TCTTAATAGG TATGATTGCG AGCAPIACCAT 
TAGAGGAGAT CATGATTTTG TTGAAGATGA TGTTTGTAAA 
GGTCCTCAGT ATTCGTGCTC TCATTTTGTG AAC 
SD105L2 	AF127294 	CATCATAATT TGGAAAATAT CAACCATGTT AATAATATTG 
ATAATGATAC GTTGTTGGCA GAAGTGTGTA TGGCAGCATA 
CTATGAAGGA GGATCTTTAA CACGTTATAA TCCAATATAT 
CAACAAAAT ATAAGGATTC TGGTTCTAAA ATATGTACTG 
AGTTG 
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Appendix: GenBank accession numbers and nucleotide 
sequences of Sudanese DBLI variants (continued) 
Variant 	Acc No 	Nucleotideseguences 
SD105M AF127295 GATCAACATT TATCACACAT CAAAGCTGAA AAAATCAATA 
ATAAACATAA TTTATTGTTA GAAGTGTGTC TTGCAGCAAA 
ATATGAACGT GAGTCATTAA AAGGTTATCA TGATAAATAT 
kATGCAACTT ATTCTGATTC TCCTTCTCAA TTATGTACTG 
TATTAGCACC AAGTTTTGCA GATATAGGAC ATATTATCAG 
AGGAAAAGAT CTTTTCATTG GTTATGATAA AAAAGATAGA 
GTACAAAAAA AAATTACA AGATAGTTTG AAAAACATTT 
TCGGGAATAT ATATAATGAG TTGACCACGA GCGGGAAGAA 
TGTGGACAAA GCAAAAGCTC GCTACAATGA TCCTAAAGGA 
GATTTTTTTC AATTACGAGA AGATTGGTGG GCACTTAATA 
GAGAAAAAGT ATGGAGTGCT ATCACATGCA ACGCTCAAGG 
TAATAAATAT TTTCGACCAA CATGTTCTGG TGGAGAAAGT 
ATCGCTCATA ATAAATGCAC ATGTATTAAT GGAGATCCTC 
CTACGTATTT CGATTATGTC CCTCAATATT TACGTTGGTT 
CGAGGAATGG GCCGAAGATT TTTGTCGTAA ACGAAAACAT 
AAATTACAAA ATGCTAAAGA ACAATGTCGC GGAAAAAATG 
GTGAAGATAA ATATTGTGAT CTTAATGGAT ATGATTGTAA 
GAGAACTATA AGTGCAGAAA AGAAACTTTT CCCCGATTCT 
GATTGTAATA AATGTTCCTA TTCATGTATT CCTTTTAGAA 
CA 
SD105N 	AF'127296 	GTTAGAAATT TGGAAAATAT CAGTAATTAT GGTAAAATTA 
ATAATGACAC ATTATTAGCC GATGTGTGTC TTGCAGCCTT 
ACATGAAGGG GCGGCAATAT CATCTGATCA TGGAATAT 
CAGAAACTA ATAATGATGT CAATGCCAAT ATATGTACTA 
TGTTG 
SD105P 	AF127297 	AACAAAAATA TGGAAAAAAT GGGCAGAACG TCGACAACGA 
AGCATGATTT GTTGTTAGAT GTGTGTATGG CAGCAAATTA 
CGAGGCACAG TCATTAATAC GTTATCATGA CAAACATCAA 
CTGACTAATG AGGGTTCTCA AATATGTACC GTATTA 
SD105Q 	AF127298 	GATCAAAATT TAGAACTAAT AAAACCAAAG AATATAACAA 
CACATAATTT ATTGGTGGAT GTGTGTCTTG CTGCAAAATT 
TGAAGCAGAG TCATTAAAAA CATATCGTGG AAAATATCAA 
CTAACTAATC ATGGTTTCCA TACCAATATA TGTACTGAGT 
TGGCACGAAG TTTTGCAGAT ATAGGAGATA TTATTCGCGG 
AAAAGATCTA TATCGTGGTA ATAACAAAGA AAAAGATAGA 
TTAGAAGATA ATTTAAAAAA AATTTTCAAG CAATTATATG 
AAGAATTAAC AAAGAACAAT AAGAATGAGG CGATAAAAAC 
TCACTACCAA GATGATGATC CAAATTATTA TAAATTAAGG 
AATGCTTGGT GGGAAGCTAA TAGACAAGAA GTATGGAAAG 
CTATCACGTG CGGTGCTGGG GGTTCTAAAT ATTTTCGACA 
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Appendix: GenBank accession numbers and nucleotide 
sequences of Sudanese DBLI variants (continued) 
Variant 	Acc No 	NucleotideseguenceS 
SD105Q (cont.) AF12729 8 	CACATGTGGT ACAGGAACGC CGACTGATGA TAAATGCCGA 
TGTGCGATAA ATGATGTTCC TACATATTTT GATTATGTGC 
CACAGTATCT TCGCTGCTTC GAGGAATGGG CCGAAGATTT 
TTGTCCTAAA CGAAAACATA AATTAAAAGA TCTTAAAACA 
AATTGTCGTG GAGAAAATGC TACAGATCCA TATTGTAGTG 
GTAATGGATT AGATTGCACA AAAACTATTA GAGCCAAATA 
TATCTATGCT ATAGGTAGTG AATGCACTAA ATGTTCTTTT 
TTGTGTGGTT TTTATAAAPA A 
SD105R 	AF127299 	AACAAAAPTA TGGAAAAAAT GGACTCAACG AAAATCAAGG 
ATAAAAATGT TCTGCTGGCC GACGTGTGTT ATGCAGCAAA 
ATATGAAGGC AAATCATTAG TAGAAAAATA TAAGAATAT 
AAACAACCGA ATAATGATTC CGATACCGAT ATATGTACAG 
CCTTGGCACC AAGTTTTGCA GATATAGGAG ATATTGTAAG 
ACCAAAAGAT CTGTATCACG GTTATGACGA TGAGGAAAAA 
AAACAAAGAG ATGAATTAGA AGAAAATTTG AAAACAATTT 
TCAAGAATAT ATATGGCAAT TTGGATAAAA AAGATCGCTA 
CGAAGCTGAT ACTAAAAATT ATTATCAATT AAGAGAAGAT 
TCGTGGTATG CTAATAGAAG ACAGGTATGG AAAGCTATCA 
CGTGCGACGC TAAGGCTTTT ?ACTATTTTA GZAAATACATG 
TAATGGAGAA ACTCCAACTA AAGGTTACTG CCGGTGTAAC 
GACGACCAGC CAATGCCGA CAAGCCAAAT ACCGATCCCC 
CAACCTATTT TGACTATGTG CCGCAGTATC TTCGCTGGTT 
CGAGGAATGG GCAGAAGACT TTTGTAGGAA AAkAATAAA 
AAATTAAATG ATGTTAAAAA ACAGTGTCGT GGAGATAATG 
GTACAGATCG ATATTGTAGT GGTAATGGAT ATGATTGCAC 
AAAAACTATT AGAGCAATAG GTAAGTATGC TATAGGTGAT 
GAGTGTACTA AATGTTCTTT TTGGTGTCGT ATGTATGAA 
CT 
SD1O5S 	AF127300 	GATCAAA.kTT TAGAACTAAT Z½AAACCAAAG AATATAACAA 
CACATAATTT ATTGGTGGAT GTGTGTCTTG CTGCAAAATT 
TGAAGCAGAG TCATTAAAAA CATATCGTGG AAAATATCAA 
CTAACTAATC ATGGTTTCCA TACCAATATA TGTACTGAGT 
TGGCACGAAG TTTTGCAGAT ATAGGAGATA TTATTCGCGG 
AAAAGATCTA TATCGTGGTA ATACAAGA AAAAGATAGA 
TTAGAAGATA ATTTAAAAAA AATTTTCAAG CATTATATG 
AAGAATTAAC AAAGAACAAT AAGAATGAGG CGAThAAAAC 
TCACTACCAA GATGATGATC CAPATTATTA TAAATTAAGG 
AATGCTTGGT GGGAAGCTAA TAGACAGAA GTATGGAAAG 
CTATCACGTG CGGTCCTGGG GGTTCTAAAT ATTTTCGACA 
CACATGTGGT ACAGGAACGC CGACTGATGA TAAATGCCGA 
TGTGCGATAA ATGATGTTCC TACATATTTT GATTATGTGC 
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Appendix: GenBank accession numbers and nucleotide 
sequences of Sudanese DBLI variants (continued) 
Variant 	Acc No 	NucleotideSequences 
SD105S (cant.) AF1273 00 	CACAGTATCT TCGCTGGTTC GAGGAATCGG CCGAAGATTT 
TTGTCGTAPA CGAAAACATA AATTAAAAGA TGTTAAACA 
ATTGTCGTG GAGAAAATGG TACAGATCGA TATTCTAGTG 
GTAATGGATT AGATTGCOAA A\AACAGTTA ACGCACGAGG 
TAAAGTACGT ATGGGTAAAG GTTCCACTGA CTGTTTTTTT 
GCATGTAATC CTTACGTTGA T 
SD105T 	AF127301 	GATAGAAATT TAGAACAGAT AAAACCTCAT ACAATAACAG 
CAACACATAA CTTATTGGTG GATGTGTGTT ATGCAGCACA 
ATTTGAAGGA AAATCAATTT CAGGTTATTA TCCAGATAT 
CAAACAAAAT ATAAGGATTC TGGTTCTACA ATATGTACTG 
TATTA 
SD105U 	AF127302 	GTTAGAAATT TGGAAAATAT CAATGATTAT AGTAAAATTA 
ATAATAAACA TAATTTATTG GTAGAAGTGT GTCTTGCAGC 
CAAATATGAA GGGGAATCAA TAACAGGTCG TTATCCACAA 
CATCAAGAAA CTAATCCTGA TACTAAATCT CAICTATGTA 
CTGTATTAGC ACGAAGTTTT GCAGATATAG GTGATATTAT 
AAGAGGAAAA GATCTCTATC GTGGTGGTAA TACCCCCGAA 
AAAAAAAAAA GAAAAAAATT AGAAGAAPAT TTAAAAACGA 
TTTTCGCGCA TATATATGAT GAATTGAAGA ATGGGAAGAC 
GAATGGGGAG GACGAGCTAC CAAAACGCTA CCGAGGTGAT 
AAAGATAATG ATTTTTATCA ATTACGAGAA GATTGGTGGG 
ACGCTAATCG AGAAACGGTA TGGAAAGCTA TCACATGCAA 
CGCTGCAAGT TATCAATATT CTCAACCAAC ATGTGGTCGT 
GGAGAAATTC CATATCTGAC GCTTAGTAAA TGCCGATGTA 
TTGCTGGAGA TGTTCCTACA TATTTTGACT ATGTCCCACC 
ATATTTGAGA TGGTTCGAGG AATGGGCAGA AGACTTTTGT 
CGTAAAAGAA AAAAAAA7tAT ACCAAACGTT AAAACAAATT 
GTCGTCAGGT ACACAGGGGT AAAGAAAAAT ATTGTGATCG 
TGATGGATAT AATTGTCATG GTACTATTAG AAAGCAATAT 
ATTTATCGTT TGGATACTGA TTGTACTAAA TGTTCTCTTG 
CATGTAAGAC TTTTGCGGAA 









TAGAACATAT TAAACATGAT AAAATAACAA 
CTTGGCAGAT GTGTOCGAGG CAGCAAAATT 
TCATTAGAAA AATATCGTGG ACAATATCAA 
CTGATCTCAA TATCAATATA TCTACTGAGT 
TTTTGCAGAT ATAGGTGATA TTGTAAGAGG 
TATCGTGGTA ATGATAAAGA AAAAGATAGA 
ATTTAAGAAA GATTTTCAAA AAAATATATG 
CGATGCACAT GTGCTAGAAC ACTACCAAGA 
GGAACTAAAA ATTATTATAA ATTAAGGAAT 
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Appendix: GenBank accession numbers and nucleotide 
sequences of Sudanese DBLI variants (continued) 
Variant 	Acc No 	NucleotideSeqi.iences 
SD106A (cont.) AF1273 03 	GCTTGGTGGG AAGCTAACAG ACAAACAGTA TGGAAAGCTA 
TCACATGTGG CGCTGCCGGT GGTACATATT TTCGACAAAC 
ATGTGGTACA GGAACGTGGA CTAATGAAAA ATGCCGATGT 
CCGATAAATG ATOTCCCCAC ATATTTTGAC TATGTGCCAC 
AGTATCTTCG CTGGTTCGAG GAATGGGCGC AAGATTTCTG 
TCCTAAAAAG AAGAAATATG TTGATATAGT TAAAACAAAT 
TGTCGTAATT ACTCAAGAAA TTTATATTGT AGTGGTAATG 
GATTAGATTG TCAAGAAACT ATTAGAGTAA TAGGGCACCA 
TGTTATAGGT AGTGAATGCT CTAAATGTTC TGTTTGGTGT 
CGTCGTTATA AAAAA 
SD106B 	AF127304 	GACAAAAATA TCCAACAGAT AAAAACTGAA AATATAACAA 
CACATAATTT ATTATTAGAT GTGTGTCTTG CAGCAAAATT 
TGAAGGACAA TCAATAACTG GTTATCATCC ACAATATGAA 
GTACAATATC CTTCTTCTGG TTCTACAATG TGTACTATGT 
TA 
SD106C 	AF127305 	GTTAGAAATT TGGIAAAAAT GGACTCAACG AAAATCAAGG 
ATAAAAATGT TTTGCTGGCA GAAGTGTGTT ATGCAGCCAA 
ATATGAAGGG ACGTCATTAA AAGGTTATCA TGACCAACAT 
AAAGGAACTA ATCCTGATTC TAAAATATGT ACTGTATTAG 
CACGAAGTTT TGCAGATATA GGAGACATTG TCAGAGGAAG 
AGATCCATTT TATGGTAATA CACAAGAAAG TACACAAAGC 
GAAAAATTAC AGAAGAATTT GAAAGAAATT TTCAAGGAAA 
TACATAATGG ATTGGATGGG GAAGCACAAG CTCGCTACAA 
TGGTGATACT GATAATTATT ATAAATTAAG GGAAGATTGG 
TGGACAGCGA ATAGGCACAC CGTGTGGGAA GCTATCACGT 
GCGAAGCTGG GAATCATTCT CAATATTTTC GACCAACATG 
TGGAGGTAAT GAAAAAAATT CAACTCTGGC TAAAGACAAA 
TGCCGCTGTA AGGACGAAAA ATTCACAAAA GAGACCGACC 
AGGTTCCTAC ATATTTTGAC TACGTGCCAC AGTTTCTTCG 
CTGGTTCGAG GAATGGCCAG AAGATTTTTG TAGATTAAGA 
AAACGTAAAT TAAAGGATGC GATACAAAAA TGTCGTGGAA 
AAGATAAGA TGG'TAAGAAA CTATATTGTG ATCTTAATAG 
GTATGATTGT GAAAAAACAG CTAGCGGAAA ACATGATTTT 
TTTGAAGAGG ATGATTGTAA AGATTGTCAC TTTTCGTGCG 
CTCGTTTTGT AAAA 
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Appendix: GenBank accession numbers and nucleotide 
sequences of Sudanese DBLI variants (continued) 
Variant 	ACC No 	NucleotideSequences 
SD106D AF127306 GACACAAACT TAGAACAkAT AGATCCTGCA AAAATAACAA 
CAACACATAA TTTATTGGTA GATGTGTTAC TTGCAGCAAA 
ACATGAGGGA GAATCTATA TTGACAACTA TCCTTCAGAC 
CATCACAATA AAGAAGGTAT TTGTACAGCA CTT 
SD106E 	AF127307 	GACCAACATT TATCGCACAT GAAAGCTGAA AAAATTAATT 
CTAAAGATAA TTTGTTCTTA GAAGTGTGTC TTGCAGCACA 
ATATGAAGGA GAATCATTAG TAGAAAAACA TAAAGATTT 
AAAAAAACAC ATAACGATTC CAATATATAT ACTATATTG 
SD106F 	AF127308 	GACCAACATT TATCGCACAT GAATGCTGGT AAAACTAATA 
CGACAGATAA TTTATTGTTA GAAGTGTGTC TTGCAGCAAA 
ATATGAAGGA GAATCATTAG TAGAAAAACA TAAAGAATTT 
AAAAAAACAC ATAACCATTC CAATATATCT ACTATATTG 
SD106G 	AF127309 	GTTAGAAATT TACAAAATAT AAGTCCATTG GATAAGATTA 
ATAATGATAC CTTATTGGCA GATGTATCTC TTGCTGCCCT 
ACATGAAGGA CAATCAAThA CACAACATTA TCCAAAATAT 
CAACCACAAT ATGCTTCTTC TTTTTCTCCT TCTCAAATAT 
GTACTATGTT G 
SD126A AF127310 	 GACCAACATT TATCGCACAT GAAAGCTGAA AAAATTAAGA 
ATAAACATAA TTTCTTGTTA GAAGTGTGTC TTGCAGCGAA 
CCATGAAGGA CAATCAATAG CAGGTCAACA TGGAAAATAT 
CATACAGATG GTTCTGCTTC TACAATGTGT ACCGTGTTGG 
CACGAAGTTT CGCAGATATA GGTGATATTA TACCACGAAA 
AGATCTTTAT ATTCGTAATA AACGAGAAAA AGATAGATTA 
GAAAAGAATT TGAAAAAAAT TTTCGAAAAA ATTAAGGGAA 
ATAATCGAAA ACTAAGTACC CTTGAAGATG ACCAAATTAG 
GGAATACTGG TGGGAACTTA ATAGAGAAAT GGTATGGTAC 
GCGATAACAT GCGGCGCTGC GGGTGGTACA TATTTTCGAG 
GAACATGTGT TGGAAGAAAT TCAACTAATG A1AAATGCCG 
ATGTCCTAGT CATAAGGTCC CCACATATTT TGATTATGTG 
CCACAGTATC TTCGCTGGTT CGAGGAATGG GCAGAAGACT 
TTTGTACAAA AAGAAAACAT AAATTACAAA ATGCTAAAGA 
ACAATGTCGT GGACAAGATA AATATGGTAA CGAACGATAT 
TGTGATCTTA ATAGGTATGA TTGCACAAAA ACTAAAAGTG 
CAAAACATGA ACTTGTGCAA GGAGAGGAAT GTAAAAAATG 
TTCTGTTGTA TGTATTCCTT TTGGACCC 
5D126B 	AF127311 	GACAGAAACC TAGAACAGAT AGAGCCTATA AA.AATAACAA 
ATACTCATAA TTTATTGGTA GATGTGTGTC AGGCAGCAAA 
ATTTGAAGGA CAATCAATAA CACAAGATTA TCCAAAATAT 
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Appendix: Gen Bank accession numbers and nucleotide 
sequences of Sudanese DBLI variants (continued) 
Variant 	ACC No 	NucleotideSequences 
SD126B (con .) AF127311 CGAGCAACAT ATAPTGATTC TCCTTCTWI ATGTGTACTA 
TGTTAGCACG AAGTTTTGCT GATATAGGTG ATATTATAAG 
ACGAAAAGAT CTTTATCTTG GGAATAAAAA AAAAATGAA 
AATAAIACAG AGAAGAAAA ATTAGAAAAC AAATTAAPG 
AATATTTCGA GAAAATATAT AATAGTTTAG AAAGTAGCAT 
AAAATCAAAC TATAATIATG ATACTAAAAA TTATTATAAA 
TTAAGAGAAG ATTGCTGGGC TGCAAATCGC GCCACAATCT 
GGGAAGCCAT CACGTGCAAC GCTGGGGGTG GTACATATTT 
TCGAGGAACA TGTGGTACAG GAACGGGGAC TAATGACAA 
TOCCGATGTC CCAATGGTAA AAATTCCGAC CAGGTCCCCA 
CATATTTTGA CTACGTGCCC CAGCTTCTTC GCTGGTTCGA 
GOAATGGGCA OAAGACTTTT GTCGTAAAAA AAZACACAAA 
TTAA7GGATG CGATACAAAA ATGTCGTGAA AAAGATAAAG 
ATGCTAAGGA TCGATATTGT GATCTTAATG GCTACGATTG 
CGAAAACC AAAGAGTAA GAAACATTTA TCGTTGGGAT 
TACAAATGTA CAGCCTGCTT CCGTTCTTGC TCTCATTTTA 
GAACA 
SD126C 	AF127312 	GATAAAAATC TAGAACAGAT AAAAGTGGAA CZAATAACAA 
CACATAATTT ATTGGTAGAT GTGTTTCAGG CAGCAAAATT 
TGAAGGACAA TCAATAAGAG GTTATCAAGA GCAATATGAA 
GTACAATACC CTGCTTCTGG TTCTGGTTTT ACATTGTGTA 
CTATGTTAGC ACGTAGTTTT GCAGATATAC GAGATATTAT 
ACGAGGAAAA GATTTATTTA TTGGTAATAA CAAAAGAGAT 
AAATTAGAAA AACAATTACA AAAATATTTC AAG2AA1TAT 
ATGACAAATT GGATGGGAAG AAGAAGAAGG AAGCAAAAGA 
CTACTACCAA GATCGAACTG AAAATTATTA TCTATTAAGA 
GAAGATTGGT GGAATAATA7 TAGAAAAATG GTATGGTACG 
CGATAACATG CGGCGCTGAG AATGATTCTC AATATTTTCG 
AGGAPCATGT GGTAGTGGAG AAACTGCACC TCGGACTCCT 
AGTCAATGCC GATGTAAGAC AAATGTTGTT CCCACATATT 
TTGACTACGT GCCACAGTTT CTTCGCTGGT TCGAGGAATG 
GGCAGAAGAC TTTTGTCGTA AACGAAAPAA AAAAATAGAA 
AATGCTATAA AAATTGTCG TGGAGATAGT GGTAAGGAAC 
GATATTGCGA TCTTPATGGA TATGATTGCG AACAAACTAT 
TAGAGGAAAA AAGAAACTTG TTGAAGGTGC AGATTGTAA 
AAATGTTCTG TTGCATGTAA TCCTTTTGTA CCCT 
SD126D 	AF127313 	GATAAAAACT TGGAAGCTTT AACTGTGGAA AATACACAA 
ATTGTGACGA CTTGTTAGGA AATATATTGG TAGCAGCAAA 
ATACGAAGGT CAATCTATTG TTAATAATTA TCCAGATAAA 
AATAATTCAA ATAATAAATC AAGTATATGT ACTGCTCTT 
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Appendix: GenBank accession numbers and nucleotide 
sequences of Sudanese DBLI variants (continued) 
Variant 	Acc No 	NucleotideSeguenceS 
SD126E AF127314 GATCAATT TAGAACAGAT AkAACCTCAT CAAATTACAA 
GTACTCATAP TTTGTTGGCA GATGTGTGTC TTGCAGCACA 
ACATGAAGGA CAAATGTTAG TAAAGAAGCT TCAAGATAT 
GATCCAAATA ATTATGAATC ACGAACATGT ACTGTATT 
SD126F 	AF127315 	CATCATAATT TGGI½AACCAT AAAGAATACA ACGTCGATGA 
CGACGACTAG TGACACGTTG TTGGCAOAAG TGTCTTATGC 
AGCAAAAGAG GAAGGGGAAT CAATAAAAPC ATATTATCCA 
CCACATCAAC ACAAATATGA TCCTTCTCAA CTATGTACCG 
TGTTG 
SD126G 	AF127316 	GTTAGAAATT TAGAAATAT AAGTGCATTG CATAAGATTA 
ATATCATAC ATTATTGGCG GATGTGTGTC TTGCAGCCCT 
ACATGAAGGG GCGGCAATAT CACGAATCA TGGZAAACAT 
CAACTGACTA ATTCTTATTC TCAATTATGT ACTGAGTTG 
SD126H 	AF127317 	CATTATAATT TOGAAAAAAT GGGCACT1AA AAAAACAAAG 
CTAGACATAA TTTGCTGGCA GAAGTGTGTT ATGCAGCAAA 
ATTTGAAGGG CAATCAATAA CAGGTCGTTA TCGACAATAT 
CAPGCAACAT ATGGTGATTT TGGTTCTACA ATATGTACGG 
TATTA 
SD126J 	AF127318 	GTTAGAAATT TAGAAAATAT AAGTGCATTG CATAAGATTA 
ATAATCATAC ATTATTGGCG GATGTGTGTC TTGCAGCCCT 
ACATGGAGGG GCGGCAATAT CACGAAATCA TGGAAAACAT 
CAACTGACTA ATTCTTATTC TCAATTATGT ACTGAGTTG 
SD126K 	AF127318 	CATCATAATT TGGAAACCAT AAACAATACA ACGTCGACGA 
CCCATAAGTT GTTGCCAGAG GTGTGTCTTG CAGCCAAACA 
TGAAGGAGAA TCGTTAGTAG AAAAATATAA AGAATATAAA 
GAAAAAAAAA ATACTAATTT CCATACCAAT TTATGTACTA 
TATTG 
SD126M 	AF127320 	GACAGAAATT TAGAACATAT TGAACCTGAT CAAATCACAA 
GTACTCATAA TTTATTGGTA GATGTATTAC TTGCAGCCAA 
ACATGAAGGA GATTCAATAA TTAATAACTA TCCTGATAAC 
CCTGACAAAA AAGAAGGAAT TTGTACACCA TTGGCACGAA 
GCTTTGCAGA TATAGGCGAT ATTATAAGAG GAAAAGATCT 
TTTCCTTGGT CATCAACAAA GAAAAAAATA TTTAGAAGCA 
AGATTAGAAC AAATGTTTAA GAACATTCGC AATGAAAATA 
ATAATAAACT ACGTAGACTT TCAATCGAAC AAGTTAGAGA 
ATATTGGTGG TATGCTAATA GAATAATGGT ATGGAACGCC 
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Appendix: GenBank accession numbers and nucleotide 
sequences of Sudanese DBLI variants (continued) 
Variant 	Acc No 	NucleotideSeguences 
SD12 6M (cont.) AF12732 0 ATAACATGCG GCGCTGGGG TTCTCAATAT TTTCGACACA 
CATGTGGTAG TGGAAAAACT CCGACTGATG ATAAATGCCA 
CTGTACCAAT CATGGTGTTC CTACATATTT TGACTATGTG 
CCGCAGTATC TTCGCTGCTT TGAGCAATGG GCAGAAGACT 
TTTGTACAAA AAGAAAACAT AAATTACAAA ATGCTAAAGA 
ACAATGTCGT AGACCAAATG GTGAAGATAA ATATTGCGAT 
CTTAATGGTT ATAATTGCCA AAAAACTATT AGAGGAAAAA 
AGAAACTTCT CTCGGATATC GAATGTACTA AATGTTCCTC 
TTCATCTATT CCTTTTGTGG AC 
SD126N 	AF127321 	GATAGAAATT TGGAATATTT AAATAACAAT AATACGGCAA 
CTACCCATGA TTTATTGGGA AATGTGTTAG TTACAGCAAA 
ATATCAACGT GCCTCTATTG TTGCAAAGCA TCCACATAAA 
GATATTAATG GTAATAAATC AGGCATATGT ACTGCACTC 
SD128A 	AF127322 	GACTATAATT TGCAAAGTAT CAGTAATTAT AATAGTAATG 
CTAGACATAA ATTCCTGGCA GAAGTGTGCA TGGCAGCAAA 
ATATGAAGCA AACTCAATAA ATACACATTA TACACCACAT 
GAACAAGCCA ATCCTGATAC TAAATCTCAA TTATGTACGC 
TGCTC 
SD128B 	AF127323 	GATCAACACT TAGAACATAT GGACACCAAT AAAATTAATA 
ACACTCATAA TTTATTATTA GAGGTGTCAC TTGCAGCGAA 
GCATGAAGGA CAATCAATAA CTGGTTATTA TCCAAAATAT 
GAAGTACAAT ATCCTGGTTC TACTTTTACA ACGTGTACTA 
TGTTG 
SD128C 	AF127323 	GATCAACACT TAGAACATAT GGACACCAAT AAAATTAATA 
ACACTCATAA TTTATTATTA GAGGTGTCAC TTGCAGCGAA 
GCATGAAGGA CAATCAATAA CTGGTTATTA TCCAAAATAT 
GAAGTACAAT ATCCTGGTTC TAGTTTTACA ACGTCTACTA 
TGTTC 
SD128D 	AF127324 	CACAAAAATC TGGAAACTAT CAGTAATGAT GATAGThATG 
CTAAACATAA GTTGTTGGCA GAAGTGTCCA TGGCAGCAAA 
AGAGGAAGGG GACTTAATAA AAACACGTTA TACAATACAT 
CAAGCAACAT ATGCTGATTC TGCTGCTGAA TTATGTACTG 
TATTA 
SD128E 	AF127325 	GATCAAAATT TAGAACAAAT AAGGCCTGAA CAAATCACAA 
GTACTCATAA TTTATTGGTA GATGTGTGTA TGGCAGCACA 
ATTTGAAGGA AAATCAATTT CAGGTCGTTA TCGACAATAT 
IM 
Appendix: GenBank accession numbers and nucleotide 
sequences of Sudanese DBLI variants (continued) 
Variant 	Acc No 	NucleotideseguenceS 
SD128E(cont.) AF127325 CAAATAkAT ATGATGATTC TCCTTCTCAA ATATGTACTA 
TGTTA 
SD128G 	AF127326 	GATCACATT TGGAAAAAAT CAATGATTAT GAAPATATTA 
CAAATGATAC ATTATTGGTA GATGTGTGTA TTGGAGCAAA 
ATTTGAGCA GAGTCATTAA AACATATCG TGCACAATAT 
CAAGACAAAT ATCCTGGTTC TACTTTTACA ATGTGTACTA 
TGCTG 
SD128H 	AF127327 	GACAGAAACC TAGAACAGAT AGAGCCTATA AAAATAACAA 
ATACTCATAA TTTATTGGTA GATGTGTGTC AGGCAGCAAA 
ATTTGAAGGA CAATCAATAA CACAAGATTA TCCAAATAT 
CGAGCAACAT ATAATGATTC TCCTTCTAAA ATGTGTACTA 
TGTTA 
SD128J 	AF127328 	AGTCATAATT TGAAAACCAT AAACAATACA ACGTCGATGA 
CGAAGCATGA TTTATTGGCA GAAGTGTGTA TGGCAGCA1A 
ATATGAAGGG GAAACTTTAA CAAGTTATCA TCCACAATAT 
CAAGGAACTA ATCCTGATTC TCAATATGT ACCGTATTA 
SD128K 	AF27329 	CATCATAATT TGGAATCTAT AGACACAACG TCGATGACGC 
ATAAGTTGTT GTTAGAGGTG TGTATGGCAG CGAPATACGA 
AGGAAACTCA ATAGAAACAT ATTATACACC ATATCAACAC 
ATAATGAGG GTACTGCTTC CCAATTATGT ACTGTATTA 
SD128L 	AF127330 	GATCATCATT TATCATACAT CAATGCTGGT AAAACTAATA 
CGACAGATAA TTTATTGTTA CAGGTGTGTA TGGCAGCACA 
ATTTGAAGGA AAATCAATTT CAGGTCGTTA TCCACAATAT 
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Abstract 
The var genes of Plas.inodium falciparum encode a family of parasite erythrocyte surface antigens, the PfEMP- I 
proteins, which function as adhesion ligands for host endothelial and erythrocyte receptors. PfEMP-1 is extremely 
polymorphic although the extent of this variation in naturally transmitted parasite populations is unclear. We have 
identified 56 different sequences from the Duffy binding-like (DBL-l) domain of var genes amplified from six different 
P. falciparum clones isolated from patient infections in a Sudanese village in October-November 1989. These clones 
have been compared with 25 PfEMP-1 sequences expressed from different var gene loci by the 3D7A clone and 48 
PfEMP-1 sequences from different isolates in endemic areas such as Kenya, Brazil, Gambia, Vietnam and Vanuatu 
to analyse diversity in clonal, local and 'global' P. falciparum populations. Evidence that certain conserved sequences 
recur in clones from one Sudanese village and in isolates from all over the world suggests that var gene diversity is 
the result of recombinational reshuffling of a subset of conserved, presumably ancestral sequences. Recurrence of 
particular var sequence blocks thus leads to 'overlaps' in the PfEMP-1 sequence repertoire of different P.Jalciparum 
clones. © 1999 Elsevier Science B.V. All rights reserved. 
Keywords: Plasmodium falciparum; Antigenic variation; var gene recombination; Global diversity 
1. Introduction 
Abbreviations: CIDR, cysteine-rich interdomain region; 
DBL, Duffy antigen binding-like region. 
Note: Nucleotide sequence data reported in this paper are 
available in the EMBL, GenebankTM  and DDJB data bases 
under the accession numbers AF127272-AF127330 and 
AF152572-AFI 52582. 
* Corresponding author. 
Plasmodium falciparum parasites are genetically 
diverse [1-4] and patient infections are frequently 
mixtures of several haploid parasite clones [5,6]. 
Many immunogenic P. falciparum antigens are 
polymorphic and most parasite isolates have dif-
ferent combinations of variants of these antigens. 
0166-6851/99/ - see front matter © 1999 Elsevier Science B.V. All rights reserved. 
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This between-clone antigenic diversity in the para-
site population is generally considered to benefit 
the parasite in that it renders host immunity 
relatively clone-specific. 
The discovery of the var multi-gene family es-
tablished that P. flulciparum also has within-clone 
antigenic diversity generating mechanisms [7,8]. 
Each of several dozen genomic var genes encodes 
a PfEMP-1 which acts as an endothelial and 
erythrocytic adhesion molecule on the surface of 
parasite infected red blood cells. Although 
PIEMP-1 sequences are highly polymorphic, all 
var genes encode proteins containing 1-5 Duffy 
binding-like (DBL) domains with a cysteine rich 
interdornain region (CIDR) adjacent to the 
N-terminal DBL-1 domain. Switches in PfEMP-1 
expression occur within clones[9] and correlate 
with changes in the cytoadherent and antigenic 
properties of the infected red blood cell [10]. This 
allows clonal infections to evade immune re-
sponses against essential, but vulnerable, ery-
throcte membrane proteins by switching between 
antigenically distinct but functionally similar 
proteins. 
Two studies have shown a positive correlation 
between the capacity of individuals' serum to 
agglutinate a larger number of parasite isolates 
and protection from clinical malaria attacks 
[11,12]. The possible relationship between anti-
PfEMP-1 antibody responses and clinical protec-
tion has led to the prediction that immune 
selection will shape the genetic structure of P. 
falciparum populations in order to minimise over-
lap in var gene repertoires. This would generate a 
population 'strain structure' in which each 'strain' 
has a distinct, non-overlapping repertoire of 
PIEMP-1 variants [13]. We have analysed the first 
'Duffy binding-like' domain (DBL-1) of PfEMP-1 
genes in P. falciparuin clones isolated from 
malaria patients in a Sudanese village during the 
malaria transmission season of 1989. These were 
compared to the expressed var sequences of the 
3D7A clone and the existing databank of PfEMP-
1 sequences to analyse the var repertoires of 
'global' and 'local' populations of P. falciparum. 
Phylogenetic analysis has been used to determine 
the most statistically likely relationships between 
these sequences.  
2. Materials and methods 
2.1. Parasite clones 
The parasite clones SDI01, SDI02, SDI05, 
SDI06, SDI26 and SDI28 were made from six 
unrelated Sudanese patient samples isolated dur-
ing October and November 1989 [14]. Each of 
these parasites has a distinct phenotype, genotype 
and molecular karyotype [2,14,15]. The 3137A 
clone [16] derives from the Nijmegan NF54 isolate 
originally isolated from a young Dutch girl who 
spent one night on a boat several miles from 
Amsterdam Airport in July 1979. This isolate is 
thus of mysterious provenance although its sensi-
tivity to all anti-malarial drugs makes an African 
origin seem most likely. 
2.2. Preparation of parasite DNA and RNA 
Parasites were grown to a 5% parasitaernia in 
culture and parasite pellets obtained by saponin 
lysis. Parasite pellets were digested with 
proteinase K in the presence of 101 X) sodium dode-
cyl sulphate, and DNA isolated by phenol chloro-
form extraction and subsequent ethanol 
precipitation [17]. RNA was extracted using the 
Genosys RNA Isolator kit. 
2.3. PCR and RT PCR amplification  of var 
DBL I sequences 
PCR amplification of var DBLI sequences was 
obtained using the 5' oligonucleotides Forward I 
(CGAGGATCCGGWGCWTGYGCWCCWTW-
YMG) and Forward 2 (CGAGGATCCCCA-
TATAGACGATTACATSTATG) and the 3' 
oligonucleotides Reverse I (GCACTCGAGTT-
AWATRTCYGCAAAACTKCGTG), Reverse 2 
(GCACTCGAGTTANARRTAYTGWGGWAC-
RTARTC) and Reverse 3 (GCACTCGAGT-
TATTCTTYTYTTTGGTTATCTATCCA). For 
ward 2, Reverse 1 and Reverse 3 are based on 
primer sequences kindly provided by Dr Sue 
Kyes, Oxford University [18]. Forward 1 and 
Reverse 2 are based on published primer se-
quences [8]. Reverse transcription PCR used the 
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Boehringer Expand Kit and cDNA primer 
(CCWGGWACATAWATATCATTWATRTC) 
followed by PCR forward primer RTI (GCACG-
MAGTTTTGCRGAYATWGG) and PCR re-
verse primer RT2 (GTATARTCGTCGYC-
TCCTGGGTGGSAYAC). (Redundancies, M= 
A/C R=A/G; W=A/T;  S=C/G; Y = C/T; 
K=G/T;  V = A/C/T; 1-I = A/C/T; D = A/G/T; 
B = C/G/T; N = A/C/G/T). 
2.4. Cloning of var DBL I sequences into the 
vectors pCRII and pGEM 
PCR amplified var gene fragments were cloned 
into the plasmid vectors pCRII and pGEM using 
the Invitrogen TA cloning kit and the Promega 
pGEM-T Vector System I cloning kit respectively. 
E. co/i XL-1 blue was used as the host cell line for 
the recombinant plasmids. 
2.5. Sequencing of cloned var gene fragments 
The Qiagen Spin Plasmid kit was used to pre-
pare recombinant plasmid for use as the template 
in sequencing reactions. Sequencing was carried 
out using the ABI PRISM automated sequencing 
system with the ABI Dye Terminator sequencing 
kit.  
2.6. Analysis of var gene sequences 
For the purposes of this analysis the first Duffy 
Binding-like domain (DBL-l) is defined as the 
amino-terminal 400 amino acids of the var-1 type-
sequence [8]. The defining features of the domain 
are the l6-18 conserved cysteine residues (Fig. 1). 
The figure shows the positions of the forward and 
reverse primer sequences that have been used to 
amplify and sub-clone DBL-1 var sequences for 
this study and the sequence blocks used to analyse 
phylogenctic relationships. Sequences obtained 
were confirmed as var fragments by BLAST anal-
ysis. var sequences from parasite isolates from the 
Gambia, Brazil, Indochina, Kenya, Papua New 
Guinea, Vanuatu, Vietnam and from 3137A were 
obtained from the Genebank database. Deduced 
amino acid alignments of these Genebank se-
quences with the Sudanese and 3D7A DNA se-
quences were made using the GCG pileup and 
MacVector clustal functions. Alignments were 
created using program default parameters with 
gap weight of 3.0 and gap length weight of 0.1 
and edited by hand. Phylogenetic analysis of se-
quence alignments from two regions of DBL-I 
was carried out using the computer program 
PAUP 3.1.1 [19]. Further cladograms and align-
ments containing all of the Sudanese and'global' 
50 100 150 200 250 300 350 400 
Amino acids 
Fig. 1. A schematic model of DBL-l. The relative positions of the conserved cysteines 1-18 are indicated by asterisk. The anealing 
sites of primers Fl, F2, RI, R2, R3 and RTI are shown, the RTPCR reverse primer RT2 anneals to a region 3 of DBL-1 and is 
not shown. The hatched area corresponds to the region of sequence aligned in Fig. 2 and used to generate the phlyogenetic model 
presented in Fig. 4. The black area corresponds to the highly conserved LARSFADIGDI motif and is the binding site of RI and 
RT 1. 
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Table I 
List of Sudanese var gene sequences amplified by different primer combinations 
Primer 	Length of fragment 
combination"' 	(No. amino acids) 
Variants' 
Fl/RI 	 -70 SD102A, SDI02B, SDI02C, SDI02D, SDI02E, SDI02F, SDI02172, SDI02G, 
SDI02I-I, SD102J, SDI05G, SDI05L2, SDI05N, SDI05P, SDI26E, SDI26F, 
SDI26G, SDI26H, SDI26J, SDI26K, SDI26N, SDI28J 
FI/R2 	 -.200 SDI05A, SDI0513, SDI05D, SDI05E, SDI05F, SDI05K 
Fl/R3 -280 SDI05C, SDI05J, SDI05L, SDI05M, SD126M 
F2/R1 	 -70 SDI05T, SDI06B, SD106D, SDI06E, SDI06F, SDI06G, SD126D, SDI28A, 
SDI28C, SDI28D, SDI28E, SDI28G, SDI28H, SDI28K, SDI28L 
F2/R2 	 -.200 SDIOIA, SD10I13 
F2/R3 -280 SD105Q, SDI05R, SD105S, SDI05U, SD106A, SDI06C, SDI26A, SDI26B, 
SDI26C 
Primer anealing sites are indicated in Fig. I. 
The sequences obtained by each primer combination are in Fig. 2. Only those sequences amplified by the primer combinations 
F1/R2, FI/R3, F2/R2 and F2/R3 are aligned in Fig. 3. 
The name of each variant indicates the parasite clone from which it originated e.g. the variant SDI 02A was isolated from the 
parasite clone SD 102. 
sequences analysed can be obtained from the 
authors. 
3. Results 
3.1. var gene sequences from clones isolated in a 
Sudanese village in October and November 1989 
DNA isolated from parasite clones SD1O1, 
SD102, SDI05, SD106, SD126 and SD128 was 
used to amplify the DBL-1 domains of their var 
genes. All of the sequences analysed encode at 
least the 50-60 amino acids between the F2 and 
RI primer sequences (Fig. 1). Excluding the 
primer sequences, an alignment over this region of 
55 different sequences from the Sudanese clones is 
presented in Fig. 2. Each sequence was isolated 
from a subclone library at least twice. Different 
subsets of var genes were obtained from each 
parasite clone when different primer pairs were 
employed. Frequently, var types amplified using 
either Fl or F2 with either R2 or R3 were also 
isolated when using these forward primers and Ri 
(RI encodes part of the LARSFADIGI motif 
found in all PfEMP-1 sequences). Table 1 lists the 
var types obtained using each primer combination 
and the length of fragment amplified. In three  
cases, identical sequences were identified from 
different parasite clones from different patients 
(SDIO1A (F2/R2) and SDI02C (Fl/Rl) SDI02E 
(Fl/Rl) and SDI26F (Fl/Rl); and SD126B (Fl/ 
RI) and 5D128H (Fl/Rl)). 
Fig. 3 shows alignments of 22 sequences gener-
ated using the R2 and R3 reverse primers. Figs. 2 
and 3 together show Pileups aligned around 13 
conserved cysteine residues (positions 6- 18 in 
Fig. I). Cysteine 6 is missing in 7/58 of these var 
variants (SD105A, SD106D, SDI06E, SD126C, 
SD126D, 5D126M, SD126N and SDI28C). 
SD126D is missing cysteine 6 but has a cysteine at 
an unusual position (position 15, Fig. 2). Cysteine 
7 is not found in 1/58 sequences (SD106E) and 
cysteine 9 and 11 are absent from SD 105L and 
SDI05D respectively. SD1O1A has an 'extra' cys-
teine adjacent to cysteine 8 (position 102 in Fig. 
3). Cysteines 8, 10 and 12-18 are conserved in all 
Sudanese var genes examined. The large aromatic 
amino acids phenlylalanine, tryptophan, and ty-
rosine are highly conserved in the P. falciparum 
PfEMP-1 DBL-1 domain, a feature also observed 
in the Duffy-binding antigens of P. knowlesi and 
P. vivax [20]. 
The region from cysteine 7-18 (Fig. 3) contains 
between 182 and 204 amino acids. In three pairs 
of these sequences this sub-domain contains iden- 
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tical numbers of amino acids. Several almost iden- 	cysteine 15. SDI05L and SD105L2 are practically 
tical large sequence blocks occur in more than one identical (53/55) residues over the region covered 
PfEMP-1 protein in this region. SDI05Q and 	by the F2 and RI primers and similarly SDI02F 
SDI05S are identical at nucleotide level over a and SDI02F2 share 52/54 residues in the same 
region encoding 155 amino acids but diverge after 	region. 
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Fig. 3. Alignment of 22 Sudanese DBL-I sequences from four parasite clones over the region between R  and R2 (see Fig. 1). The 
first two residues of this alignment overlap with Fig. 2. Conserved residues are boxed and shaded dark grey; conservatively 
substituted residues are boxed and shaded light grey. Consensus residues are shown below the alignment.. The conserved cysteines 
at positions 1, 101, 118, 132, 134, 176, 190, 202, 209, 225, 228 and 232 correspond to cysteines 7-18, respectively. The aromatic 
residues phenylalanine, tyrosine and tryptophan are highly conserved at positions 8, 21, 45, 69, 80, 81, 87, 88, 96, 112, 113, 157, 158, 
160, 164, 167, 168, 171, 176, 201, 207 and 235. The sequences SDI 05Q and SD105S are identical until position 209 after which they 
diverge. 
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3.2. DBL-1 domain variation between different var 
gene loci in the 3D 7A clone 
To analyse PfEMP-1 variation in a single 
clone, reverse transcription of clone 3137A 
mRNA followed by PCR amplification and sub-
cloning was used to obtain expressed PfEMP-1 
sequences from a laboratory isolate, 3D7A, cur-
rently being sequenced by the P. Jàiciparuni 
Genome Project [21]. The sequence of 3137A 
Chromosome 2 has recently been reported [22] 
and it contains two sub-telomerically located full-
length var genes in addition to five small ORFs 
with sequences resembling the var exon 11-related 
Pf60.1 genes which lack DBL-1 domains [23]. 
Asynchronous in vitro cultures of this clone ex-
press numerous different var genes. To date 25 
different expressed PfEMP-1 eDNA sequences 
have been identified. Alignments have been made 
of these 25 sequences with 20 DBL-1 sequences 
from Genebank and the 22 Sudanese sequences 
over the region corresponding to positions 14-
102 in Fig. 3 (data not shown). The patterns of 
variation in these sequences are essentially identi-
cal to that found in the Sudanese sequences 
analysed above and in an earlier comparative 
analysis of a smaller number of sequences [18]. 
Several large sequence blocks are shared with 
other sequences in the global data bank. The 
sequence 3137-93 is identical to the Sudanese se-
quence SD105J. 3137-16 and SDI05M have a 
single synonymous substitution. Other 3D7A se-
quences are very similar to some Sudanese se-
quences. For example, 3137-111 and SDL05L 
(73/74 identical amino acids); 3D7-11 and 
SDI05R (69/71); 3137-3 and SDI05F (54/63, with 
the 9 differences occurring in consecutive 
residues); and 3137-44 with SD105E (66/78, all 
differences within a 32 residue block). 
3.3. Phylogenetic analysis 
Phylogenetic analysis was performed to investi-
gate the relationship between the 56 Sudanese 
sequences and their relationship to 47 'global' 
DBL-1 sequences. Trees were generated using the 
same region of the molecule as was used to align 
the Sudanese sequences presented in Fig. 2. Nei- 
ther the Sudanese nor any other set of sequences 
form an isolated sub-group of distinct DBL-1 
domains. A total of 34 of the Sudanese sequences 
and 17 'global' sequences formed clusters statisti-
cally supported by the bootstrap re-sampling 
method (100 re-samples). A cladogram illustrat-
ing the relationships between these sequences is 
presented in Fig. 4. 
Sudanese sequences cluster with sequences 
from Vietnam (bootstrap values of 70-96%); 
Brazil (bootstrap values of 96-981/o); Gambia 
(bootstrap values of 74-89%); Kenya (bootstrap 
value of 70%) and 3137A (bootstrap values of 
83-100%). Three Sudanese sequences are identi-
cal to 3D7A sequences in this region (SD 1USD 
and 3137A-4; SDI05Q/SDI05S and 3D7A-2: 
SDI05R and 3137A-1). SDI06D is identical to 
the Brazil-I sequence. SD106A shares 53/54 
amino acid residues with the Kenya-i sequence 
and SDI06G shares 51/57 amino acid residues 
with the Vietnarn-4 sequence. 
Certain sequences from different Sudanese par-
asite clones appear closely related and cluster 
together. Cluster I (bootstrap support of 96%) 
contains five different sequences from 5/6 of the 
Sudanese clones analysed (SD 101 A/SD I 02C, 
SD105N, SDI06G, SDI26G and SD126J) and 
the Vietnam-4 sequence. These sequences share 
around 80% of residues over this 	60 amino 
acid sub-region. Cluster II (bootstrap support of 
86%) contains the closely related sequences 
SD105D, SDI0613, Gambia-I and 3D7A-4. 
A further phylogenetic analysis was performed 
on the region corrsponding to positions 14-102 
in Fig. 3 (data not shown). Included in this anal-
ysis were 25 expressed 3137A sequences, 22 Su-
danese sequences and 20 'global' database 
sequences. Sudanese and 3137A sequences 
grouped together in six clusters in this analysis 
(bootstrap values of 83-100°A). Two of the ex-
pressed 3137A sequences grouped with a Brazil-
ian sequence (66% bootstrap support). Around 
half of all the sequences used in these compari-
sons (22 Sudanese and 29 'global' sequences) did 
not resolve into any statistically supported cluster 
because they are no more closely related to any 
one sequence than they are to any other in the 
data set. 
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Fig. 4. A phylogenetic model of the relationship between 34 
Sudanese and 17 Genebank sequences from diverse geographi-
cal locations. The model was generated by performing a 
Maximum Parsimony analysis using the PAUP program on a 
sequence alignment of the same region of DBL-1 as presented 
in Fig. 2. The alignment was made using the GCG and 
MacVector programmes and edited manually. Statistical sup-
port is provided by the booststrap resampling method (100 
resamplings). Bootstrap values are shown above branch lines. 
Branches with a bootstrap value of less than 501/o are col-
lapsed. The non-Sudanese sequences have the following acces-
sion numbers 3D7A-1 (z94746); 3D7A-2 (z94751); 3137A-3 
(z94750); 3D7A-4 (z94749); Vietnam-1 (z94744); Vietnam-2 
(z94737); Vietnam-3 (z94745); Vietnam-4 (z94741); Kenya-1 
(z94730); Gambia-i (u67960); Gambia-2 (a1003473); Gambia-3 
(u67959); Brazil-1 (142245); Brazil-2 (y13408); Brazil-3 
(yl3402); Brazil-4 (142247); and Brazil-5 (01083). 22 Sudanese 
sequences and 31 sequences from the 'global' databases did 
not form statistically significant clusters with any of the other 
sequences analysed and are not included in this cladogram. 
4. Discussion 
The original sequence comparisons of PfEMP-1 
variants showed that each protein had one to four 
domains with a sequence motif which had been 
noted in the Duffy positive erythrocyte binding 
domains of a merozoite surface protein of P. 
vivax and P. knowlesi [20]. This Duffy binding-
like (DBL) motif has also been found in a P. 
Jàlciparum erythrocyte-binding antigen (EBA 175) 
that binds erythrocyte surface sialic acid [24]. 
Even in the most conserved region of PfEMP-1, 
the DBL-1 domain, no more than 15-20% of 
amino acids are conserved in all variants and 
many thousands of different DBL-1 sequences 
must circulate in the parasite population's oar 
genes. This study has analysed variation in this 
domain in sequences expressed by a single labora-
tory clone, in a set of clones derived from patients 
during the autumn 1989 malaria season in a Su-
danese village and in the database of P. .Ialci-
parum sequences. 
Comparisons between these sequences show 
that there is marked conservation of the positions 
of certain residues in the DBL-1 domain. In par-
ticular, the positions of eight to nine pairs of 
cysteine residues are essentially invariant. The ma-
jority of DBL-1 sequences contain nine cysteine 
pairs although some variants lack one or two of 
these residues, or contain an additional cysteine. 
Positions of bulky aromatic residues such as tryp-
tophan, tyrosine and phenylalanine are also con-
served (as previously noted in related Plasmodium 
adhesion receptors [20,25]). The length of the 
hyper-variable regions between conserved motifs 
shows very little variation between different se-
quences. Large numbers of DBL-1 sequences 
share short (10-20 amino acid) regions of se-
quence including the one universally conserved 
sequence, the 11 amino acid LARSFADIGDI 
motif. Longer (20-80 amino acid) regions of ho-
mology can be identified in parasite clones iso-
lated from patients in a Sudanese village, in 
isolates taken from infections in other areas of the 
globe and in the laboratory clone 3137A. 
These observations support a hypothesis that 
the structural framework of the DBL-1 domain in 
most, if not all, of these molecules is highly con- 
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served. Variants with unusual numbers of cys-
teines however, may form a subset with altered 
antigenic and adhesive properties. Possible selec-
tive constraints may be the requirement for bind-
ing to relatively invariant host receptors during 
erythrocyte invasion [20,24], or adhesion to unin-
fected red blood cells in the rosetting reaction 
[26,27]. Some mutations may be selected because 
they give rise to antigenic differences between 
functionally similar molecules. Structural diversity 
in PfEMP-1 DBL-1 domains seems less like that 
observed in the non-adherent variable try-
panosome surface antigens and more analogous 
to the situation found in adhesion receptor-bind-
ing viruses such as Foot and Mouth Disease Virus 
(FMDV). In FMDV virions three diverse capsid 
proteins mask an essential RGD adhesin motif in 
the first virion protein which is essential for recep-
tor binding and host cell invasion [28]. The 
LARSFADIGDI motif could have an analogous 
role in PfEMP-1 function. 
Long stretches of amino acid identity occur 
between DBL-1 domains in the PfEMP-1 
molecules of parasites from different locations 
and universally conserved motifs exist. Thus al-
though the var genes potentially encode a vast 
amount of antigenic diversity, PfEMP-1 proteins 
appear to be composites of a set of more con-
strained sequences, presumably evolved from a 
common ancestral protein. Previous reports have 
differed on the extent to which the human aggluti-
nating antibody responses to infected erythrocytes 
(considered to be mainly directed against PfEMP-
1) are isolate specific [29,30]. In a recent study of 
agglutinating antibody specificity, isolates from 
infections in a Sudanese village were genetically 
characterised and their capacity to be recognised 
by sera samples from individuals from the same 
village was analysed [31]. Each of the isolates 
induced agglutinating antibodies capable of recog-
nising at least some of the serotypes expressed by 
the other parasite isolates. Our data on PfEMP-1 
diversity demonstrates that different parasite iso-
lates can encode stretches of similar or identical 
PfEMP-1 sequence. It can therefore explain 
observations that agglutinating antibodies some-
times cross-react with geographically diverse iso-
lates. 
Generation of diversity by recombination has 
been suggested as the reason for the sub-telomeric 
chromosomal location of many var genes and 
their association with repetitive sequences [32]. 
Frequent recombination has been demonstrated 
in laboratory crosses of the parasite [16,33], and 
high rates of recombination have been observed in 
natural populations of P. Jalciparum [34]. A P. 
falciparum population model has proposed that 
individual PfEMP-1 variants can confer enhanced 
and long lasting immunity relative to sporozoite 
and merozoite antigens and will thus structure the 
parasite population into distinct and rarely re-
combining strains that have little overlap between 
their PfEMP-1 repertoires [13]. The phylogenetic 
analysis presented here, places var sequences from 
genetically different co-circulating parasite clones 
in clusters with a high bootstrap support. It also 
places some var genes from parasite isolates of 
diverse origin in well-supported clusters. Finally, 
it illustrates that many DBL-1 sequences are not 
more closely related to any particular sequence 
than they are to any other. Recombination be-
tween rapidly evolving sequences is the most plau-
sible mechanism to explain these patterns of 
DBL-1 diversity. The phylogenetic analysis sup-
ports neither a 'distinct strains' model for P. 
ft1ciparum, nor distinctly segregating repertoires 
of var genes. Rather, it adds to the accumulated 
evidence for frequent recombination in randomly 
mating populations of P. falciparurn. [35,36]. Ex-
tra-cellular portions of PfEMP-1 other than DBL-
I are known to be immunogenic [37] and it 
remains possible to hypothesise that such epitopes 
could be sufficiently immuno-dominant to 'strain-
structure' the parasite population. However these 
regions of the protein are even more polymorphic 
than the DBL-1 domain, and it is unlikely that 
they are exempt from the exchanges that appear 
to be shuffling and reshuffling DBL-l. 
DBL-1 is only one of several distinct domains 
of the complex PfEMP-1 molecule and the other 
part of the conserved 'head structure', the CIDR 
domain, can bind CD36 without help from any 
other PfEMP-1 sequences [37,38]. Binding to 
thrombospondin, to CD36 and the rosetting of 
uninfected erythrocytes are the most common ad-
hesive phenotypes of parasitised erythrocytes [39— 
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41]. Parasitised cells are known to express the 
cytoadherance phenotype prior to rosetting and 
immunoglobulin binding [42]. Whether CIDR-
mediated endothelial adhesion precedes DBL-1-
mediated red blood cell capture within capillary 
beds or whether sequestrin [39], other regions of 
PfEMP-1, or other variable parasite encoded 
erythrocyte membrane proteins [43,44] are in-
volved in these processes is not known. 
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